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Cartilage regeneration is one of the most widely studied areas in tissue-
engineering.  Despite significant progress, most efforts to date have only focused on 
generating homogenous tissues whose bulk properties are similar to articular cartilage. 
However, anatomically and functionally, articular cartilage consists of four spatially 
distinct regions: the superficial, transitional, deep, and calcified zones. Each zone is 
characterized by unique extra-cellular matrix (ECM) compositions, mechanical 
properties, and cellular organization. The ECM is primarily composed of type II 
collagen and glycosaminoglycans (GAGs), whose relative concentrations vary between 
zones and therefore lead to distinctive mechanical properties.  
One of the major unsolved challenges in engineering cartilage has been the 
inability to regenerate tissue that mimics the zonal architecture of articular cartilage. 
Recent studies have attempted to imitate this spatial organization using zone-specific 
chondrocytes isolated from donor animal cartilage. Directed differentiation of a single 




This dissertation reports that hydrogels, incorporating both synthetic and natural 
polymers as well as cell-induced degradability, are suitable for generating zone-specific 
chondrogenic phenotypes from a single MSC population.  Specifically, cues provided 
from the unique combinations of chondroitin sulfate (CS), hyaluronic acid (HA), and 
MMP-sensitive peptide (MMP-pep) within a PEG-based hydrogel, direct the 
chondrogenic differentiation of MSCs.  The findings of this dissertation demonstrate the 
capability of creating native-like and mechanically relevant articular cartilage consisting 
of zone specific layers. This ability provides a new direction in cartilage tissue 
engineering and could be invaluable for cartilage repair if incorporated with current 
minimally invasive surgical techniques.  
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Introduction:  Specific Aims, Overview and Significance 
 
1.1 INTRODUCTION 
Tissue engineering research for cartilage regeneration has emerged as a 
promising approach to address the needs caused by articular cartilage damage.  
Regeneration of cartilage is one of the most critical challenges in arthritis, joint 
disorders, and trauma.  Numerous studies have demonstrated the feasibility of producing 
cartilage-like tissue from chondrocytes, bone marrow stromal cells (BMSCs), or 
adipose-derived stem cells (ADSCs) [1-3]. Despite significant progress through decades 
of research in cartilage tissue engineering, some major gaps remain in our ability to 
regenerate cartilage, especially articular cartilage.   
One of the primary unsolved challenges in cartilage regeneration is the inability 
to create tissue substitutes that mimic the highly organized zonal architecture of articular 
cartilage, consisting of the superficial, transitional, and deep zones, as well as the 
calcified zone at the osteochondral junction.  The classical cartilage tissue engineering 
approaches do not try to mimic the structural organization or the zonal properties of 
articular cartilage, which is why these approaches have failed to achieve widespread 
clinical effectiveness.  Recently, Hutmacher and colleagues reviewed the need to create 
cartilage tissue that mimics the articular cartilage’s zonal architecture and identified the 
inability to mimic the complex structure of articular cartilage as a major limitation in the 
field of cartilage tissue engineering [4].  Very few studies have attempted to address the 
challenge of reproducing the zonal architecture of articular cartilage. Elisseeff and 
colleagues reported isolation of chondrocytes from various zones of bovine articular 
cartilage, culturing the chondrocytes in vitro in poly(ethylene glycol) (PEG)-based 
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hydrogels and attempted to create bi-layer hydrogels constructs to produce cartilage-like 
tissue comprised of two different zones [5]. Ng et al. created similar zonal structures by 
encapsulating zonal chondrocytes in agarose gels [6].  Additionally, Woodfield et al. 
was able to demonstrate that pre-designed 3D porous scaffolds can influence cellular 
distribution and zonal extracellular matrix (ECM) production of bovine chondrocytes 
[7].  All of the previous work mentioned thus far has been done using chondrocytes 
isolated from each zone of articular cartilage.  No studies have reported generating zone 
specific chondrocytes and zonally organized cartilage-like tissue starting from MSCs. 
Directing a single stem cell population into different zonal phenotypes within a single 
3D structure presents a major challenge and a new paradigm in cartilage research. The 
ability to direct different zonal phenotypic expressions would provide a better alternative 
for cartilage replacement techniques and eliminate the need for donor tissue. 
Biomaterial-based scaffolds, especially hydrogels, have been shown to provide 
an inductive environment for the chondrogenic differentiation of progenitor cells [8, 9].  
Hydrogels are three-dimensional networks of hydrophilic polymers that swell when 
exposed to water.  The hydrogel scaffold serves as a temporary replacement matrix for 
the damaged tissue until the encapsulated cells have established their own ECM.  
Hydrogel scaffolds can be made of either natural or synthetic materials for cartilage 
tissue engineering.  Natural materials have the desirable biological properties but are 
limited by their mechanical strength [10, 11].  Synthetic polymers are beneficial because 
they can be tailored with the desired controllable physical and chemical characteristics 
[12].  Many investigators have incorporated natural cartilage ECM components, such as 
chondroitin sulfate (CS) and hyaluronic acid (HA), into their scaffold designs to aid in 
mimicking the physiological environment of native cartilage.  Varghese et al. fabricated 
a “biogel” derived from CS with encapsulated chondrocytes that remained viable, 
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demonstrating the potential of these biogels for cartilage tissue engineering [13].  
Additionally, Hwang et al. found that CS-based hydrogels exhibited the strongest 
chondrogenic response in terms of gene expression and matrix accumulation when 
compared to collagen or HA hydrogels [14].  Leach et al. showed that HA hydrogels 
have good biocompatibility and minimal inflammatory response, demonstrating the 
potential of HA hydrogels for wound-healing applications [15].  Nettles et al. showed 
that methacrylated HA crosslinked into a hydrogel promoted the retention of the 
chondrogenic phenotype and cartilage matrix synthesis for encapsulated chondrocytes in 
vitro [16].   
Natural polymers lack mechanical stability which can result in difficult handling 
and poor tissue integration.  To address these limitations, researchers have taken 
advantage of synthetic materials that allow for the ability to fine tune physical properties 
to match native tissue.  There are many synthetic polymers that that can be potentially 
used for hydrogel synthesis. For instance, poly(propylene fumarate) and polyanhydrides 
can be used to fabricate injectable polymers while polyurethanes are used in  the 
formulation of degradable polymers in order to take advantage of polyurethanes’ 
mechanical properties [17].  However, among the extensive array of synthetic polymers 
that are available for tissue engineering applications, PEG is by far the most widely used 
[8, 9, 18-23].  PEG is hydrophilic and biocompatible with properties that limit 
immunogenicity and antigenicity, and characteristics which elicit minimal protein and 
cell adhesion [8, 24].  These properties make PEG an attractive polymer for scaffold 
development in cell-based tissue engineering applications [18, 19, 25-30].   PEG is not 
naturally degradable but can be made degradable by adding degradable linkages.  
Sawhney et al. demonstrated that PEG can be made hydrolytically degradable by 
integrating polylactide (PLA) and  polyglycolic acid (PGA) units with PEG monomers 
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[31].  However, hydrolytic degradation of PLA/PGA hydrogels occurs spontaneously 
and creates an acidic environment. Since hydrogel scaffolds shelter encapsulated cells, 
hydrolytic degradation may not be conducive for tissue formation, especially if it results 
in an acidic environment.  Thus, degradability via cell-secreted enzymes is a better 
alternative because cell directed degradation can help promote tissue remodeling without 
creating an acidic environment.  Matrix metalloproteinases (MMPs) are proteolytic 
enzymes that are secreted by cells during cartilage ECM remodeling. Several 
investigators have taken advantage of the key concept of cell directed degradation to 
create hydrogel scaffolds that are enzymatically degradable by incorporating MMP 
sensitive peptides (MMP-pep) into their scaffold design [32-34]. Hubbell et al. 
developed PEG hydrogels that are sensitive to proteolytic degradation by crosslinking 
MMP-cleavable peptide sequences into the hydrogel network [34].  Another advantage 
of designing a material with proteolytic sensitivity is that migrating cells can 
systematically degrade the synthetic polymer and eventually anchor onto the exposed 
ECM. 
In all the previous studies mentioned above, only one component—either CS, 
HA, or an MMP-sensitive peptide—was incorporated into a single hydrogel network 
[13, 15, 35].  Each of these components has its advantages as well as limitations, their 
advantages may be exploited and their limitations can be eliminated if they were 
combined together into a single hydrogel network.  No prior work explores the effects of 
combining these components together within a polymer network.  In contrast, the 
research conducted in this dissertation explored the combination of both natural and 
synthetic biomaterials to develop a novel hydrogel-based system with both the 
biological components and the ability to tailor the physical properties of the engineered 
tissue.   
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The primary hypothesis of this dissertation is that the biomaterials play an 
important role in the chondrogenic differentiation of MSCs, especially in determining 
the phenotype of the resulting cartilage-like tissue. Specifically, different combinations 
of synthetic (e.g. PEG) and natural biopolymers (e.g. ECM components) as well as cell-
induced matrix degradability, would provide unique cues for the directed differentiation 
of MSCs into zone-specific articular chondrocytes. The goal of this research project is to 
(a) identify unique hydrogel compositions that can generate the superficial, transitional, 
deep or calcified zones of articular cartilage from MSCs and (b) create multi-layered 
scaffold structures that incorporate these biomaterial compositions such that a single 
stem cell population gives rise to zonally organized articular cartilage.  
 
1.2 SPECIFIC AIMS 
In order to address the challenge of creating zonally organized articular cartilage 
tissue substitutes, the three specific aims for this research project are as follows: 
 
1.2.1 Specific Aim 1: To develop and fully characterize degradable PEG-based 
hydrogel scaffolds for differentiating MSCs into chondrocytes by (a) crosslinking a 
Matrix Metalloprotease (MMP)-sensitive peptide within PEG scaffolds and (b) 
integrating different natural matrix materials. 
The hypothesis of this aim is that the integration of a degradable peptide into the 
polymer network will allow degradation of the scaffold by cell-specific secreted 
enzymes that can be tailored to match the rate of tissue formation. The incorporation of 
natural ECM components such as chondroitin sulfate (CS) and hyaluronic acid (HA) 
within the scaffold will mimic the natural physiological environment in which MSCs 
can differentiate into cartilage tissue.  The purpose of this aim was to evaluate the effects 
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of incorporating MMP-sensitive peptide (MMP-pep), chondroitin sulfate (CS), and 
hyaluronic acid, (HA), or their combination into a PEG-based hydrogel on the scaffold 
physical properties. 
 
1.2.2 Specific Aim 2: To examine the potential of biomaterial composition in 
directing mesenchymal stem cells (MSCs) to differentiate into specific 
chondrogenic phenotypes by utilizing scaffolds consisting of various combinations 
of a Matrix Metalloprotease (MMP)-sensitive peptide and different ECM 
biopolymers (HA, CS) within PEG-based hydrogels. 
The hypothesis of this aim is that biomaterial composition provides the 
appropriate environmental cues that aid in the chondrogenic differentiation of MSCs 
into specific chondrogenic phenotypes.  The effect of various matrix combinations on 
chondrogenic differentiation of MSCs was evaluated in order to identify the unique 
biomaterial compositions that can direct zonal cartilage formation.  
 
1.2.2  Specific Aim 3: To fabricate a multi-layered scaffold with the biomaterial 
compositions determined in Aim 2 and examine the scaffold’s ability to induce the 
simultaneous differentiation of MSCs into structurally organized articular 
cartilage.  
This aim combined the results of the first two aims to create a multi-layered 
composite scaffold (representing each zone) that would be able to differentiate MSCs 
into articular cartilage with zonal architecture and mechanical properties.  Using the 
material composition determined in Aim 2, a multi-layered hydrogel construct was 
created. The hydrogel’s ability to simultaneous differentiate MSCs into zonally 
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organized articular cartilage was evaluated by measuring gene expression, matrix 
accumulation, and mechanical strength of each layer. 
 
1.3 OVERVIEW 
Chapter Two provides the background information for this research project. 
Chapter Two also highlights the most recent advances in cartilage tissue engineering and 
how biomaterials affect stem cell growth and behavior.  Chapter Three discusses the 
synthesis and modification of each biomaterial component as well as the hydrogel 
fabrication and characterization.  Chapter Four explains how the biomaterials 
characterized in Chapter Three were used to develop single layer hydrogels for the 
chondrogenic differentiation of MSCs. In Chapter Five, the findings of Chapter Four are 
incorporated to create a multi-layered hydrogel construct for differentiating MSCs into 
zonally organized chondrocytes. In both Chapters Four and Five, analyses of 
extracellular matrix production through immunohistochemistry and gene expression of 
collagens show successful differentiation of this progenitor cell population into 
chondrocytes.  Finally, Chapter Six outlines the conclusions of each chapter, the current 
animal models available for future work, and possible clinical applications of the 
findings this research project.  
 
1.4 SIGNIFICANCE OF THE PROPOSED RESEARCH STUDY 
The preliminary goal for cartilage tissue engineering thus far has been to create a 
homogeneous tissue type by encapsulating chondrogenic cells uniformly within a 
polymer matrix to mimic the overall properties of articular cartilage. However, it is well 
known that articular cartilage consists of four distinctive zones, all of which differ in 
morphology and biosynthetic activity [5].  A major challenge in tissue engineering is the 
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ability to create tissue constructs that mimic the physiological structure and function of 
native tissue.   This dissertation discusses a novel approach that utilizes a multi-layered 
hydrogel to induce the simultaneous differentiation of MSCs into zone-specific 
chondrocytes.  The findings of this dissertation demonstrate the feasibility of tissue 
engineering structurally organized and functional articular cartilage.  The ability to 
create native-like and mechanically relevant articular cartilage provides an innovative 
direction in the field of tissue engineering, towards the development of more functional 
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 The main goal of cartilage tissue engineering is to create functional tissue 
replacements to treat cartilage injuries or osteoarthritis.  To address this goal, many 
researchers have sought to combine cells, biomaterial scaffolds, and bioactive signals [1, 
2] for the purpose of repairing articular cartilage defects.  The research conducted in this 
dissertation has the same aspirations to create an articular cartilage substitute that can 
effectively restore joint function.  Before diving into the research aspect, it is important 
to have a fundamental understanding of the articular cartilage anatomy, cartilage’s 
functions and in vivo repair mechanisms, as well as currently available techniques for 
cartilage repair.  Furthermore, this chapter provides a literature review of cartilage tissue 
engineering, the available cell sources, the important mitogenic factors, and biomaterials 
used for chondrogenic differentiation. 
 
2.1 ARTICULAR CARTILAGE ANATOMY 
Articular cartilage, also known as hyaline cartilage, is a smooth and firm mass 
that is extremely elastic and covers the ends of the bones in order to help the joints glide 
smoothly during movement [3].   The thickness of human articular cartilage ranges from 
2 to 4 mm, but reaches up to 5 mm within the knee joint [4].  Although articular 
cartilage is an aneural, avascular, and alymphatic tissue, its structure is still quite 
complex.  Since cartilage is an avascular tissue, the cell density is extremely low with 
chondrocytes only making up about 1 - 5% of the tissue volume. The collagen fibers and 
proteoglycans make up the other 20% of cartilage’s wet weight [4, 5]. Chondrocytes are 
highly specialized cartilage cells that synthesize all of the extracellular matrix (ECM) 
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components and , secrete the components growth factors into the ECM, and regulate the 
matrix metabolism [5].   
The principle component of articular cartilage ECM, the structure illustrated in 
Figure 2.1 [6], is type II collagen which makes up 90-95% of the total collagen content 
in cartilage and is responsible for cartilage’s tensile strength.  Collagens V, VI, IX, X, 
and XI make up the other 5-10% of the collagen content.  All collagen types are made 
up of three polypeptide chains or "-chains, arranged in a left-handed triple helix and are 
twisted together into a right-handed super coil. The primary amino acids of the 
polypeptide chains are glycine and proline, with hydroxyproline and hydroxylysine both 
providing structure stability through hydrogen bonds and covalent crosslinks 
respectively [7, 8].   
Proteoglycans (PGs) are protein polysaccharide molecules that maintain the fluid 
and electrolyte balance of the cartilage tissue.  The two subunits of proteoglycans, 
known as glycosaminoglycans (GAGs), are bound to a protein core by sugar bonds to 
form aggrecan molecules [5, 9, 10]. GAGs are unbranched chains of repeating 
disaccharide units, with three different types found in articular cartilage including 
chondroitin(4- or 6-) sulfate (CS), keratin sulfate, (KS), and dermatan sulfate (DS) [7, 
8].  The negatively charged sulfate and carboxylate groups on these macromolecules 
regulate the flow of water, which is important for resisting mechanical stress as well as 
for nutrient diffusion through the synovial fluid [4, 5].  For additional structural support 
these proteoglycan aggrecan molecules form even larger aggregates by binding to 
hyaluronan via a link protein.  Hyaluronan or hyaluronic acid (HA) is a non-sulfated 
GAG that does not bind to a protein core. Instead, HA acts as a binding site for the 
proteoglycans consisting of the sulfated GAGs such as chondroitin sulfate (CS) and 
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keratin sulfate (KS) [7, 8].  Figure 2.2 illustrates the structural organization of the 
proteoglycan aggregates [8]. 
In addition to chondrocytes, collagen fibers, and proteoglycans, articular 
cartilage primarily consists of water, which accounts for 65-80% of cartilage’s wet 
weight.  Water is an important component of the articular cartilage anatomy because 
water aids in the transport of nutrients to chondrocytes and interacts with proteoglycans 
to provide articular cartilage with tremendous compressive strength [7, 8].   
Articular cartilage is composed of four distinctive zones that include the 
superficial, the transitional, the deep, and the calcified cartilage zone as illustrated in 
Figure  2.3 [6].  Each zone is characterized by a different collagen II orientation as well 
as different amounts of proteoglycans. The changes in proteoglycan concentration  
correlate to the changes in mechanical properties of each cartilage zone [11]. The 
superficial zone is the topmost layer, lying parallel to the joint surface and is covered by 
a thin film of synovial fluid, called proteoglycan 4 (PRG4) or lubricin. Lubricin provides 
the smooth gliding surface for articular cartilage [12].  The superficial layer also 
contains thin collagen fibrils and elongated chondrocytes, both arranged parallel to the 
articular surface.  The proteoglycan content is the lowest while the cellular density is the 
highest in the superficial zone when compared to the other three articular cartilage zones 
[5, 6, 13].  The transitional, or middle zone, contains randomly oriented collagen fibers 
that have larger diameters than the collagen fibers of the superficial zone. The cell 
density and collagen II content decreases while the proteoglycan concentration 
increases, as compared to the superficial zone.  Additionally, the chondrocytes have a 
more rounded appearance within the transitional zone.  The deep zone contains the 
highest concentration of proteoglycans with the lowest water content [5, 6, 13]. The 
collagen fibers in the deep zone have the largest diameter, out of the four articular 
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cartilage zones, and are arranged perpendicular to the joint surface. In the deep zone, 
chondrocytes density is lowest, their morphology becomes more spherical and they are 
arranged in vertical columns. Finally, the calcified cartilage zone separates the hyaline 
cartilage from the subchondral bone [11].  This mineralized zone has a very low 
metabolic activity due to its extremely low cell density.  The cells in the calcified 
cartilage zone synthesize collagen X, which functions in providing structural support as 
well as acting as a shock absorber along with the subchondral bone [14].  
In addition to the four zones of articular cartilage, the cartilage ECM is further 
organized into three distinctive regions which are comprised of the pericellular, 
territorial, and inter-territorial matrix.  The pericellular matrix contains proteoglycans, 
non-collagenous proteins such as decorin, and non-fibrillar type VI collagen that directly 
surrounds the cell membrane and is approximately 2 µm thick [5, 6, 13].  Surrounding 
the pericellular region is the territorial matrix, which can encase the pericellular matrix 
of a single chondrocyte or a cluster of chondrocytes.  Within the deep zone of articular 
cartilage, the territorial matrix envelopes the columned chondrocytes. The territorial 
matrix contains criss-crossed collagen fibrils which protect the chondrocytes from 
mechanical compression [5]. Finally, the inter-territorial makes up the rest of the 
surrounding matrix beyond the territorial region.  The collagen fibrils within the inter-
territorial region have the largest diameter and are oriented according to their zone 
location [5]. 
 
2.2 ARTICULAR CARTILAGE FUNCTION 
Articular cartilage’s main function is to resist compression by acting as a low-
friction and, wear resistant surface for shock absorption and high load-bearing [7, 8].  
Resisting compression may seem like a simple task, but in reality compression 
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resistance involves an intricate system of cellular communication via proper chemical 
and environmental cues for the chondrocytes to properly synthesize and maintain the 
integrity of the ECM. The complex composition and structural organization of articular 
cartilage produced by chondrocytes is what gives cartilage the ability to withstand 
physiological compressive, tensile, and shear forces. 
 
2.2.1 The Role of Chondrocytes 
Chondrocytes are the key players in producing, maintaining, and remodeling the 
ECM, which determines the complex biochemical properties of the cartilage tissue [15]. 
The specific organization of collagen and varying concentrations of the cells within each 
zone of articular cartilage, determine the tensile and compressive properties of each 
zone.  The crosslinking of the parallel collagen fibrils in the superficial zone is primarily 
responsible for the tensile strength, while the interaction between the negatively charged 
GAGs of the proteoglycans and the water trapped within the collagen meshwork is what 
provides compressive strength [7, 8]. Chondrocytes maintain the structural integrity of 
articular cartilage through the synthesis, assembly, and degradation of all the critical 
structural components of the ECM, which include collagen, proteoglycans, and a variety 
of enzymes [7, 8, 15]. During remodeling, the turn-over of biomacromolecules occurs 
when chondrocytes respond to changes in the matrix composition and replace the 
degraded matrix components with the correct types and amounts of the 
biomacromolecules [7, 8].    
 
2.2.2 Biomechanical Properties 
Articular cartilage is able to store, transmit, and dissipate mechanical energy that 
results from normal activity such as walking, running, and jumping.  Cartilage’s ability 
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to store energy is what prevents permanent damage, such as cartilage tear, from 
occurring during normal load deformations [7, 8].  During compression the GAG chains 
are pushed together but are also simultaneously repelled from each other due to their 
negative charges.  This repulsion causes the chains to extend, allowing water to flow 
into the collagen fibril meshwork. However, the small pore size of the collagen fibril 
meshwork greatly reduces flow rate, which causes frictional resistance to fluid flow and 
build up of water pressure. This frictional resistance along with the water pressure 
within the ECM is what gives articular cartilage its ability to withstand high mechanical 
loads [7, 8]. 
Articular cartilage is biphasic, meaning it has two phases, one solid and one 
fluid.  The macromolecular framework of collagens, proteoglycans, and noncollagenous 
proteins make up articular cartilage’s solid phase while the fluid phase refers to the 
water within the cartilage tissue [7, 8].  When mechanical stress is applied to the solid 
matrix, the matrix’s porous and permeable design enables water within the tissue to flow 
through the matrix. The water pressure of the interstitial fluid supports the majority 
(>95%) of the load and helps limit the stress level that is experienced by the solid matrix 
[7, 8].   
Articular cartilage is also viscoelastic, meaning the strain rate dictates cartilage’s 
stress-strain behavior. For instance, articular cartilage experiences increased deformation 
over time when constant compression is applied. The viscoelasticity of articular cartilage 
is due to flow-independent and flow-dependent mechanisms.  The intermolecular 
friction of articular cartilage’s proteoglycan matrix is the flow-independent aspect, while 
the flow-dependent aspect depends on the interstitial fluid flow and its frictional drag [7, 
8]. High frictional drag occurs in substances with low permeability.  The frictional drag 
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that results from the interstitial fluid flow is what gives healthy articular cartilage its 
viscoelastic property.   
In healthy cartilage, the collagen fibril framework restrains the expansion of 
proteoglycans during fluid flow and limits the water content. Damaged or diseased 
cartilage results in the disruption of the collagen framework, leading to greater 
permeability and subsequently increasing the water content in the cartilage while 
lowering the frictional drag.  As a result, the cartilage is unable to provide the stress-
shielding effect to protect the ECM [7, 8].  Mechanical failure occurs due to decreased 
cartilage stiffness making the framework less capable of supporting its mechanical load 
[16].  
 
2.3 ARTICULAR CARTILATE DEGENERATION  
Articular cartilage degeneration is a problem that will eventually affect the 
majority of the population over the age of 30.  Approximately 43 million Americans are 
affected by arthritis or related conditions with the cost of treating cartilage defects 
reaching nearly $65 billion dollars annually [17].  In the US alone, $28 billion dollars 
[18, 19] is spent per year on orthopedic repair with over 900,000 people requiring 
surgery to treat articular cartilage injuries [20]. Articular cartilage damage can be caused 
by trauma, disease, or normal wear and tear caused by increased age.   
 
2.3.1 Trauma 
Physical trauma can either be a single impact injury from a sports accident or 
from repetitive micro-trauma events. The abrupt physical force from a sports accident or 
the accumulated micro-traumatic forces can cause rips and tears damaging the cartilage.  
Articular cartilage injuries caused by blunt force trauma are extremely difficult to repair 
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because these types of injuries usually involve the disruption of the collagen architecture 
and subsequently increase cell deaths at the defect edge [21]. It was previously thought 
that cellular death was only due to necrosis. However, Redman et al. discovered that 
necrosis occurred initially at the defect edge and was followed by a propagating wave of 
apoptosis that extended deeper into the tissue [21].  Therefore, any attempt to repair the 
defect is essentially just integrating replacement tissue with dead cartilage [21].   
 
2.3.2 Disease 
Disease of the joints is known as arthritis and there are over 100 different types 
of arthritis. This section will only focus on the two major forms which are osteoarthritis 
and rheumatoid arthritis.  Osteoarthritis, also known as degenerative joint disease, is the 
most common form of arthritis and results from  trauma to the joint, infection of the 
joint, or aging of the joint [22].  Osteoarthritis can affect any synovial joint, but most 
commonly affects knees, hips, and small hand joints [23].   Osteoarthritis is a metabolic 
and dynamic process that occurs in all joint tissues within the body including cartilage, 
bone, synovium, ligaments, and muscle tissue.  During pathological changes, there is a 
loss of local articular cartilage as well as remodeling of the adjacent bone [23], the 
combination of which is viewed as a repair process of synovial joints.  Generally, the 
repair process is slow but efficient and is able to compensate for small injuries. 
However, in cases of extreme trauma the repair capabilities cannot compensate for the 
injury and result in continued tissue damage which eventually leads to symptomatic 
osteoarthritis [23].  Degradation of joints from osteoarthritis results in mechanical 
abnormalities.  The damaged articular cartilage can cause pain, stiffness, catching of the 
joint, all of which eventually lead to exposure of the underlying bone [3, 24]. When the 
underlying bone surfaces are less protected by cartilage, bone damage occurs and results 
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in decreased movement, localized muscle atrophy, and sometimes joint effusion, which 
is the buildup of intra-articular fluid [25]. There are a variety of factors that can 
contribute to joint degeneration, including hereditary, developmental, metabolic, and 
mechanical reasons [26].   
Another form of arthritis is rheumatoid arthritis (RA). RA is the most common 
inflammatory arthritis and is responsible for 250,000 hospitalizations and 9 million 
physician visits each year [27]. Approximately 25 men and 54 women per 100,000 
people are afflicted with rheumatoid arthritis, totaling to about 1% of the world’s 
population. RA is a systemic inflammatory autoimmune disorder that causes hyperplasia 
of synovial cells, excess synovial fluid, and the development of pannus (loose cartilage) 
in the synovium. RA is a chronic condition that attacks the synovial joints and often 
results in the degeneration of articular cartilage. Subsequently RA leads to painful and 
debilitating joint movements, resulting in loss of functionality and mobility.    
 
2.3.3 Age-Related Degeneration 
It is well known that articular cartilage in adults has a limited ability for self-
repair due to the lack of blood supply [28]. Wear and tear of the cartilage over time 
causes both the chondrocytes and the proteoglycan aggregates of the ECM to change in 
size. The chondrocytes become larger with age while the proteoglycan aggregates 
decrease in size, due to the shortening of the hyaluronic acid chains or the protein core 
[7, 8]. The GAG concentration changes as well, with chondroitin sulfate decreasing 
while keratin sulfate increases. Additionally, there is a shift in the ratio of chondroitin 
sulfate, chondroitin-4-sulfate decreases while the chondroitin-6-sulfate increases.  
Overall, age-related degeneration of articular cartilage causes increased protein content 
and decreased water content, which results in increased cartilage stiffness and decreased 
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solubility and elasticity [7, 8]. Figure 2.4 is an illustration and an endoscopic image of 
normal cartilage compared to damaged cartilage [29].   
 
2.4 IN VIVO CARTILAGE REPAIR & IN VITRO CHONDROCYTE CULTURE 
Human articular cartilage has a very limited intrinsic capacity for repair.  Its 
ability for self healing is dependent on the type of damage caused to the matrix as well 
as the number of functional chondrocytes remaining.  This limitation has lead 
researchers to isolate chondrocytes and culture them in vitro for use in alternative repair 
strategies. 
 
2.4.1 In Vivo Response for Articular Cartilage Repair 
Articular cartilage contains only one cell type, chondrocytes, whose primary role 
is to maintain the ECM [8]. Due to the low cellular density of articular cartilage,  the 
metabolic activity as a cell population is relative low with an extremely slow cell turn-
over rate, thus limiting cartilage’s capacity for intrinsic repair [28]. Therefore, minor 
cartilage injuries can cause progressive damage which eventually leads to joint 
degeneration. Damage to the cartilage tissue can initiate a cell-mediated repair response, 
which is dependent on the chondrocytes’ ability to sense changes in the matrix 
composition and synthesize new molecules to replace and repair the defect [28]. The 
chondrocytes’ ability for matrix repair is limited. Cartilage repair can only occur if the 
matrix loss does not exceed the rate of matrix production, the fibrillar collagen 
meshwork is not damaged, and there are enough chondrocytes remaining which are 
capable of responding to the matrix damage [28]. During superficial repair, the 
chondrocytes proliferate and increase synthesis of ECM molecules on the borders 
adjacent to the defect area. This phenomenon rapidly terminates, leading to the 
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incomplete filling of the defected tissue and thereby limiting the window for tissue 
repair. Deep tissue defects which extend to the subchondral bone result in bleeding into 
the defect area and the formation of hematomas (blood clots). Since the underlying bone 
is exposed, bone marrow stem cells, growth factors, and differentiating factors, migrate 
to the injury site and initiate an inflammatory response to augment the healing process. 
The replacement tissue contains many chondrocyte-like cells encompassed in a matrix 
consisting of collagen II, proteoglycans, some collagen I, and non-collagenous proteins, 
which are all indicative of fibrocartilage formation [28]. Fibrocartilage has impaired 
mechanical stability due to the decreased stiffness and increased permeability [28]. The 
mechanical instability usually results in further structural damage of the joint because 
the macromolecular framework will experience increased mechanical stress [28]. 
 
2.4.2  In Vitro Chondrocyte Culture for Various Repair Strategies 
The unfavorable results of in vivo articular cartilage repair have lead to the 
investigation of isolating chondrocytes and culturing them in vitro for re-implantation.  
Chondrocytes are derived from mesenchymal stem cells, which differentiate until the 
cells reach their terminal state of hypertrophy and begin endochondral ossification [30].  
At this terminal state chondrocytes rarely proliferate. However, when depleted of their 
ECM, chondrocytes can modulate their phenotype which enables the chondrocytes to 
exhibit characteristics that are normally associated with other differentiated cell types, 
such as resume DNA synthesis and cell proliferation capabilities [31].  The 
chondrocytes’ ability to alter their phenotypic expression demonstrates their plasticity. 
De-differentiation is when chondrocytes lose their chondrogenic phenotypic expression 
and re-differentiation is when they regain their chondrogenic phenotype [31]. Although 
phenotypic expression is lost during de-differentiation, the phenotypic expression can be 
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re-established (re-differentiation) with critical culture conditions. Otherwise the 
chondrocytes cells in culture may have unstable phenotypic expression and switch from 
synthesizing collagen II to synthesizing type I collagen [31]. Isolated chondrocytes 
usually appear fibroblastic in monolayer cultures, but culturing in pellet form has been 
shown to allow chondrocytes to produce ECM [20, 32]. Articular chondrocytes are very 
sensitive to their extracellular environment and initiate appropriate responses to changes 
in their surroundings. Depending on the environmental signals, chondrocytes can 
respond by alerting the products they synthesize and release. During in vitro culture, 
phenotypic de-differentiation can occur, which makes the chondrocytes appear like 
fibroblasts with abnormal characteristics. De-differentiated chondrocytes synthesize 
collagen I instead of type II collagen and engage in irregular synthesis of GAGs [31]. 
When these abnormal characteristics occur in vivo, it is an indication of a pathological 
condition of the articular cartilage such as osteoarthritis  [31]. The ability to tailor the 
culture conditions and environmental signals to maintain the desired chondrogenic 
phenotype would be advantageous for in vitro cartilage repair. Various in vitro methods 
for culturing chondrocytes with the desired phenotype are discussed in Section 2.5.5 
 
2.5  CURRENT ARTICULAR CARTILAGE REPAIR STRATEGIES 
Each year more than 385,000 articular cartilage procedures are performed in the 
United States [33]. Out of approximately 30,000 arthroscopies, there was a 63% incident 
of knee cartilage lesions with only 4% representing patients who were under 40 years of 
age. This statistic clearly indicates that cartilage lesions are an age-related condition 
[33]. Due to the overwhelming number of articular cartilage repair procedures 
performed yearly, there are a number of cartilage repair techniques that are currently 
available including lavage, debridement, marrow stimulation, and transplantation of the 
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affected tissue.  Due to the limitations of each of these techniques, there is still a need to 
develop novel strategies that can improve the effectiveness of cartilage repair.  
 
2.5.1 Lavage and Debridement 
Lavage is the oldest and simplest method for treating cartilage defects. This 
procedure involves rinsing the defected area of the joint with physiological solutions to 
decrease inflammation and remove loose cartilage bodies as well as fibrin debris [34].  
Treatments of cartilage defects with lavage have shown improvement in 80% of patients 
and can benefit the patient up to 3.5 years [35]. However, lavage treatment cannot be a 
definitive solution because the treatment does not repair the joint damage and only 
provides temporary pain management. Debridement is a similar procedure, which 
involves smoothing the cartilage edges and removing loose cartilage pieces with a 
mechanical shaver [5]. This procedure is done to relieve the pain that is caused by loose 
cartilage irritating the joint.  Similar to lavage, debridement is primarily used for small 
lesions and is only a temporary solution. Since debridement also does not repair the 
damaged cartilage, over time more loose cartilage can accumulate [36]. Even though this 
procedure is minimally invasive the patient will still be on crutches for 4-8 weeks [34]. 
Figure 2.5A shows an illustration and endoscopic images of cartilage debridement 
during and after the procedure [36]. The endoscopic image of the debrided cartilage 
clearly shows that the cartilage is still damaged. 
 
2.5.2 Marrow Stimulation  
Marrow stimulation, also known as microfracture surgery, involves the attempt 
to recruit pluripotent marrow-based stem cells into the cartilage defect area for the 
regeneration of neo-cartilage [33]. This technique is performed by drilling small holes to 
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penetrate the subchondral bone and disrupt the blood vessels. The disruption of the 
blood vessels allows for blood to flow into the defect area and initiate the natural healing 
response [5].  Mesenchymal stem cells (MSCs) migrate into the defect area and form a 
fibrin clot. The MSCs differentiate into chondrocyte-like cells that are capable of 
producing ECM [34]. The MSCs are only chondrocyte-like because they are not true 
chondrocytes and their differentiation results in the formation of scar cartilage or 
fibrocartilage [33]. Microsurgery is easy to perform and can yield positive results in   
patients. As mentioned at the end of Section 2.4.1, fibrocartilage lacks mechanical 
strength and is not as durable as native articular cartilage. Figure 2.5B shows 
endoscopic images of a cartilage defect during and after microfracture surgery [36]. The 
endoscopic image of the cartilage after microfracture surgery shows incomplete filling 
of the cartilage defect due to the rapid termination of the healing response, as discussed 
in Section 2.4.1 
 
2.5.3 Osteochondral Transplants 
Osteochondral transplantation is a technique which requires donated tissue that is 
either autogenic (the patient’s own tissue), allogenic (cadaver tissue), or xenogenic 
(animal tissue). Xenogenic tissues are rarely used because of the high risk of disease 
transmission and tissue rejection. Allogenic tissue from cadavers is a feasible tissue 
choice and can be successful in treating large cartilage defects [37]. However, it has 
been shown that fresh tissue has a better success rate than frozen tissue in terms of cell 
death and mechanical stability [38]. Tissue rejection is still a potential problem when 
using allogenic tissues [39] and transplants require the patient to take 
immunosuppressant drugs. Autogenic plugs usually contain both cartilage and bone 
obtained from a non-load bearing area of the patient, as shown in Figure 2.5C [36]. 
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Osteochondral autograft transfer system (OATS) has been widely used and is good for 
treatment of large defects or for defects where both bone and cartilage are missing [40].  
Autologous transplant for treatment of extremely large defects that require multiple 
plugs is called mosaicplasty. Mosaicplasty involves the removal of multiple plugs which 
are placed into a damaged area resulting in a mosaic appearance [41].  Autologous 
transplants can be done on an open joint or by arthroscopy [42] and have been shown to 
decrease pain and improve joint function [43].  However, the drawback to autologous 
osteochondral transplants is that the donor site defects are as large as the areas that 
require repair which can result in donor site morbidity [34]. Additionally, since the 
donor tissue is obtained from a non-load bearing area, it has been shown that the 
mechanical stress experienced by the plugs can result in chondrocyte death leading to 
the degeneration and failure of the graft [40].   
 
2.5.4 Autologous Chondrocyte Implantation  
Autologous Chondrocyte Implantation (ACI) is a technique used to restore the 
damaged cartilage with cells from the patient’s own knee and was first described by 
Brittberg in 1994 [44]. The operation is performed in two stages as illustrated in Figure 
2.6. The first step is to harvest a small amount of healthy cartilage from a non-load 
bearing area of the knee joint. The cartilage cells are enzymatically removed from its 
matrix and then cultured in the laboratory for 3-4 weeks [40]. A second operation known 
as an arthrotomy is performed to place the cartilage cells back into the knee. During the 
second surgery a periosteal patch is obtained from the top of the shin bone (medial 
tibia). Debridement of the cartilage defect is performed before the periosteal patch is 
surgically sewn on. After the patch is sewn over the defect, cartilage cells are then 
injected underneath the periosteal patch into the defect area and the periosteal patch is 
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sealed with fibrin glue [40]. This procedure has been shown to reduce pain and restore 
joint function [44]. The advantage of an ACI procedure is that it does not create large 
donor defects.  Obtaining autologous chondrocytes from a small biopsy generates only a 
small chondral defect [34]. The second stage operation of ACI is a larger procedure and 
requires 3-4 days of hospital stay. A strict rehabilitation program will commence in the 
hospital and continue for 12 weeks after the procedure [45].  
Periosteal grafts have posed problems due to graft hypertrophy and issues with 
morbidity at the harvest sites. To address issues with periosteal grafts, a 2nd generation 
ACI has been developed, which utilizes a resorbable collagen membrane [46].  
Furthermore, a 3rd generation ACI has been developed by Genzyme. This 3rd generation 
ACI uses various bioabsorbable scaffolds in a process called matrix-induced autologous 
chondrocyte implantation (MACI) [47]. The preparation for the MACI procedure is the 
same as for the first two generations of ACI. The difference between the first two 
generations of ACI and the 3rd generation ACI is that the cell suspensions produced are 
not injected into the defect site but rather seeded on a special 3D matrix scaffold where 
the cells adhere to the fibers and start the production of the extracellular cartilage matrix 
components. As the cells grow, the material of the matrix decomposes and is replaced by 
the extracellular matrix. The chondrocyte seeded scaffold is glued into the defect with 
fibrin glue. MACI has been shown to be as effective as the traditional ACI [47].  The 
advantages of MACI over the traditional ACI include reduced operation time [45] and 
reduced tourniquet time [48]. MACI also eliminates the need for a periosteal flap while 
using minimally invasive methods such as mini-arthrotomy or arthroscopy [49] during 
the surgery. Similar to microfracture surgery, the major disadvantage of the MACI 
procedure is that it induces fibrocartilage formation [50]. For this reason, some surgeons 
still prefer osteochondral transplants over MACI. 
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2.5.5 Tissue Engineering Articular Cartilage 
All the therapies described above have their drawbacks offer for treating articular 
cartilage defects. Lavage and debridement are temporary fixes and do not provide 
cartilage repair. Marrow stimulation initiates the natural healing response but the 
replacement tissue is in the form of fibrocartilage, which is mechanically inferior to 
articular cartilage.  Similarly, ACI and MACI have also been shown to produce 
fibrocartilage.  Osteochondral transplants with tissue derived from patients create large 
defects at the harvest site while harvesting tissue from cadavers requires 
immunosuppressant drugs. Additionally, animal tissue cannot realistically be used for 
human applications due to the high risk of disease transmission. Tissue engineering 
presents an alternative method to repair cartilage lesions and prevent further progressive 
cartilage degeneration. In vitro production of articular cartilage grafts grown through 
tissue engineering offers the advantage of having definitive control over the process of 
chondrocyte isolation, proliferation, differentiation, and matrix production [34]. 
Chondrocyte isolation is necessary when engineering articular cartilage 
replacements. Obtaining chondrocytes for tissue engineering applications follows the 
same processes used when acquiring chondrocytes for ACI. To harvest the 
chondrocytes, surgeons obtain a small biopsy of cartilage tissue during arthroscopy of 
the injured joint. The biopsy is  enzymatically digested to release the chondrocytes from 
their ECM and then  the chondrocytes are suspended in culture [34]. The chondrocytes 
are cultured in 2D with media supplemented with growth factors which enable the cells 
to rapidly proliferate, doubling in number within two days [51]. Once the proliferation 
of chondrocytes reaches the number of cells necessary for tissue engineering 
applications, the cells are placed in a 3D culture system. 
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As discussed in Section 2.4.2, when chondrocytes are cultured in vitro they have 
the tendency to de-differentiate. The chondrocytes lose their chondrogenic phenotypic 
expression (decreased collagen II expression and increased collagen I expression) while 
taking on a more fibroblastic morphology if the cell culture environment is not carefully 
controlled [52-54]. Culturing chondrocytes in a biomaterial-free 3D pellet [55] and 
micromass [56]. have been well established.  3D pellets are formed by centrifuging a 
cell suspension in conical tubes. A micromass is formed by adding droplets of cell-
media mix into a 24-well plate so that the cells can coalesce and form one spherical 
mass [57]. Both the pellet and micromass configuration can reinitiate and maintain 
chondrogenic differentiation of chondrocytes isolated from cartilage that are expanded 
in monolayer [56].  Tare et al. isolated articular chondrocytes from femoral heads of 
human patients and found that human articular chondrocyte cultured in pellets 
genetically expressed Sox-9, aggrecan, and type II collagen, as well as produced a 
matrix rich in collagen II and proteoglycans [20].  Additionally, there was no alkaline 
phosphatase activity (marker for mineralization) detected which demonstrates that the 
cells within the pellet are pre-hypertrophic. Pellet culture results from this study as well 
as from many other studies confirm that pellet cultures of isolated chondrocytes are 
suitable for cartilage regeneration [32, 56, 58-61]. The advantage of 3D pellet culture 
over the monolayer culture is in the ability to generate chondrocytes that exhibit similar 
morphology, gene, and protein expression, to that of in vivo chondrocytes [20].  Zhang 
et al. compared the micromass with the pellet culture system and demonstrated that the 
micromass system was superior over the pellet culture system for chondrogenic 
differentiation of human mesenchymal stem cells (hMSCs) [57]. The micromass system 
in their study had greater deposition of proteoglycans and collagen II than the pellet 
culture system. However, the disadvantages of both the micromass and pellet systems 
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are that these systems require an extremely high number of cells, which increases the 
culture time, to produce small and mechanically unstable cartilage [62].  These limiting 
factors have lead researchers to develop additional 3D culture methods to study, 
accelerate, and better control tissue regeneration. For long term success of the next 
generation of functional tissue replacements, additional exogenous influences such as 
cell-to-cell interaction may be required.   
Hydrogel scaffolds and bioreactors have been developed to study and accelerate 
maturation and integration of chondrocytes [63]. Hydrogel scaffolds are discussed in 
more detail in Section 2.8. Spinner flask bioreactors provide convective mixing while 
perfusion bioreactors provide convective flow [63].  Bioreactors can improve size, 
cellularity, and molecular composition when used to culture engineered tissues [64-66]. 
Pei et al. showed that rotating bioreactors provides a mechanically active environment 
that improved in vitro chondrogenesis resulting in cartilaginous constructs that are larger 
and with better structural, functional, and molecular properties [64]. Additionally, 
Vunjak-Novakovic et al. utilized spinner flasks to dynamically seed bovine 
chondrocytes on to polyglycolic acid (PGA) scaffolds and found that the chondrocytes 
maintained their spherical cell shape. Their findings indicate that cell seeding in spinner 
flasks provides a permissive environment for chondrogenic differentiation [65].  In 
addition to being able to accelerate tissue growth and differentiation, bioreactors can 
also be utilized to test the physiological responses of the engineered constructs to 
environmental conditions that the constructs will be exposed to after implantation [63]. 
 
2.6 STEM CELLS FOR CARTILAGE TISSUE ENGINEERING 
Section 2.5 discussed tissue engineering strategies involving isolated 
chondrocytes. As mentioned previously, chondrocyte isolation is a complicated and time 
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consuming process that requires an initial surgical procedure. To eliminate the need for 
chondrocyte isolation many researchers have turned to stem cells as a viable alternative 
cell source for cartilage tissue engineering. Stem cells are characterized by their capacity 
for self renewal through mitotic cell division and their ability to differentiate into a 
diverse assortment of specialized cell types [67].  Stem cells can be broken down into 
two main categories, embryonic and adult stem cells, which are distinguished by the 
cells’ differentiation potential. Both embryonic and adult stem cells have shown great 
potential for cartilage tissue engineering. 
 
2.6.1  Embryonic Stem Cells  
The fertilized egg is considered the ultimate stem cell because of the cell’s 
ability to transform into a plethora of undifferentiated cell lineages. This ability is called 
totipotent, meaning that this single cell can differentiate into any and all the tissue types 
of the body.  Embryonic stem (ES) cells are the daughter cells derived from the fertilized 
egg. ES cells retain the same self renewing ability and they are pluripotent, meaning 
they can differentiate into any of the three germ layers. ES cells’ self replication and 
pluripotent properties have made these cells of great interest for tissue engineering 
applications, especially in cartilage regeneration [56, 68-87]. Generally, the 
differentiation of ES cells parallel early embryonic development by forming embryoid 
bodies (EBs) [86]. It has been established that growth factors provide the necessary 
biological signals to induce EBs to differentiate towards the chondrogenic lineage [73, 
78, 79].  Hwang et al. demonstrated that TGF-!1 induced the chondrogenesis of EBs 
encapsulated in poly(ethylene glycol)  (PEG) hydrogels with high aggrecan expression 
[74]. In the same study, Hwang et al. compared the chondrogenic capabilities of ES cells 
in a monolayer culture versus ES cells encapsulated in PEG hydrogels [74].  Hwang and 
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colleagues found that ES cells cultured in PEG hydrogels upregulated the expression of 
aggrecan and Sox-9, which is a transcription factor for cartilage, over the monolayer 
culture. They believe that the enhanced differentiation of ES cells within the 3D 
hydrogel construct is due to closer cell-to-cell interaction, entrapment of secreted ECM, 
and the maintenance of the ES cells’ spherical cellular morphology. Additionally, 
numerous works have shown that ES cells encapsulated within 3D scaffold systems can 
potentially be used for tissue regeneration [82-84]. Although ES cells can serve as an 
unlimited cell source for tissue engineering applications, ES cell use is limited by the 
fact that it is extremely difficult to control the cells’ differentiation and obtain a 
homogenous cell population [74]. Therefore, researchers have turned to autologous adult 
stem cells because they are non-immunogenic given that they are autogenic cells with 
the added benefit in that their differentiation can be better controlled. 
 
2.6.2 Adult Stem Cells  
Adult stem cells that are commonly used for cartilage tissue engineering include 
mesenchymal stem cells (MSC), adipose stem cells (ASC), adipose-derived stem cells 
(ADSC), and to a lesser extent synovial-derived stem cells (SDSC).  MSCs are the most 
widely used adult stem cells for cartilage tissue engineering.  MSCs are derived from the 
bone marrow and are multipotent, which means that they are progenitor cells that have 
the potential to give rise to multiple but not all cell lineages. MSCs are known to have 
the capability to differentiate into multiple cell lineages including osteocytes, 
chondrocytes, and adipocytes as illustrated in Figure 2.7 [88].  In addition to MSCs 
being multipotent, they also have the ability to maintain cell differentiation potential in 
culture, they are simple to isolate, and they have been shown to grow rapidly in vitro, 
which allows for large expansions to obtain large cell numbers. MSCs also have a 
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number of unique properties such as potent immunosuppressant and anti-inflammatory 
effects. MSCs are able to influence the local tissue environment and effectively 
stimulate regeneration in situ by secreting important soluble factors [89]. These 
characteristics make MSCs a promising candidate for a number of therapeutic uses 
including tissue engineering applications [89].  Due to their array of unique properties, 
MSCs have been widely used for cartilage tissue engineering through a variety of 
techniques including pellet culture, encapsulation in scaffolds of different material 
composition, and dynamic culture in bioreactors [57, 90-93]. MSCs can be induced to 
differentiate into the chondrogenic pathway in vitro using serum-free media containing 
transforming growth factor-! (TGF-!) within a 3D structure. Biosynthesis of GAGs and 
genetic expression of cartilage-specific markers such as Sox-9 (chondrogenic 
transcription factor), aggrecan, collagen II, and collagen X have been used to determine 
the differentiation of MSCs into the chondrogenic pathway [94].   
The differentiation pathway of MSCs into mature chondrocytes was investigated 
by Barry et al [30]. Results from this study indicate that the chondrogenic differentiation 
of adult bone marrow MSCs involves a change in cell morphology, formation of an 
integrated ECM, and upregulation of GAG synthesis. Barry and colleagues also 
determined that collagens I, II, and X are synthesized sequentially during differentiation 
by the same cells. The differentiated MSCs exhibit early expression of collagen I, 
followed by collagen II, and terminating with collagen X. Barry et al. concluded from 
this study that there are three separate stages that occur during cell differentiation. Stage 
I occurs during the first 6 days of differentiation, the cells upregulate a number of genes 
including fibromodulin, cartilage oligomeric matrix protein (COMP), aggrecan, 
versican, and decorin, as well as initiate GAG synthesis.  Stage II occurs 7 days after 
differentiation, during which the expression of collagen II, chondroadherin, and biglycan 
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were observed. During stage III, the accumulation of GAG proceeds over the next 14 
days and eventually leads to the formation of mature chondrocytes [30].  Figure 2.8 
shows a timeline of defined events in the chondrogenic differentiation of MSCs during 
pellet culture. Barry et al.’s work allowed researchers to obtain a better understanding of 
the MSC differentiation pathway into the chondrogenic phenotype, which in turn lead to 
improved strategies for directed MSC differentiation.   
Pellet culture was the initial standard method for chondrogenic differentiation of 
MSCs but it may not be the best method for cell differentiation. As mentioned 
previously, Zhang et al. showed superior chondrogenesis within micromass systems over 
the pellet culture system, likely due to the poor nutrient diffusion resulting in MSC 
apoptosis within the central region of the pellet system [57].   
As research has progressed and a greater understanding is gained of MSC 
differentiation, new and improved MSC differentiation methods have been developed. 
Meinel et al. encapsulated human MSCs within various protein scaffolds such as 
collagen, crosslinked collagen, silk, and silk modified with RGD (Arg-Gly-Asp, an 
adhesion peptide) [92].  Meinel et al. demonstrated that silk scaffolds performed the best 
in the chondrogenic differentiation of human MSCs, exhibiting the highest type II 
collagen expression as well as GAG production [92]. Meinel and colleagues attributed 
the increased chondrogenic induction to the highly porous and slow degradation nature 
of silk scaffolds as well as the silk scaffolds’ structural stability.  Additionally, Marolt et 
al. took MSC laden silk scaffolds and cultured them in rotating bioreactors [91] to study 
the MSCs’ and silk scaffolds’ combinatorial effect.  They found that although the 
constructs cultured in chondrogenic medium had an increase in GAG content, the 
overall chondrogenic differentiation of MSCs was slow and incomplete, suggesting that 
the combined utilization of scaffolds and bioreactors for chondrogenesis may not be 
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optimal [91]. Li et al. also studied the multi-lineage differentiation capabilities of human 
MSCs seeded onto nanofibrous poly(#-caprolactone) (PCL) scaffolds [90].  For 
chondrogenesis of human MSCs, Li et al. found that after 21 days of culture, the cells 
expressed both AGN and Col II mRNA. Additionally, the cells functionally produced 
aggrecan and collagen type II. Furthermore, Li and colleagues also observed 
morphologically round chondrocytes embedded in a sulfated proteoglycan-rich ECM 
with collagen type X mRNA downregulated, suggesting a stable and non-hypertrophic 
phenotype for the chondrocytes within the engineered construct. Finally, Varghese et al. 
demonstrated that incorporating chondroitin sulfate (CS) into a PEG-based hydrogel, 
helped mimic the native cartilage environment and thus enhances the chondrogenic 
differentiation of MSCs [93].  
The multitude of studies done on differentiating MSCs into the chondrogenic 
phenotype, has established MSCs as a good cell source for cartilage repair strategies. On 
the other hand, the procedure to acquire bone marrow for MSC harvesting is invasive 
and sometimes painful for patients. Extracting bone marrow requires general or local 
anesthesia and can result in a low yielding cell count. The low cell count is a significant 
limiting factor because cell harvesting is time consuming and an expensive ex vivo 
expansion process that can also run the risk of contamination. A better alternative would 
be a cell source that is easily attainable and capable of yielding large enough cell counts 
to prevent the need for culture expansion.  
In the recent years adipose stem cells (ASC) or adipose-derived adult stem cells 
(ADSC) have become popular among researchers for cartilage tissue engineering 
because these cells are easily obtainable. Adipose tissue contains a heterogeneous 
stromal cell population.  Within this heterogeneous population there are stems cells that 
have the potential to differentiate into adipogenic, osteogenic, chondrogenic, and 
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myogenic cells when cultured in vitro in the presence of lineage-specific growth factors 
[95]. The liposuction procedure used to obtain these cells results in minimal patient 
discomfort and is capable of yielding enough cells to be expanded in culture [95], 
making ASCs and ADSCs an ideal source of adult autologous stem cells. Guilak et al. 
found that human ADSCs are a multipotent adult stem type and not a mixture of 
unipotent (differentiate into only one cell type) progenitor cells, due to ADSCs’ multi-
lineage differentiation capacity [96].   
A number of researchers have exploited this multipotent characteristic of ADSCs 
to investigate ADSCs’ potential application in cartilage tissue regeneration [96-98].  
Guliak et al. explored the chondrogenic differentiation potential of fibroblast-like 
populations called processed lipoaspirate (PLA) obtained from processed liposuctioned 
human adipose tissue [96].  The PLA cells were cultured in a 3D micromass pellet with 
chondrogenic media containing dexamethasone and TGF-!1. The PLA cells formed 
dense nodules exhibiting sulfated proteoglycans and collagen type II, characteristics that 
were not observed in undifferentiated PLA cells [96].  Estes et al. cultured ADSCs in 
monolayer and found that the cell culture environment as well as the growth factors such 
as epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), and TGF- !1, 
significantly influenced ADSCs’ ability to proliferate and maintain their multipotent 
characteristics [97].  Additionally, Estes and colleagues’ findings suggest that increasing 
passage number of ADSCs in monolayer culture may increase the adipose-derived adult 
cells’ chondrogenic potential [97].   
Mahmudifar et al. performed a comparative analysis study on the chondrogenic 
potential of ADSCs encapsulated in polyglycolic acid (PGA) compared to ADSCs in 
pellet culture [98] and found that there were higher GAG and collagen II expressions 
among ADSCs that were encapsulated in PGA scaffolds. The enhanced chondrogenic 
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induction of ADSCs within scaffold biomaterials from this study alludes to the 
importance of cell-matrix interactions for chondrogenic differentiation. Furthermore, 
additional studies done by Guilak et al. confirmed that biomaterials provide guidance for 
the development and commitment of stem cells towards specific tissue formation [99].   
As with other stem cell sources, the use of ADSCs also has a number of 
drawbacks. Liposuction is a relatively simple procedure with minimal patient discomfort 
but if performed without the utmost care, damage to the underlying muscle or disruption 
of the blood vessel supply can occur, which can be harmful to the patient [95]. Damage 
to the muscle during liposuction can lead to the contamination of the myogenic 
precursor and satellite cells into the PLA population which subsequently can lead to 
unwanted myogenic differentiation. Pericytes have the ability to differentiate into a 
fibroblast, smooth muscle cell, or macrophage. Damage to the blood vessel during 
liposuction could release the pericytes, which then mix with the PLA population and 
subsequently cause simultaneous differentiation into multiple unwanted lineages. 
Both MSCs and ADSCs have been widely used in the cartilage tissue 
engineering field. Multiple investigators have questioned which cell source is better for 
chondrogenic differentiation, thus numerous comparative studies have been done to 
determine which adults stem cells have superior chondrogenic potential for tissue 
engineering. Jakobsen et al. performed a comparative study between MSCs, ADSCs, 
and chondrocytes. In the study, MSCs and ADSCs were seeded onto hyaluronic acid 
(HA) scaffolds. Jackobsen and colleagues found that MSCs induced a much higher 
mRNA expression of type II collagen than both ADSCs and chondrocytes when cultured 
in chondrogenic media [100].  Additionally, Winter et al. demonstrated that the 
chondrogenic potential of MSCs and ADSCs were indistinguishable in monolayer 
culture with similar cell morphology. However, when switched to a high-density 3D cell 
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culture system, MSCs had improved chondrogenesis over ADSCs [101].  Furthermore, 
Diekman et al. confirmed that MSCs have overall greater chondrogenic response than 
ADSCs when cultured in alginate beads or cartilage-derived matrices exhibiting higher 
upregulation of type II collagen and more extensive matrix synthesis [102]. Finally, 
Puetzer et al. did a comparative literature review and found that MSCs repeatedly 
undergo chondrogenesis more thoroughly than ADSCs under the same culture 
conditions [101-107].   
Although this dissertation focuses on the differentiation of MSCs, it is still 
important to acknowledge that there are other cell sources available for future work.  For 
instance, stem cells derived from the synovial lining are termed as synovial-derived stem 
cells (SDSC). SDSCs serve as a good cell source for cartilage tissue regeneration 
because the cells share similar properties to chondrocytes. For example, SDSCs produce 
similar chondrogenic proteins such as cartilage oligomeric matrix protein (COMP) [108-
110], link proteins [111], and sulfated GAGs [112]. Pacifici et al. determined that both 
articular cartilage cells and synovial cells originate from the same precursor population 
[113], therefore establishing their close functional relationship. Additionally, both Allard 
et al. and Xue et al. showed that pathological conditions can induce synovial cells to 
express strong chondrogenic characteristics [114, 115] such as the production of 
collagenase during arthritis [31].   
Due to the heterogeneous nature of the synovium, Pei et al. developed a method 
called “negative isolation,” in which Pei and colleagues removed macrophages and 
purified synovial fibroblasts (SFBs) [116]. The purified SFBs have high chondrogenic 
potential when cultured with TGF-!1 [117].  Pei et al. performed a comparative study to 
compare the chondrogenic potential of the “negative isolated” cells with conventional 
passage SDSCs. They found that conventionally passed SDSCs exhibited weak and 
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sparse distribution of GAG, type II collagen and strong expression of type I collagen 
when compared to the SDSCs that were purified by negative isolation [116].  The 
presences of macrophages were observed in the conventional passage SDSCs. The 
macrophages can contribute to the inhibition of SDSC-based chondrogenesis and 
subsequently exhibited weak and sparse distribution of GAG and collagen II with high 
expression of collagen I and macrophage antigen [116].   
In a separate study, Fan et al. encapsulated rabbit SDSCs into two different 
hydrogel scaffolds. One hydrogel scaffold was a non-degradable photo-crosslinked 
poly(ethylene glycol) diacrylate (PEGDA) and the other scaffold was a degradable 
phosphoester-poly(ethylene glycol) (PhosPEG). Fan and colleagues demonstrated that 
SDSCs have high viability in both hydrogel scaffolds with positive chondrogenesis of 
SDSCs when cultured with TGF-!1 or TGF-!3; however the PEGDA system had the 
better chondrogenic outcome [118].  Although SDSCs are not as widely used as MSCs 
and ADSCs, these studies demonstrate that SDSCs have great potential for chondrogenic 
differentiation and can be a useful cell source for tissue engineering applications such as 
cartilage regeneration.  
 
2.7 CHONDROGENIC MEDIA AND GROWTH FACTORS 
MSCs have the ability to differentiate into multiple lineages, therefore, the 
proper media formulations is crucial in directing MSC differentiation into the 
chondrogenic pathway.   Mitogenic signals, such as grow factors are essential signaling 
components in MSC differentiation.  Members of the transforming growth factor-! 
(TGF-!) family have been well established as a key element for the chondrogenic 




2.7.1 Chondrogenic Media 
Chemical induction of MSC chondrogenesis has been widely used and for the 
most part was a process required for successful chondrogenic differentiation [30, 59, 71, 
106, 119, 120]. The standard formulation of chondrogenic media is Dulbecco’s modified 
Eagle’s medium (DMEM) with high (4500mg/L) or low (1000mg/L)   glucose 
supplement. The addition of ITS+ premix, ascorbate, and pyruvate is also quite 
common.  ITS stands for insulin, transferrin, and selenium, with the “+” indicating that 
the premix also contains bovine serum albumin and linoleic acid. Although serum can 
still be used in the chondrogenic differentiation of MSCs, most researchers lean towards 
serum-free culture due to the fact that serum in media can induce de-differentiation [68, 
70, 121]. The addition of various growth factors has been shown to greatly increase the 
chondrogenic potential of MSCs, especially when using members of the transforming 
growth factor-! (TGF-!) family. However, there is a dose dependent response as shown 
by Yoo and colleagues [59]. Yoo et al. found that lower concentrations (0.01-0.1 ng/mL) 
of TGF-!1 had no significant effect on MSC differentiation while high concentrations 
(10 ng/mL) caused MSCs to differentiate into chondrocytes [59]. Additionally, Yoo et 
al. also determined that dexamethasone when combined with TGF-!1, influences MSC 
chondrogenesis by increasing ECM formation [59]. Based on these studies, the 
chondrogenic media formulation in this dissertation is serum free, containing 1% 
penicillin/streptomycin, 10nM dexamethasone, 50 µg/mL ascorbic acid-2-phosphate, 40 
µg/mL L-proline, 5 mL ITS+1, and 10 ng/mL TGF-!1. 
 
2.7.2 Transforming Growth Factors-! 
Members of the transforming growth factor-! (TGF-!) family have been 
extensively studied and widely established as inductive agents for the chondrogenic 
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differentiation of MSCs [71, 80, 81, 85, 122-125].   TGF-! was first discovered in 1981 
and named for its ability to elicit phenotypic transformations in rodent fibroblasts [126, 
127].  TGF-!1, TGF-!2, and TGF-!3 are all TGF-! isoforms that function through the 
same receptor signaling systems and.  All of which have distinct spatial and temporal 
expressions of both mRNA and proteins in development, regeneration, and pathological 
responses [128].  All three isoforms are multifunctional peptides and while heterodimers 
of TGF-!1 and TGF-!2 have been known to occur [129], there have been no reports of 
heterodimers involving TGF-!3. Although these three isoforms are similar, TGF-!1, 
TGF-!2, and TGF-! still show subtle differences between each other. For instance, their 
N-terminal regions only show 27% sequence identity to each other.  TGF-!1 only has 
about 72% identity to TGF-!2 while mature TGF-!3 shows about 80% identity to both 
TGF-!1 and TGF-!2 [130]. The contribution and expression of TGF-!2 in MSCs during 
chondrogenesis has not been fully determined [128], thus this section will focus on the 
discussion of TGF-!1 and TGF-!3. 
Goessler et al. found that TGF-!1 was constantly expressed during chondrogenic 
differentiation of MSCs [128]. Goessler and colleagues also determined that TGF-!1 
acted in unison with other TGF-!s but that they are not involved in the de-differentiation 
of chondrocytes. Goessler et al. also found that although TGF-!3 was constantly 
expressed during chondrogenic differentiation of MSCs, Goessler and colleagues 
believed that TGF-!3 assists with the de-differentiation process in some way [128].  
Barry et al. reported that the combination of dexamethasone and TGF-!1 showed less 
chondrogenic induction of human MSC pellets than when hMSCs are exposed to 
dexamethasone combined with TGF-!3 [30]. Lower GAG accumulation, less collagen II 
staining, and smaller pellet size were observed in TGF-!1 induction than in TGF-!3 
induction. [30].  Although, Barry and colleagues showed that TGF-!3 had a more 
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inductive effect on the chondrogenic differentiation of human MSCs, studies conducted 
by Chimal-Monroy et al. showed a reverse effect on mouse MSCs [69, 131]. Chimal-
Monroy et al. demonstrated that mouse MSCs were more responsive to TGF-!1, 
exhibiting higher ECM accumulation and enhanced expression of sulfated 
proteoglycans, type II collagen, and cartilage link protein. However, with TGF-!3 there 
was a diminished effect [69, 131]. Since the research discussed in this dissertation was 
conducted using mouse MSCs, it was determined that TGF-!1 would be a better choice 
based on the findings of Chimal-Monroy et al. Additionally, TGF-!1 is not involved in 
the de-differentiation process while TGF-!3 has been found to assist this process.  
 
2.8 BIOMATERIALS FOR CARTILAGE TISSUE ENGINEERING 
As described in Section 2.6.2, a number of investigators, including Mahmudifar 
and Guilak, have shown that scaffold biomaterials enhance chondrogenic differentiation 
of stem cells. Mahmudifar and Guilak believe that biomaterials provide guidance for the 
development and commitment of stem cells towards specific tissue formation [98, 99].  
Therefore, this section focuses on the influence of biomaterial composition on stem cell 
differentiation into the chondrogenic lineage. 
 
2.8.1 Hydrogel Scaffolds for Tissue Regeneration 
Hydrogels represent an important class of biomaterials because they exhibit 
excellent biocompatibility, have the ability to imbibe a large amount of water, and 
minimize inflammatory responses which can result in thrombosis and tissue damage 
[132, 133]. Hydrogel scaffolds can be made of synthetic, natural materials, or a 
combination of both. Natural materials provide easy cell transplantation but are limited 
by their mechanical strength and their uncontrollable degradation rates [134-136]. 
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Natural biopolymers will be discussed in more detail in Section 2.8.3. Synthetic 
polymers are beneficial because their properties can be fine-tuned to produce scaffolds 
with desired and controllable physical and chemical characteristics [137].   
In designing a polymer scaffold, there are a number of criteria that must be 
satisfied before the scaffold can successfully serve its purpose. The scaffold material has 
to be biocompatible and biodegradable with a controlled degradation rate that is 
compatible with the development of nascent tissue. Scaffold properties, such as 
mechanical strength, must match the properties of the surrounding tissue so that tissue 
function can be restored immediately. Additionally, the microenvironment has to 
promote diffusion of nutrients or metabolic wastes, support cell viability, and provide 
ease of cell seeding [134]. Therefore, the usage of biodegradable synthetic polymers 
offers a number of advantages for developing scaffolds. For instance, biodegradable 
polymers provide mechanical support during tissue growth and then gradually degrade 
at a desired rate.  In addition to being able to control degradation kinetics, other desired 
properties such as mechanical strength, geometric shapes, pore sizes, and morphologic 
features, can be manipulated to be conducive for tissue growth. Furthermore, polymers 
can also be designed with chemical functional groups within their polymer network or 
the functional groups can be attached to the polymer backbone. These attached chemical 
functional groups can induce and enhance a number of cellular functions such as cell 
signaling and adhesion to promote tissue growth. 
An important synthetic polymer, and the one used in the work of this 
dissertation, is poly(ethylene glycol) (PEG).  PEG is hydrophilic and biocompatible with 
properties that limit immunogenicity and antigenicity, with minimal protein and cell 
adhesion [138, 139]. These properties make PEG an attractive polymer for scaffold 
development in cell-based tissue engineering applications [140, 141]. For example, 
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photo-curable hydrogels that are PEG-based are widely used to encapsulate cells into 
scaffolds because of the hydrogels’ inert and non-immunogenic nature [94, 139, 142-
145].  However, scaffolds with incorporated PEG chains can be modified with bioactive 
peptides to do the reverse, i.e. induce cellular behavior such as adhesion to proteins 
[146-148]. PEG is not naturally degradable but similarly to PEG chains’ stealth 
characteristics, PEG chains’ degradation properties can be altered to make them 
degradable by adding degradable linkages. Sawhney et al. showed that by integrating 
hydrolytically degradable PLA and PGA units with PEG monomers, they could create 
degradable constructs [149]. This process is done by first end-capping the PEG 
macromers with acrylate groups and then photopolymerizing the PEG to cross-link the 
PLA and PGA onto the PEG chains. [149].   Tighter cross-links can be created by using 
lower molecular weight PEG monomers, making this system a tunable one for the 
desired degradation rate.     
 
2.8.2 Enzymatically Degradable Scaffolds in Tissue Engineering  
One method of regenerating tissue is by combining isolated cells with 
appropriate bioactive agents in a biomaterial scaffold, which supports the production of 
the tissue matrix. It is widely recognized that scaffold architecture can greatly influence 
the behavior of cells on tissue-engineering constructs. The structural environment, cell-
biomaterial interaction, and biological signals incorporated in the scaffold are all 
essential elements that play an important role in tissue development [150]. 
Biodegradability and biocompatibility of the polymer are also important elements in 
promoting cellular function in vivo, as the degradation kinetics of the scaffold influences 
cell morphology, spreading and migrating encapsulated cells [151]. 
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Matrix metalloproteinases (MMPs) are proteolytic enzymes that are secreted by 
cells in order to degrade certain components of the extracellular matrix (ECM) during 
ECM remodeling. Both the Healy and Hubbell research groups have taken advantage of 
this key concept by incorporating MMP sensitive peptides into their scaffold designs to 
make the scaffolds degradable [152-154]. It has been shown that osteoblasts secrete 
MMP-13, which functions in degrading type II collagen during bone remodeling [152]. 
The expression of MMP-13 during bone remodeling and its specificity for collagens is 
what makes MMP-13 sensitive crosslinkers ideal candidates for integration into 
hydrogel designs that foster bone regeneration. Healy et al. have specifically used MMP-
13 degradable peptide crosslinkers to develop thermoresponsive p(NIPAAm-co-AAc) 
semi-interpenetrating polymer networks (sIPNs)  [152].  Healy and colleagues showed 
that the degradation of the peptide occurred in an enzyme dose-dependent manner. 
Additionally, Healy et al. showed that the enzymatic degradation products did not 
significantly affect cell viability. Hubbell et al. developed PEG hydrogels that contain 
MMP-2 cleavable crosslinks in their polymer backbone making the hydrogel sensitive to 
proteolytic degradation via cell-derived MMP-2 [154]. The advantage of designing a 
material with proteolytic sensitivity is that migrating cells could systematically degrade 
the synthetic polymer and eventually anchor onto the exposed ECM. 
 
2.8.3 Natural Polymers in Cartilage Tissue Engineering 
There are a vast number of naturally derived polymers that have been used for 
tissue engineering purposes. Some of these natural polymers include ECM proteins such 
as collagen, glycosaminoglycan, and chitosan [155].  Sebra et al. demonstrated that 
collagen type I can be grafted onto polymer substrates to promote cellular adhesion 
through the use of cell-adhesive peptide moieties within the structure of collagen type I 
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[156]. Nettles et al. demonstrated that chitosan scaffolds can support chondrocyte 
attachment and cartilaginous matrix biosynthesis. Nettles and colleagues showed that 
chondrocytes grown on chitosan scaffolds can synthesize an extracellular matrix 
containing proteoglycans and type II collagen [157].  
As discussed in Section 2.1, proteoglycans are one of the major macromolecules 
found in articular cartilage. These molecules consist of a core protein and covalently 
attached glycosaminoglycan (GAG) chains. The GAGs are long, unbranched 
heteropolysaccharides, consisting of repeated disaccharide units. The cartilage-specific 
GAGs include chondroitin 4-sulfate, chondroitin 6-sulfate, keratan sulfate, and dermatan 
sulfate [158].  
A brief recap here, chondroitin sulfate (CS) is a sulfated GAG composed of a 
chain of alternating sugars consisting of N-acetylgalactosamine and glucuronic acid.  
Chondroitin sulfate is a major component of the ECM of cartilage and functions in 
maintaining the structural integrity, by retaining water and nutrients, and allowing 
movement of other molecules through cartilage [158]. The ability of molecules to 
diffuse through cartilage is essential due to the fact that there is no blood supply to the 
cartilage. The attachment of CS to proteins forming proteoglycans is what gives 
cartilage its elasticity and is also believed to play a role in cartilage formation and repair.  
The tightly packed and highly charged sulfate groups of chondroitin sulfate generate 
electrostatic repulsion which provides the compression resistance of cartilage [93, 159].   
CS is a great candidate to use as scaffolding material because is it a natural 
component of the cartilage ECM and is naturally degraded by chondroitinase, which are 
produced by chondrocytes. Since CS is such an important component of the cartilage 
ECM, many researchers have used them to investigate MSC chondrogenesis [93, 160-
163]. Varghese et al. were able to show that encapsulated chondrocytes within CS 
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biogels remain viable, therefore demonstrating the potential of these biogels for cartilage 
tissue engineering [93]. Additionally, Varghese et al. combined PEG, a synthetic 
polymer, with CS to form a synthetic-biological composite hydrogel scaffold for 
differentiating mesenchymal stem cells (MSCs) [93]. Here.  In this study, Varghese and 
colleague were able to demonstrate that the incorporation of CS as a scaffold component 
enhances chondrogenic differentiation of MSCs [93].  In addition, van Susante et al. 
attached CS on type I collagen scaffolds and studied its effect on the cell proliferation 
and matrix production of encapsulated chondrocytes. Van Susante et al. showed that CS 
can be used as a biochemical component of a cell-delivery scaffold in tissue engineering 
articular cartilage [163]. Pek et al. evaluated the properties of collagen-CS scaffolds 
based on different methods of crosslinking; non-crosslinks, physical crosslinks, 
chemical crosslinks, and the combination of both physical and chemical crosslinks 
[161]. Pek et al. demonstrated that the swelling ratio, compressive modulus, and 
enzymatic degradation are all affected by the different crosslinking methods. Pek and 
colleagues found that the chemically crosslinked collagen-CS scaffolds resulted in 
matrices with higher inverse swelling ratio, higher compressive modulus, and slower 
degradation rates than the non-crosslinked or physically crosslinked matrices. This study 
showed that CS allows the scaffold to have tunable properties via chemical crosslinking, 
further proving CS’ potential for use as a scaffold material for tissue engineering [161].   
Again briefly, hyaluronan, also known as hyaluronic acid or hyaluronate (HA), is 
a non-sulfated GAG that is an important component of articular cartilage. HA is an 
important cartilage GAG because it is one of the major components in synovial fluid and 
contributes significantly to cell proliferation and cell migration as well as wound healing 
and tissue hydrodynamics. HA can form large highly negatively-charged aggregates 
when bound to aggrecan. The aggregates imbibe water and are responsible for the 
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resilience of cartilage [157]. Many unique properties of HA, including its 
biocompatibility, viscoelasticity, and lack of immunogenicity, have made it an appealing 
material for tissue engineering. Additionally, purified HA has been employed as a 
structural biomaterial because of its high molecular weight and gel forming ability 
[158]. Leach et al. demonstrated that the physical properties of their GMHA (glycidyl 
methacrylate-HA) hydrogels, such as swelling ratio, crosslink density, mesh size, and 
complex modulus, can be fine-tuned by simply varying the levels of methacrylation 
during their GMHA synthesis process [164]. Yoo and colleagues showed that 
chondrocytes that were seeded with HA modified poly(lactic-co-glycolic acid) (PLGA) 
scaffolds had increased cellular attachment, GAG, and total collagen production over 
unmodified PLGA scaffolds [165]. Nettles et al. demonstrated that their HA-MA (photo-
crosslinkable hyaluronan) formulation promoted the retention of the chondrogenic 
phenotype and cartilage matrix synthesis for encapsulated chondrocytes in vitro [166].  
HA may be a potential candidate for a cell-carrier material in chondrocyte 
transplantation therapy as shown by Robinson et al. [167]. Additionally, Butnariu-
Ephrat et al. demonstrated that bone-marrow-derived mesenchymal cells, delivered in 
HA hydrogels, have the  potential for cartilage resurfacing in animal models [168].  
These studies and others have determined that HA-based hydrogels have great potential 









2.9 FIGURES  
 
Figure 2.1 Schematic of the Extracellular Matrix (ECM) of Articular Cartilage 
showing chondroitin sulfate (CS), hyaluronic acid (HA) and Type II collagen as 











Figure 2.2 Schematic of the Proteoglycan Structure (A) Details of proteoglycan 
monomer structure showing chains of chondroitin sulfate (CS) and keratin sulfate 
(KS) as well as the attachment of the monomer to the hyaluronic acid chain via a 
link protein. (B) Molecular conformation of a typical proteoglycan aggregate 





Figure 2.3 Schematic of Articular Cartilage Organization showing the four 
distinctive zones: the superficial, transitional, deep, and calcified zone (adopted 



























Figure 2.5 Illustration and Endoscopic Images of Current Cartilage Repair 
















Figure 2.6 Illustration of the Autologous Chondrocyte Implantation (ACI) surgical 
technique for repair of chondral defect in the knee joint [5].  Surgical images of a 
































Figure 2.8 Schematic of the of MSC Chondrogenic Differentiation which illustrates 
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ECM Mimicking Hydrogel Scaffolds for Cartilage Tissue Engineering 
 
3.1  INTRODUCTION 
The essence of tissue engineering is in the usage of synthetic or natural materials 
to engineer biomaterials to replace damaged or defective tissues in humans. The 
polymer scaffold is an important component of tissue engineering. Scaffolds made from 
natural or synthetic materials can be implanted temporarily into the body. Scaffolds can 
either degrade and absorbed into the body or be removed. Removal of scaffolds can be 
invasive, time consuming, and costly to the patients, thus for patient compliance 
purposes, degradable scaffolds are more attractive in tissue engineering applications. 
Degradable scaffolds can function as matrices or templates that allow cells to grow and 
subsequently form new tissues while the scaffolds gradually degrade [1].   
In cartilage tissue engineering, degradability and cell-induced remodeling of the 
hydrogel microenvironment are key elements for successful tissue generation, as the 
degradation kinetics of the scaffold influences cell morphology, spreading, and 
migration [2]. Poly(ethylene glycol) (PEG)  is a synthetic polymer that is widely used 
for scaffold development in cell-based cartilage tissue engineering applications because 
it is biocompatible and can be easily functionalized [3-12].  Although PEG is not 
naturally degradable, many investigators including Anseth and coworkers have shown 
that PEG hydrogels can be made hydrolytically degradable by crosslinking poly(lactic 
acid) (PLA) monomers into the hydrogel network, creating an acidic environment as a 
result [13].   
Alternatively, synthetic peptide sequences that are degradable by cell-specific 
collagenase have been used to make PEG enzymatically degradable. Enzymatic 
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degradation allows for cell specific degradation as well as eliminates the creation of an 
acidic environment.  Matrix metalloproteinases (MMPs) are proteolytic enzymes that are 
secreted by cells in order to degrade and remodel the extracellular matrix (ECM).  
Several investigators have taken advantage of this key concept by incorporating MMP -
sensitive peptides (MMP-pep) into their scaffold design to make them degradable when 
exposed to the MMP enzymes [14-16]. Kim et al. demonstrated that osteoblasts secrete 
MMP-13, which functions in degrading type II collagen during remodeling [14]. Healy 
and colleagues developed thermoresponsive p(NIPAAm-coAAc) semi-interpenetrating 
polymer networks (sIPNs) with  MMP-13 as degradable crosslinkers and showed that 
the degradation occurred in a dose-dependent manner. Additionally, this study they also 
showed that the enzymatic degradation products did not significantly affect cell 
viability. Hubbell et al. developed PEG hydrogels that are sensitive to proteolytic 
degradation by incorporating cell-derived MMP-2 peptide sequences onto the polymer 
backbone [16].   
Unlike synthetic polymers, natural hydrogels have inherent biological sites for 
cell-mediated degradation. Thus, natural ECM proteins such as collagen and GAGs have 
been widely used for tissue engineering of cartilage [17].  For instance, chondroitin 
sulfate (CS) and hyaluronic acid (HA) are natural components of cartilage’s 
extracellular matrix (ECM), and thus their incorporation into scaffolds helps mimic the 
physiological environment of native cartilage. Li et al. created CS-based hydrogels to 
enhance bioactivity of the scaffold and found that encapsulated chondrocytes remained 
viable within the hydrogels [18]. Pek et al. showed that CS incorporation into scaffolds 
allowed for tunable properties via chemical cross-linking [19]. Additionally, Hwang et 
al. examined the biological response of chondrocytes within PEG-based incorporating 
either type I collagen, HA, or CS.  Hwang and colleagues found that CS-based 
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hydrogels exhibited the strongest response with high chondrogenic gene expression and 
matrix accumulation [20]. Another important component of articular cartilage is HA, 
which is a non-sulfated GAG constituent of synovial fluid. HA contributes significantly 
to cell proliferation and migration as well as wound healing and tissue hydrodynamics 
[21], characteristics which have made HA an appealing material for tissue engineering.  
Since HA has a high molecular weight and can easily form hydrogels, it has been 
employed by many investigators as a structural biomaterial [20, 22-26]. Butnariu-Ephrat 
et al. demonstrated that BMSCs encapsulated within HA hydrogels, have the potential 
for cartilage resurfacing in animal models [27]. Yoo et al. found that HA modified 
poly(lactide-co-glycolic acid) (PLGA) scaffolds increased cellular attachment, 
glycosaminoglycan (GAG), and total collagen production of seeded chondrocytes over 
unmodified PLGA scaffolds [26]. Nettles et al. showed that chondrocytes retained their 
chondrogenic phenotype and cartilage matrix synthesis when encapsulated within 
crosslinked methacrylated HA hydrogels [28]. Although these studies and others have 
determined that both CS and HA-based hydrogels individually have great potential in 
cartilage tissue engineering, there is still a lack of knowledge of the combined effects of 
CS, HA, and MMP-pep for cartilage regeneration.   
In this chapter novel hydrogels containing a combination of CS, HA, and MMP-
pep within a PEG-based hydrogel, were fabricated to investigate how each component 
affects the hydrogels’ physical properties. The combination of both natural and synthetic 
biomaterials has not been previously explored. Thus this chapter evaluates whether or 
not their combination produces a synergistic effect on the differentiation of MSCs. The 
findings of this chapter indicate that hydrogels’ physical properties can be tailored by 
altering their biomaterial composition. Chapter Four evaluates whether or not their 
combination produces a synergistic effect on the chondrogenic differentiation of MSCs.   
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3.2 MATERIALS AND METHODS 
 
3.2.1 MMP-Sensitive Peptide Synthesis & Modification 
The MMP-sensitive peptide (MMP-pep) (QPQGLAK: Gln-Pro-Gln-Gly-Leu-
Ala-Lys) peptide shown in Figure 3.1 was synthesized using an automatic peptide 
synthesizer (Protein Technologies, Inc. Symphony Quartet) and optimized protocols for 
the Fmoc/tBu solid-phase synthesis method. The Fmoc/tBu method utilizes orthogonal 
protecting groups, a base-labile N-Fmoc (9-fluorenylmethyl chloroformate) group to 
protect the "-amine and an acid-labile side-chain protecting group. An acid-labile rink 
resin was used for the synthesis of the C-terminal amidated peptide. After the peptide 
was synthesized, the resin was washed with N-Methylpyrrolidone (NMP), 
dichloromethane (Cl2CH2), and methanol (MeOH) three times each and dried on the 
synthesizer. The peptide was cleaved off the resin for 3 hours with a cleaving cocktail 
{CF3COOH/triisopropylsilane/water (98:1:1, vol/vol/vol). The cleavage solution was 
concentrated using a stream of nitrogen and the peptide was precipitated with ether, 
followed by three ether washes and a lyophilization step overnight.  After lyophilization 
the peptide was analyzed using a MALDI-TOF to ensure that the molecular weight 
matched the peptide sequence.   
The MMP-pep was modified as illustrated in Figure 3.2 by adding acrylate 
groups to the amine group of the N-terminal and to the amine group on the lysine. This 
acrylation method was done in aqueous solution and the pH was closely monitored to 
ensure the reaction continued at the proper pH. The success of the reaction was 
monitored by mass spectrometry to determine the optimal reaction time. Briefly, 10 mg 
of unprotected MMP-pep was dissolved in 1 mL of H2O and 10 µL of DIPEA (N,N-
Diisopropylethylamine) was added to the peptide solution. The pH was checked to 
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verify that the pH level was at 12 or 13. Once the pH was approximately at 12, then 2 
µL of acryloyl chloride was added, the solution was vortexed and the reaction was 
allowed to occur for 1 minute. After 1 minute the pH was checked; if the pH level was 
too acidic then an aliquot of 10 µL DIPIA was added until the pH reached about 12 or 
13. Again, once pH reached about 12, an additional aliquot of 2 µL of acryloyl chloride 
was added, vortexed and the reaction was allowed to continue for 1 more minute. These 
steps were repeated 12 more times, totaling 14 one-minute reactions. At the end of the 
last reaction time, 10 µL of DIPIA was added to raise the pH once again and to 
minimize side reactions. For analysis of the final product, 4 µL of the reaction solution 
was diluted with 196 µL of 50% methanol to determine the mass of the synthesized 
peptide on a MALDI-TOF. The reaction solution was purified using HPLC.  The peptide 
was collected and lyophilized overnight. Nuclear Magnetic Resonance Spectroscopy 
(NMR) was performed on dried peptide to validate the ratio of peptide to acrylate 
groups.   
 
3.2.2 Bioactivity of Modified MMP-Sensitive Peptide 
The bioactivity of the modified MMP-pep was evaluated using an analytical 
HPLC.  A 5 picomole/µL concentration of the peptide was made by dissolving 2 mg of 
the dried modified peptide in 2 mL of dH2O. An aliquot of 1.7 µL of the dissolved 
peptide was then added to 398.29 µL of TES (tris-EDTA) buffer as the control. Another 
aliquot of 1.7 µL was also added to 398.29 µL of TES containing collagenase 
(Collagenase Type 3, Worthington, Lakewood, NJ) to test for peptide cleavage. Both the 
control (peptide in TES buffer) and the peptide in TES buffer containing collagenase 
were allowed to sit at room temperature for 1 hour before being analyzed using a 
Beckman System Gold HPLC with a diode array detector. A reversed phase column was 
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used at room temperature (column: 0.8 mm x 250 mm, Jupiter 10 u C18 300 angstrom).  
Flow rate used was 120 µL per minute. Two types of buffer were used, buffer A 
contained 0.1% TFA in Liquid Chromatography Mass Spectrometry (LC/MS) grade 
water, buffer B was 0.08% TFA in acetonitrile. The gradient was 0-2 minutes held at 0% 
B, 2-70 minutes linear gradient of 0-65% B, from 70-78 minutes 65-100% B, 78-82 
minutes 100%, 82-84 minutes 100-0% B, and from 84 to 100 minutes at 0% B. 
Absorbance was monitored at 214 nm. Figure 3.3 shows the chromatogram of the 
control peptide in TES buffer (red) and of the peptide in TES buffer containing 
collagenase (blue). The tall single peak in red clearly shows that the peptide did not 
degrade and the two shorter peaks in blue demonstrate that the peptide was cleaved into 
two fragments in the buffer containing the collagenase.  The cleavage fragments of the 
MMP-pep indicated that the modified peptide is bioactive and degradable by 
collagenase. 
 
3.2.3 Biopolymer Modification 
Chondroitin Sulfate A (CS) was methacrylated using methods adopted from Li et 
al. [18] with slight modifications as shown in Figure 3.4. Briefly, 1 g of CS was 
dissolved in 10mL of PBS. 1 mL of glycidyl methacrylate was added to the CS solution 
and the reaction was stirred at room temperature for 15 days. After 15 days the CS was 
precipitated in acetone (1 part CS: 20 parts acetone). The precipitant was filtered with 
filter paper. The precipitant was re-dissolved in 100 mL of dH2O then extracted with 
chloroform at equal volume (100 mL chloroform and 100 mL CS). CS was collected 
with a separation funnel then concentrated back to about 10mL with a rotavap. The 
concentrated CS solution was precipitated again in acetone (1:20). The precipitant was 
centrifuged and the acetone was removed and the precipitant was collected and dried 
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under vacuum for 48 hours. The CS was re-dissolved in water and lyophilized. NMR 
was performed on the dried sample to check the degree of acrylation.   
Hyaluronic acid (HA) was methacrylated following a protocol adopted from 
Leach et al. [23] as shown in Figure 3.5. Briefly, 0.5 g of HA was dissolved in 25 mL of 
deionized water and 25 mL of acetone and mixed overnight. 3.6 mL of triethylamine 
was added to the solution and mixed thoroughly for 2 hours. 3.6 mL glycidyl 
methacrylate (GM) was then added and the reaction was allowed to occur at room 
temperature in a sealed flask for 24 hours. The GMHA solution was next precipitated in 
acetone (one part GMHA solution to 20 parts acetone).  The GMHA solution was slowly 
added to the acetone while stirring with a glass rod. The GMHA precipitated as a 
cottony white solid and was collected on the glass stirrer. The precipitate was transferred 
to a dish and rinsed with acetone. The precipitate was then dissolved in 50 mL dH2O 
overnight. The GMHA was re-precipitated in acetone, rinsed with acetone and dissolved 
in 50mL dH2O overnight. The GMHA solution was then lyophilized for 48-72 hours. 
NMR was used to check the degree of acrylation.   
 
3.2.3 Hydrogel Fabrication 
A total of 10 groups of hydrogel scaffolds were fabricated using poly(ethylene 
glycol) dimethacrylate (PEGDA), MMP-pep, and the modified CS and HA biopolymers. 
The hydrogels were fabricated by dissolving the materials of each group in phosphate 
buffered saline (PBS, pH 7.4) containing 0.05 wt% photoinitiator, Irgacure 2959 (2-
hydroxy-1-[4-(2-hydroxyethoxy) phenyl]-2-methyl-1propanone, Ciba Geigy Corp., 
McIntosh, AL) and polymerized using a long-wave ultraviolet lamp (Model B100AP, 
Blak-Ray) at the intensity of ~10 mW/cm2 for 10 minutes. The 10 groups of hydrogels 
are listed in Table 3.1. Bryant et al. found that the crosslinking density of PEG 
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hydrogels influences the compressive modulus and the morphology of chondrocytes 
[29]. Leach et al. [22] created PEG-based hydrogels with 1-2% HA, Varghese et al. [30] 
incorporated equal volumes of 20% (w/v) PEG and 20% CS in their study and He et al. 
[31] fabricated poly(lactide ethylene oxide fumarate) (PLEOF) hydrogels with 
equimolar concentrations of the MMP-pep.  Base on these studies, 20% (w/v) hydrogels 
were fabricated for the desired compressive strength and HA was incorporated at 1%, 
CS was incorporated at equal volume and MMP-pep was incorporated at equimolar ratio 
with PEG. 
 
3.2.4 Hydrogel Characterization 
The swelling ratio, compressive modulus, and enzymatic degradation of these 
hydrogels were examined.  The swelling properties were determined by swelling the 
hydrogels after polymerization in PBS for 72 hours after equilibrium had been reached.  
The hydrogels were then lyophilized over night to obtain their dry weight.  The changes 
in hydrogel weight between drying (Wdry) and swelling (Wswollen) were used to determine 
the volumetric swelling ratio and equilibrium water content which were calculated using 
the following formulas:  
 












The compressive modulus of the various swollen hydrogels were determined at 
room temperature on an In-spec 2200 Instron mechanical tester with a 125 N loading 
cell using a parallel plate apparatus and a loading of 20% of the initial thickness per 
second (0.1 mm/sec).  The polymer solution was polymerized in a square mold (~ 2 mm 
high, ~ 7 mm wide, and ~ 7 mm long) for mechanical testing and was compressed to the 
maximum thickness of 2 mm. The compressive moduli of blank hydrogels were 
determined by analyzing the linear region of the stress versus the strain curve of the 
samples.  
The degradation profiles of each hydrogel composition were determined.  
Briefly, the hydrogels were polymerized, swollen in PBS overnight, and then degraded 
in 1.5 mL of collagenase (25 µg/mL, Worthington), hyaluronidase (500 U/mL, Sigma) 
or chondroitinase (0.15 U/mL, Sigma) which was replaced every 72 hours throughout 
the study.  The hydrogel samples were incubated at 37 °C on an orbital shaker and at 
various times during the course of the experiment the hydrogels were removed from the 
degradation solution and their swollen weights were weight was measured (n=3 per 
composition).  The percent mass loss of the hydrogels was recorded over time based on 
the initial swollen weight (Winitial) and their weight at time t (Wtime). The weight 









3.2.5 Statistical Analysis 
All quantitative data were expressed as mean ± standard error and were verified by 
analysis of variance using student T-Test with equal variance. P values of less than 0.05 




3.3.1 Material Synthesis & Modification 
A molecular weight comparison of the synthesized peptide with the theoretical 
molecular weight of the peptide sequence was performed using MALDI-TOF on 
lyophilized peptides. Figure 3.6A represents the MALDI-TOF spectra of the 
unmodified peptide. Observed peaks at 739 [MH+], 761 [MH+Na+], and 779 
[MH+Na+H2O+] m/z (mass-to-ratio charge) indicate that the peptide with the correct 
sequence was synthesized. Figure 3.6B shows a proton NMR of the peptide before 
modification. Figure 3.7A represents the MALDI-TOF spectra of the modified peptide 
with observed peaks at 870 [Diacrylate MMP-pep+Na] m/z and 885 [Diacrylate MMP-
pep+Na+H2O+] m/z.  The increase in molecular weight of 110 was due to the addition of 
the acrylate groups.  Figure 3.7B shows a proton NMR of the modified peptide 
verifying that the MMP-pep was correctly modified. To analyze the degree of acrylation, 
the ratio of the integrals at 5.6 – 5.7 ppm and 6.0 – 6.2 ppm to the integral at 0.75 ppm 
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was obtained.  The results indicate successful modification with two acrylate groups per 
peptide sequence. 
The degrees of CS and HA acrylation were confirmed using NMR. Figure 3.8A 
shows the NMR of unmodified CS with an inset of the chemical structure and Figure 
3.8B is an expanded NMR shows that there are no methacrylate protons near the 
anomeric proton peak at 5.14 ppm.  Figure 3.9A shows the proton NMR spectra of the 
acrylated CS verifying modification and Figure 3.9B is the expanded NMR of the 
methacrylate portion showing the integrals of each individual peaks. The ratio was 
calculated by dividing the integral of one of the bound methacrylate proton peak at 5.5 
ppm by the anomeric proton peak at 5.1 ppm, which yielded one acrylate group for 
every two units of CS. Figure 3.10A shows the NMR of unmodified HA with an inset of 
the chemical structure and Figure 3.10B is an expanded NMR that shows the HA 
methyl proton peak at 1.84 ppm. Figure 3.11A shows the proton NMR spectra of the 
acrylated HA with an inset of the chemical structure and Figure 3.11B is the expanded 
NMR of the methyl protons. The degree of HA acrylation was calculated by comparing 
the peaks at 1.92 ppm, which represents the methyl protons of HA, and 1.84 ppm which 
represents the methyl protons of the glycidyl methacrylate (GM) that has bounded to HA 
during acrylation. Calculation of the ratio of these two integrals yielded one acrylate 
group for every eight units of HA. 
 
3.3.2  Hydrogel Characterization 
The volumetric swelling ratios in Figure 3.12A demonstrate the ability of the 
hydrogels to absorb water. The hydrogel groups containing MMP-pep exhibited a lower 
swelling ratio than their corresponding matrices without MMP.-pep.  However, the 
swelling ratio for the PEG hydrogel group was not significantly different from the PEG 
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hydrogels containing MMP-pep.  Since the MMP-sensitive peptide sequence is short, 
the reduction in swelling ratio could be attributed to the decrease in mesh size during 
crosslinking. These results also suggest that CS aided in the absorption and retention of 
water which increased the equilibrium water content of the hydrogels containing CS. 
The equilibrium water content as shown in Figure 3.12B was similar for all hydrogel 
matrices containing CS with ratios of ~0.9, whereas the hydrogel matrices without CS 
had lower ratios ranging from 0.76 to 0.86. The equilibrium water content of the 
hydrogel groups follows the same trend as their swelling ratios. The swelling ratio and 
equilibrium water content of the 20% w/v PEG hydrogels within this study are 
comparable to the values reported earlier by Bryant et al [29, 32]. The significant 
increase in the swelling ratio and equilibrium water content when CS is added to the 
PEG hydrogels is consistent with the results obtained by Li et al. who also found that 
pure CS hydrogels swelled and absorbed more water than PEG hydrogels [18]. 
The compressive moduli of the various swollen hydrogels represent their ability 
to withstand compression and are shown in Table 3.2.  For the blank hydrogels, PEG, 
PEG:HA, and PEG:MMP,-pep had the highest compressive moduli, with no significant 
difference from each other.  The addition of CS, MMP,-pep and the combined addition 
of HA and MMP-pep to the PEG hydrogels significantly (p<0.05) decreased the 
compressive modulus. Interestingly, adding HA and MMP-pep alone to the PEG 
hydrogels did not significantly change the compressive modulus. The pure HA 
hydrogels had a significantly lower compressive modulus, compared to all other 
hydrogel groups.  The compressive modulus of the pure CS hydrogels were only 
significantly lower than that of PEG, PEG:MMP-pep, PEG:HA, and PEG:HA:MMP-pep 
hydrogels. These results indicate that the addition of MMP-pep or CS to the hydrogel 
construct lowered the compressive modulus of the hydrogel matrices while adding HA 
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to the matrices raised the compressive modulus. In previous studies conducted by Bryant 
et al, the compressive modulus for a 20% (w/v) poly(ethylene glycol) dimethacrylate  
(PEGDA, mw: 3400) were found to be about 360 kPa, which is comparable to the 20% 
(w/v) PEGDA (mw: 3400) hydrogels in this study (293.21 ± 39.18 kPa) [29, 32].  
Figure 3.13A shows the degradation profiles for the hydrogel matrices and the images 
of the hydrogels at day 10 (Figure 3.13B) and 21 (Figure 3.13C).  As expected, the 
PEG hydrogels did not degrade in any of the enzyme solutions while the pure CS and 
HA hydrogels degraded very rapidly.  Incorporating CS, HA, and MMP-pep into the 
PEG hydrogels made them degradable.  Incorporating CS into the hydrogels 
demonstrated the fastest degradation kinetics while incorporating HA resulted in the 
slowest degradation rates.   
 
3.4 DISCUSSION 
Since the overall goal of this dissertation is to differentiate MSCs into 
chondrocytes, the hydrogel properties determined in this chapter need to mimic the 
native environment of articular cartilage, which is crucial for cell survival. The essential 
properties of articular cartilage include cell-mediated degradability, water absorption, 
and compressive strength [34].  As discussed in Chapter Two, the major component of 
articular cartilage ECM is type II collagen, which is degraded by matrix 
metalloproteinases (MMP) during ECM remodeling [33].  Native articular cartilage is 
made up of about 65-80% water; therefore, the hydrogels’ ability to absorb water is 
crucial in attempting to mimic native articular cartilage environment [33]. As 




Therefore, this chapter discussed the synthesis and modification of an MMP-
sensitive peptide (MMP-pep). The main purpose for incorporating the MMP-pep into the 
hydrogel network was to enable cell-mediated degradation to occur.  The results 
indicated that not only was peptide synthesis possible but that its modification did not 
interfere with the peptide’s bioactivity.  The degradation profile shown in Figure 3.13A 
demonstrates that the incorporation of the MMP-pep into the PEG hydrogel network 
made the hydrogels degradable by collagenase.    
To mimic the native articular cartilage water content and compressive strength, 
CS and HA were modified for their incorporation into the PEG hydrogel. The findings 
of this chapter determined that the incorporation of CS aided in water absorption while 
the incorporation of HA increased the compressive strength. The results of water content 
within all the hydrogel compositions illustrated in Figure 3.12B demonstrated that all 
hydrogel compositions containing CS had higher water content than all the opposing 
compositions that did not contain CS. This clearly indicates that the incorporation of CS 
into the hydrogel network increased the hydrogel’s ability to absorb water.  
Since articular cartilage’s main function is to resist compression [34], it is  very 
critical for the hydrogel’s compressive modulus to match the compressive strength of 
native cartilage. The compressive moduli of all the hydrogel compositions are listed in 
Table 3.2.  The results indicate that the addition of MMP-pep into the hydrogel network 
decreased the modulus of the hydrogel constructs, where as the incorporation of HA 
greatly increased the modulus.  Furthermore, the PEG:HA hydrogel composition had the 
highest modulus of 330.6 kPa ± 19.13kPa, which was most similar to native cartilage.   
In summary, the results of this chapter demonstrated that the hydrogels’ 
properties can be tailored by altering their material composition. For instance, 
incorporating an MMP-pep makes the hydrogels enzymatically degradable by cell-
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secreted collagenase, whereas CS incorporation aids in the hydrogels’ ability to absorb 
water.  Finally, due to HA’s high molecular weight, its incorporation into the hydrogel 
network significantly increased the hydrogels’ compressive strength.  Based on the 
findings of this chapter, it was determined that hydrogel properties can be fine-tuned to 
match all the essential properties of articular cartilage.  The ability to closely mimic 
native articular cartilage ECM will enhance the capability of hydrogel scaffolds to direct 
the differentiation of MSCs into chondrocytes. In Chapter Four, hydrogels were 
fabricated using the specific biomaterial formulations characterized in this chapter and 



















3.5 FIGURES  
 
 























Figure 3.2 Schematic Drawing of the MMP-Sensitive Peptide Acrylation 
illustrating the attachment of acrylate groups onto the N-terminal amine and the 





Figure 3.3 Chromatograph of the MMP-pep Degradation in collagenase.  The red 
peak represents the intact MMP-pep in TES buffer and the blue peaks represent 
the degraded MMP-pep in TES buffer containing collagenase.  This demonstrates 



























Figure 3.4 Schematic Drawing of Chondroitin Sulfate Acrylation adapted from 
Elisseeff et al. (2003) showing the ethylene oxide ring opening up and attaching to 











Figure 3.5 Schematic Drawing of Hyaluronic Acid Acrylation adapted from 
Schmidt et al. (2005) showing the ethylene oxide ring opening up and attaching to 





Table 3.1 Hydrogel Biomaterial Composition and Concentration 
Group  Hydrogel  PEG CS HA MMP-pep 
1  PEG  20%    
2  PEG:MMP-pep  16%   4% 
3  CS   20%   
4  PEG:CS  10% 10%   
5  PEG:CS:MMP-pep  9% 9%  2% 
6  HA    1%  
7  PEG:HA  19%  1%  
8  PEG:HA:MMP-pep  15%  1% 4% 
9  PEG:CS:HA  9.5% 9.5% 1%  


















Figure 3.6 MALDI-TOF Spectra & NMR of the Crude MMP-pep (A) Peaks at 739 
[MH+], 761 [MH+Na+] and 779 [MH+Na+H2O+] m/z indicating correct molecular 
weight of peptide. (B) An NMR of the peptide before modification showing that 





Figure 3.7 MALDI-TOF Spectra & NMR of the Modified MMP-pep (A) Successful 
acrylation is indicated by MALDI-TOF spectra showing the modified peptide 
peaks at 870 m/z and 885 m/z with an increase in molecular weight of 110 from the 
addition of the acrylate groups. (B) NMR of modified peptide further validates 
successful acrylation.  Ratio of the integrals at 5.6 – 5.7 ppm and 6.0 – 6.2 ppm to 






Figure 3.8 Unmodified CS NMR (A) Unmodified CS NMR with an inset of its 
chemical structure. (B) Expanded NMR of the no methacrylate portions near the 





Figure 3.9 Modified CS NMR (A) NMR spectra of acrylated CS showing 
methacrylate peaks around 6 ppm. (B) Expanded NMR of the methacrylate portion 
showing the integrals of each individual peak.  The ratio of the integral of one of 
the bound methacrylate proton peak at 5.5 ppm and the anomeric proton peak at 





Figure 3.10 Unmodified HA NMR (A) Unmodified HA NMR with an inset of the 






Figure 3.11 Modified HA NMR (A) Acrylated HA (B) Expanded NMR of the 
methyl protons.  The ratio of peaks at 1.92 ppm, which represents the methyl 
protons of HA, and 1.84 ppm, which represents the methyl protons of the 
glycidyl methacrylate (GM) that has bounded to HA during acrylation verified 





Figure 3.12 Swelling Ratio & EWC (A) Volumetric swelling ratios of various 
hydrogel constructs correlate to the ability of the hydrogels to absorb water. Pure 
CS and HA hydrogels exhibit the highest swelling ratio.  (B) Equilibrium water 
content of various constructs illustrates that the incorporation of CS into the 





Table 3.2 Compressive Moduli of Blank Hydrogel Constructs 
 
Blanks 
Hydrogel Groups Moduli (kPa) Standard Error 
PEG 293.21 ± 39.18 
PEG:MMP-pep 261.88 ± 1.51 
CS 82.39 ± 38.82 
PEG:CS 117.8 ± 54.46 
PEG:CS:MMP-pep 105.78 ± 26.89 
HA 31.48 ± 8.86 
PEG:HA 330.6 ± 19.13 
PEG:HA:MMP-pep 184.28 ± 26.76 
PEG:CS:HA 74.02 ± 11.10 





















Figure 3.13 Hydrogel Degradation Profiles (A) PEG-based hydrogels incorporating 
CS, HA, and MMP-pep were determined to see how each component affects 
degradation kinetics. The addition of CS into PEG-based hydrogels yield the fastest 
degradation rate where as the addition of HA yield the lowest degradation rate.  
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The preliminary goal for cartilage tissue engineering is to create a homogeneous 
tissue type by encapsulating chondrocytes uniformly within a polymer matrix to mimic 
the overall properties of articular cartilage.  However, as discussed in Chapter Two, it is 
time consuming to isolate chondrocytes and they have the tendency to de-differentiate 
during in vitro culture [1, 2].  To this end, many investigators have utilized hydrogel-
based approaches to induce the chondrogenic differentiation of stem cells.   
As described in Chapter Two, stem cells are characterized by their capacity for 
self renewal and their ability to differentiate into a diverse assortment of specialized cell 
types [3].  Embryonic stem (ES) cells and adult stem cells are distinguished by the cells’ 
differentiation potential. Both embryonic and adult stem cells have shown great potential 
for cartilage tissue engineering [3-12].  ES cells can serve as an unlimited cell source 
but; however, it is extremely difficult to control the cells’ differentiation and obtain a 
homogenous cell population [7].  Therefore, researchers have turned to adult stem cells 
whose differentiation pathways can be better directed. Adult stem cells that are 
commonly used for cartilage tissue engineering include mesenchymal stem cells (MSC), 
adipose stem cells (ASC), adipose-derived stem cells (ADSC), and to a lesser extent, 
synovial-derived stem cells (SDSC) [11-18].  Although MSCs and ADSCs have been 
widely used in the cartilage tissue engineering field, numerous comparative studies have 
determined that MSCs have superior chondrogenic potential for tissue engineering [13-
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15, 19-21]. Thus the research conducted in this dissertation utilized MSCs for 
chondrogenesis. 
In this chapter, MSCs were encapsulated within PEG-based hydrogel scaffolds 
containing a combination of CS, HA, and MMP-sensitive peptide (MMP-pep) to 
investigate the effects of biomaterial compositions on MSC differentiation into 
chondrocytes.  PEG-based hydrogels were used to create the complex biomimetic 
environment because they have tunable properties, can be functionalized easily, and are 
non-immunogenic [22-26]. Within the PEG-based hydrogel, an MMP-pep was 
incorporated because matrix matelleoproteases (MMPs) have been shown to be secreted 
by cells during ECM remodeling, and MMPs are capable of cleaving the "-chains of 
collagens type I, II and III [27-29]. CS and HA are natural components of the ECM; 
therefore, their incorporation into the hydrogel network aids in mimicking the natural 
cartilage environment. CS has the ability to retain water, which allows the diffusion of 
nutrients. The electrostatic repulsion caused by the sulfated groups of CS contributes to 
the compressive strength of articular cartilage [30, 31]. Hyaluronic acid (HA) has been 
shown to contribute to cellular proliferation, migration, and wound healing [32].   
The findings of this chapter indicate that biomaterials indeed play an inductive 
role in the chondrogenesis of MSCs.  Furthermore, the results demonstrated that a 
particular biomaterial composition can induce the differentiation of MCSs into a specific 




4.2 MATERIALS AND METHODS 
 
4.2.1 Cell Encapsulation and In Vitro Culture 
To evaluate the affects of biomaterial composition on chondrogenesis, D1 ORL 
UVA (ATCC, Manassas, VA) cells, a mouse bone marrow stem cell line [33, 34], were 
encapsulated within each composite hydrogel construct previously listed in Table 3.1 
and cultured for 2, 4, or 6 weeks in a chondrogenic medium containing TGF-!1 [35, 36].  
A progenitor cell line was used instead of isolated primary stromal cells in order to keep 
the cell properties constant across various experiments in order to be able to better 
evaluate the influence of the material compositions. A cell density of 20 million 
cells/mL were mixed with the syringe filtered polymer solution and 125 µL  of the 
cell/polymer mixed was placed in a square mold (7x7x2mm) and polymerized for 10 
minutes using a long-wave ultraviolet lamp (Model B100AP, Blak-Ray) at the intensity 
of ~10 mW/cm2.  The hydrogels were cultured in serum-free chondrogenic media 
containing 1% penicillin/streptomycin, 10nM dexamethasone, 50 µg/mL ascorbic acid-
2-phosphate, 40 µg/mL L-proline, 5 mL ITS+1, and 10 ng/mL TGF-!1 for 2, 4, and 6 
weeks in a 12-well plate.  The media was changed every other day. 
 
4.2.2 RNA Isolation and RT-PCR 
Chondrogenesis was determined by the gene expression of collagen I, II, X and 
X I within these hydrogel matrices at 2, 4, and 6 week time points.  The hydrogel 
matrices were removed from culture and the gene expressions of encapsulated cells were 
analyzed. The hydrogels were placed into individual 2mL microcentrifuge tubes, and 
200µL of TRIzol® was added to the tubes.  The hydrogels were then crushed using a 
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homogenizer (Wheaton, Millville, NJ). After complete homogenization, another 800µL 
of TRIzol® was added to each tube.  
The RNA isolation of the homogenized scaffolds was performed following the 
manufacture’s protocol. Briefly, the crushed scaffolds were incubated on ice for 45 
minutes.  200µL of chloroform was added to each tube and then agitated vigorously for 
15 seconds. The tubes were then incubated again at room temperature for 3 minutes and 
centrifuged at 12,000 RCF for 15 minutes at 4 °C. The aqueous layer was transferred to 
new tubes containing 400 µL of new chloroform and centrifuged again at 12,000 RCF 
for 15 minutes at 4 °C.  The aqueous layer was transferred into a new tube, this time 
containing 500µL of 100% isopropanol and 20µL of glycogen (5mg/mL, Ambion, 
Austin, TX) in each tube, for the visibility of the RNA pellet. After the addition of the 
glycogen, the tubes were manually rotated for 4 minutes and incubated for 6 minutes at 
room temperature. The tubes were then centrifuged at 12,000 RCF for 10 minutes at 4 
°C, the isopropanol was poured out, and 1mL of 80% ethanol was added to each tube to 
re-suspend the RNA pellet. The tubes were then centrifuged again at 7,500 RCF for 10 
minutes at 4 °C. The ethanol was poured out and the tubes were air dried for 10 minutes. 
Then, 21µL of nuclease free water was added to each tube and incubated at 55 °C for 10 
minutes. After the incubation, the RNA concentration for each hydrogel sample was 
determined using a NanoDrop with the ND-1000 software.   
Genomic DNA was removed using Deoxyribonuclease I (Invitrogen, Carlsbad, 
CA). First a strand of cDNA was synthesized by reverse transcription (RT) using 
Superscript
TM 
III kit (Invitrogen, Carlsbad, CA), following the manufacturer’s 
instructions. The RT reaction was performed at 25°C for 10 minutes, 50°C for 50 
minutes, and terminated after 5 minutes at 85°C.  
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Quantitative polymerase chain reaction (PCR) was performed using an ABI 
Prism® 7900 Real Time thermal cycler and HotStartTaq DNA Polymerase with SYBR 
green/ROX PCR master mix (SA Biosciences, Fredrick, MD). Primers for the 
housekeeping gene (GAPDH), collagen type II, type X and type I (SA Biosciences, 
Fredrick, MD) are listed in Table 4.1. GAPDH was used as the housekeeping gene 
because it is expressed in both differentiated and undifferentiated MSCs. As discussed in 
chapter two, collagen type II is a standard genetic marker to determine chondrogenesis 
because collagen type II is the most abundant type of collagen in articular cartilage. The 
expression of type X collagen is a genetic marker for hypertrophic chondrocytes, thus 
type X collagen expression indicates terminal differentiation. MSCs have a basal level 
expression of type I collagen, therefore the early expression of type I collagen is 
expected. However, type I collagen expression at later time points is an indication of 
either fibrocartilage formation or de-differentiation. During the PCR reactions, the 
HotStartTaq DNA Polymerase was first activated at 95°C for 10 minutes then the next 
40 cycles ran at 95°C for of 15 seconds per cycle.  After the DNA strand was denatured, 
it was then elongated with 2 cycles. The first cycle was 60 seconds at 60°C and the 
second for 60 seconds at 72°C.  
Threshold cycle (C
T
) values were determined using the ABI PRISM
® 
7700 
Sequence Detection System software and also used to analyze the total product.  The 
housekeeping gene, GAPDH, was used to normalize relative gene expression through 
the 2
-$$CT 
method [37]. GAPDH was used to normalize the genes of interest since this 
gene remains proportional to the amount of starting total RNA that was initially isolated 
from each sample. Gene expression fold differences were then determined via 2
-$$CT 
method, and the derivation of this analysis were described in detail by Livak and 
Schmittgen [37, 38].  Negative controls to assess the quality of the primers and total 
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RNA was also assessed, which consisted of running samples without templates and 
synthesizing cDNA without reverse transcriptase, respectively. All samples were run in 
triplicate within the assay. 
 
4.2.3 Endpoint RT-PCR 
End-point RT-PCR was performed to verify the results from the quantitative real 
time PCR. The cDNA was fragmented via gel electrophoresis. Briefly, 2.25g of agarose 
was added to 150 mL of Tris borate EDTA (TBE) buffer to create a 1.5% agarose gel. 
The agarose solution was covered with saran wrap and heated for 3 minutes in a 
microwave until the agarose was completely dissolved. The solution was allowed to cool 
for 10 minutes at room temperature before being poured into a gel frame. A well-comb 
was placed at one end of the gel and the agarose solution was allowed to stand in room 
temperature for 1 hour to harden and cool. Meanwhile, 5 µL of amplicons for each 
hydrogel group were obtained from the previous real time PCR experiment and added to 
1 µL of DNA loading buffer. An aliquot of 5 µL of the DNA ladder was also added to 1 
µL of the loading buffer. Once the gel hardened, the cDNA and DNA ladder were 
loaded into individual lanes. The gel ran for 1 hour and 30 minutes at 100V and then 
images were taken with the alpha imager software. 
 
4.2.4 Histology and Immunohistochemistry 
Histology of these hydrogel matrices was performed to investigate the 
chondrogenic differentiation and verify the quantitative real time data. At 2, 4, and 6 
week time points, hydrogels were removed from culture and fixed in 4% 
paraformaldehyde at 4°C for an overnight period. Fixed hydrogels were then dehydrated 
for paraffin embedding using 1-hr sequential steps in the following order: 80%, 95%, 
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95% ethanol in dH2O, 100% ethanol, 50/50 ethanol/CitriSolv, 100% CitriSolv, 100% 
CitriSolv, 60°C molten paraffin, and 60°C molten paraffin for an overnight period. 
Paraffin-embedded hydrogels were sliced in transverse sections at 10%m using a rotary 
microtome (Labmaster).  Sections were stained for differentiation markers.  
Double Sequential immunohistochemistry was performed to stain for collagen II 
(green) and collagen X (red) using rabbit polyclonal primary antibodies (Abcam, 
Cambridge, MA) and Texas red (collagen II) or FITC (collagen X) conjugated 
secondary antibodies. Slides containing sectioned hydrogels were blocked for unspecific 
binding for 30 minutes at 37 °C using 3% (w/v) bovine serum albumin (BSA) in PBS 
(pH 7.4). The slides were rinsed with 0.05% tween 20 in PBS solution three times. 
Washed slides were incubated with primary antibody for 30 minutes at 37 °C. The slides 
were rinsed again before the second incubation with the secondary antibody for 30 
minutes at 37 °C. These steps were repeated for collagen X on the same slides. The 
slides were imaged using a confocal fluorescence microscope (Leica SP2 AOBS, 63X).   
 
4.2.5 Biochemical Characterization 
Glycosaminoglycan (GAG) production within each hydrogel group was 
determined using the Dimethylmethylene blue (DMMB) assay. Briefly, at 2, 4, and 6 
week time points, hydrogels were removed from culture. Wet weights (ww) and dry 
weights (dw) after 48 hours of lyophilization were obtained for each construct (n=3).   
The dry constructs were then digested in 1 mL of papinase (papain, 125 µg/mL; Sigma, 
St. Louis, MO) at 60°C overnight. 200 µL of the DMMB solution was added to each 
well of the 96 well plates; then 50 µL of standard solution and sample solutions were 
added. The plate was shaken for 10 seconds before reading the absorbance at 525nm. To 
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account for the hydrogel material, absorbance of blank hydrogels was subtracted from 
the sample values.  
The DNA content was determined using Sigma’s DNA quantification kit (DNA-
QF) in order to normalize the GAG production. The assay was carried out following the 
manufacture’s protocol for multiwall assay. Briefly, 50 µL of sample was added to 1 mL 
of the bisbenzimide H 33258 dye solution (0.1 µg/mL). Then 200 µL of sample-dye 
solution was pipetted in triplicate into a 96 well plate. The fluorescence was read at 360 
excitation and 460 emissions. The calibration curve was obtained by plotting the total 
DNA concentration versus the relative fluorescence units. 
 
4.2.6 Mechanical Compression of Cell Laden Hydrogels 
The compressive modulus of the various cell-laden swollen hydrogels were 
determined at room temperature on an In-spec 2200 Instron mechanical tester with a 125 
N loading cell using a parallel plate apparatus and loading of 20% of the initial thickness 
per second (0.1 mm/sec). The pre-sterilized cell-polymer solution was polymerized in a 
square mold (2 mm x 7 mm x 7 mm) for 10 minutes using a long-wave ultraviolet lamp 
(Model B100AP, Blak-Ray) at the intensity of ~10 mW/cm2. The polymerized hydrogel 
constructs were then used for mechanical testing and were compressed to the maximum 
thickness of 2 mm. The compressive modulus of the cell-laden hydrogels were 
determined by analyzing the linear region of the stress versus the strain curve of the 




4.2.7 Statistical Analysis 
All quantitative data were expressed as mean ± standard deviation and were 
verified by analysis of variance using student T-Test with equal variance. P values of 




4.3.1 Chondrogenic Differentiation of MSCs 
The gene expression of type II collagen was used to verify chondrogenesis since 
collagen II makes up approximately 90% of the collagen in articular cartilage. Type X 
collagen was used to determine chondrocyte hypertrophy. Only the hypertrophic 
chondrocytes in the calcified cartilage zone produce type X collagen. The gene 
expression of type I collagen indicates fibrocartilage formation or chondrocyte de-
differentiation. The average fold difference as compared to undifferentiated cells 
encapsulated within PEG-only hydrogels for collagen II and X for each hydrogel 
construct are shown in Figures 4.1A and 4.1B respectively.  Average fold difference for 
collagen type I is shown in Figure 4.2A and Figure 4.2B is an expansion of type I 
collagen expression at 6 weeks. Figure 4.3 are the gel images of endpoint RT-PCR for 
GAPDH, collagen II, and collagen X at 2, 4, and 6 weeks.   
At all time points, the various hydrogel matrices exhibited similar trends in type 
II collagen expression. The collagen II expression increased between week 2 and week 4 
but decreased by week 6 in all of the hydrogel matrices. The addition of CS to the PEG 
hydrogels only significantly increased collagen II expression at the 2 week time point. 
However, at all time points, the combined addition of CS and MMP-pep into the PEG 
hydrogels significantly increased collagen II expression indicating that the combination 
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of CS and MMP-pep enhanced chondrogenesis. The addition of HA alone to the PEG 
hydrogels had no significant effect on the collagen II expression, however the combined 
addition of HA and MMP-pep to PEG hydrogels significantly increased the collagen II 
expression at all time points. Although the combined addition of CS and MMP-pep as 
well as HA and MMP-pep to the PEG hydrogels, significantly increased the collagen II 
expression, the PEG:CS:MMP-pep hydrogels had significantly higher collagen II 
expression than the PEG:HA:MMP-pep hydrogels at 2 weeks. The results from this 
study demonstrate that the interactions of CS and MMP-pep are initially more favorable 
than the HA and MMP-pep interaction for chondrogenesis.  
At 2 weeks, collagen X expression was very low for all the hydrogel matrices 
with the exception of CS-only hydrogel matrices. Collagen X expression increased in all 
hydrogel groups at 4 weeks. The CS-only hydrogel group exhibited the greatest collagen 
X expression, which was significantly (p<0.05) higher than all other hydrogel groups for 
both 2 and 4 weeks. At 6 weeks the collagen X expression decreased in all groups except 
those that contained CS in their hydrogel composition, where collagen X expression 
continued to increase. This implies that CS may play an inductive role in differentiating 
MSCs into the hypertrophic phenotype by accelerating differentiation into the terminal 
state.   
Relatively low levels of type I collagen expression were present in all hydrogel 
groups at 2 weeks and steadily decreased to a non-detectable level at 6 weeks. At 2 and 
4 weeks, the PEG:CS hydrogel group had significantly higher collagen I expression than 
almost all other hydrogel groups. Both the pure CS and HA hydrogel groups had 
collagen I expression that were significantly lower than almost all other hydrogel 
groups. The down regulation of type I collagen expression at 6 weeks verified that 
chondrogenesis was directed towards the articular cartilage and not the fibrocartilage 
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phenotype. Additionally, the lack of type I collagen expression signifies that the 
differentiated chondrocytes did not de-differentiate into the fibroblastic form at 6 weeks. 
 
4.3.2 Histological Analysis of Imaged Hydrogels 
For further verification of chondrogenesis and to validate the quantitative data, 
immunohistochemical staining was performed to determine the cells’ production of 
collagen II and collagen X. At all time points, positive staining for both collagen II and 
X was observed in the fluorescent images shown in Figure 4.4. At 2 weeks the PEG:CS 
and the PEG:MMP-pep hydrogels showed more positive staining for collagen II than the 
PEG hydrogels, which was consistent with the gene expression analysis. The 
PEG:CS:MMP-pep hydrogel matrix exhibited the most collagen II staining. The CS-
only hydrogels also showed the greatest amount of collagen X staining at 2 weeks, but 
the distribution appears to be clustered. At 4 weeks, large aggregates of collagen X 
staining were observed with increased intensity shown in the CS-only hydrogel group. 
The collagen II staining at 4 weeks became more clustered in the PEG:MMP-pep and 
the PEG:CS:HA hydrogel groups but remained evenly distributed for the other hydrogel 
groups. At 6 weeks the collagen X staining intensified while the collagen II staining 
decreased for all hydrogel groups, which were again consistent with our gene expression 
data at 6 weeks. Due to the low levels of type I collagen gene expression; 
immunohistochemical staining was not performed for this gene. 
 
4.3.3 Protein Analysis for Total GAG Production  
Biochemical composition, specifically DNA and GAG concentration of the 
hydrogel matrices, was observed to be dependent on matrix composition and time spent 
in culture. Given the differences in material composition and cell density of the 
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hydrogels, blank (without cells) hydrogels were subtracted as background and matrix 
accumulation was normalized to the DNA content. Thus, the observed differences are 
indications of the biosynthetic activity of the cells within each hydrogel group. The 
GAG/DNA ratios of all the hydrogel groups are shown in Figure 4.5. At 2 weeks, the 
addition of CS to the PEG hydrogels significantly increased the GAG production. HA-
only hydrogels produced significantly less GAG than the PEG:HA and PEG:HA:MMP-
pep groups, at 2 weeks. For all hydrogel groups the GAG production increased from 2 to 
4 weeks. Interestingly though, greater matrix accumulation was observed in hydrogel 
groups containing HA compared to hydrogel groups that did not contain HA, at all time 
points. At six weeks the GAG production in most of the hydrogel groups decreased, with 
the exception of pure CS and HA hydrogels which increased in matrix accumulation.   
 
4.3.4 Mechanical Strength of Hydrogel Constructs 
The compressive modulus of each hydrogel group at 2, 4, and 6 weeks was also 
determined and listed in Table 4.2. The results indicate that the compressive modulus 
increased with time for all hydrogel groups with the exception of the HA-only 
hydrogels. The HA-only hydrogel group is the only group that showed a decrease in 
compressive modulus from 2 to 4 weeks. At 6 weeks the compressive modulus of the 
pure HA hydrogel group could not be obtained due to the complete degradation of the 
hydrogels. The CS-only hydrogel constructs, exhibited the lowest compressive modulus 
at 2 weeks, but continued to increase at both 4 and 6 weeks. The PEG:HA hydrogel 
group exhibited the highest compressive modulus at all time points. Similar to the 
findings from Chapter Three, it was observed that the addition of MMP-pep or CS to the 
hydrogel constructs lowered the compressive modulus while adding HA to the matrices 




To evaluate chondrogenesis, D1 mouse progenitor cells were encapsulated 
within each hydrogel group and cultured for 2, 4, and 6 weeks.  At each time point the 
GAG production as well as the gene expression for type II, X, and I collagen was 
determined. RT-PCR results for the gene expression of type I, II, and X collagens were 
in accordance with previous studies conducted by Barry et al. [39]. Barry et al. 
demonstrated that the encapsulated MSCs showed a temporal expression of the different 
kinds of collagen, with early expression of type I, followed by the expression of collagen 
II and terminating with the increasing expression of collagen X [39]. Undifferentiated 
MSCs have been shown to uniformly express type I collagen [39, 40]. Additionally, type 
I collagen is a genetic marker for fibrocartilage because it is the only type of cartilage 
that contains type I collagen in addition to the normal type II collagen [41]. Therefore, 
type I collagen expression was used to determine cell de-differentiation and formation of 
fibrocartilage. For all hydrogel groups, type I collagen was present at low levels at 2 
weeks and steadily decreased to an almost undetectable level at 6 weeks. The decrease in 
type I collagen is an indication that the initial type I collagen expression at two weeks is 
from undifferentiated cells and not from fibrocartilage. If the MSCs were differentiating 
into fibrocartilage, the type I collagen expression would increase with time instead of 
decrease.   
Type II collagen is a common genetic marker used to determine chondrogenesis 
because it makes up approximately 90% of the collagen in articular cartilage. Collagen 
II expression for all hydrogel compositions was relatively high at 2 weeks and continued 
to increase at 4 weeks for most hydrogel groups. However, by 6 weeks type II collagen 
expression decreased, while type X collagen increased in all hydrogel groups. At all time 
points, the addition of CS:MMP-pep or HA:MMP-pep into PEG hydrogels significantly 
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increased collagen II expression, while the addition of CS or HA alone had only a 
modest effect. At 2 and 4 weeks, PEG:CS:MMP-pep scaffolds had significantly higher 
collagen II expression than PEG:HA:MMP-pep hydrogels. 
Type X collagen is only produced by hypertrophic chondrocytes. The increase in 
type X collagen indicated that chondrogenesis during this study occurred up to 4 weeks, 
and by the 6 week time point all the chondrocytes became hypertrophic.  Hypertrophic 
chondrocytes terminally differentiate and either begin endochondral ossification 
resulting in the creation of bone tissue [42] or undergo apoptosis [43-45] depending on 
their location. According to the mRNA results, the MSCs within all hydrogel groups 
began differentiation at 2 weeks and continued to differentiate into chondrocytes up to 4 
weeks. At 6 weeks there were very few undifferentiated cells and the majority of the 
chondrocytes had undergone terminal differentiation into the hypertrophic phenotype.   
Histology and immunohistochemistry confirmed the mRNA results and revealed 
that cartilage-specific proteins were produced within the hydrogel matrices.  
Immunohistochemical staining for types II and X collagen (Figure 4.4) indicated 
significant differences between 2 and 6 weeks. At week 2 the MSCs in all hydrogel 
groups produced more type II collagen, but after 6 weeks of culture, type X collagen 
production dominated in all hydrogel groups, which agreed with the RT-PCR data.  At 2 
weeks the observed collagen II staining were high in PEG:CS:MMP-pep, PEG:CS:HA, 
and PEG:MMP-pep hydrogels, while CS-only hydrogels exhibited the highest amount of 
collagen X staining. At week 4, PEG:CS:MMP-pep and PEG:CS:HA hydrogel 
constructs continued to express high levels of collagen II and low levels of collagen X 
staining, while CS-only hydrogels still showed very high collagen X expression. 
However, PEG:MMP-pep hydrogel constructs also showed significantly higher levels of 
collagen X expression at 4 weeks compared to week 2. Cells cultured up to 6 weeks 
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exhibited higher levels of collagen X staining in all formulations, indicating that 
prolonged in-vitro culture of MSC-derived chondrocytes resulted in a hypertrophic 
phenotype [45].  
Biochemical analysis for total GAG production (normalized to DNA content; 
blank hydrogels as background control) indicated that proteoglycan synthesis and matrix 
remodeling are significantly influenced by biomaterial composition. The GAG/DNA 
ratios for all hydrogel groups are shown in Figure 4.5. GAG production appears to be 
time dependent, increasing from 2 to 4 weeks and then decreasing at week 6, once 
terminal MSC differentiation is achieved. In addition, matrices incorporating HA 
showed significant increases in GAG production compared to PEG-only hydrogels at 4 
weeks. The greater matrix accumulation observed in hydrogel groups containing HA 
compared to those that did not contain HA, may be an indication that the presence of 
HA within the hydrogel matrix enhances GAG production. The GAG production 
increased between 2 and 4 weeks for all hydrogel groups but dropped off at 6 weeks 
with the exception of the pure CS and HA groups.  The cause for the continued increase 
in GAG production in these two hydrogel groups is unclear, but the structural integrity 
of these hydrogels at 6 weeks may play a role. The degradation results from Chapter 
Three determined that the pure CS and HA hydrogels degraded very rapidly. This rapid 
degradation was observed during the differentiation studies, where both pure CS and HA 
hydrogels degraded by 6 weeks.   
Hydrogels without PEG lacked mechanical stability as shown by the hydrogels’ 
compressive modulus listed in Table 4.2. Mechanical strength is important for the 
structural support of the cells within these matrices. As discussed in Chapter Two, 
chondrocytes are responsible for the maintenance of the cartilage ECM [46] and 
therefore they are extremely sensitive to their external surroundings. Without structural 
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support, chondrocytes will attempt to compensate by synthesizing their own ECM, 
which could be a reason for the increased GAG production at 6 weeks within the CS and 
HA hydrogels. The cells within the other hydrogel groups showed a decrease in GAG 
production once they reached their GAG production threshold, which has been shown to 
occur by Day 21 [39]. Barry et al. demonstrated that during the hMSC differentiation 
pathway, matrix accumulation occurs until the ratio of chondroitin-6-sulfate and 
chondroitin-4-sulfate reaches approximately 4 (CS6:CS4), which is the GAG production 
threshold [39]. Once the threshold has been reached, chondrocytes stop synthesizing 
additional GAG and begin to turn-over the GAG during remodeling [39, 46]. The 
findings of this study illustrate the capacity of MSCs for biochemical activity within the 
various hydrogel compositions. Additionally, the mRNA and biochemical results 
indicated that specific hydrogel compositions have unique regulation of chondrogenic 
genes and GAG production that correlate to the specific zones of articular cartilage. 
The results of this study demonstrate that biomaterial composition not only 
induces the chondrogenic differentiation of MSCs but that the differentiation can be 
correlated to the specific zones of articular cartilage. Figure 4.6 illustrates the 
correlations between the various composite hydrogel constructs and the specific zones of 
articular cartilage. In particular, the PEG:CS:MMP-pep hydrogel composition had the 
highest collagen II expression as well as the lowest GAG production at  2, 4, and 6 
weeks, which can be correlated to the superficial zone of articular cartilage. The 
PEG:CS composition had midrange expression of collagen II and GAG content for all 
time points, which is similar to that of the transitional zone. The PEG:HA hydrogel 
composition can be correlated to the deep zone of articular cartilage because of its high 
GAG content and low expression of collage II. The MSCs within the CS-only hydrogel 
composition differentiated into hypertrophic chondrocytes with very high expression of 
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collagen X; thus, the CS-only hydrogel composition can be used to induce 
chondrogenesis specific to the calcified cartilage zone.   
As discussed in Chapter Two, the mechanical properties of each articular 
cartilage zone is dependent on the matrix composition within each zone [47]. The 
compressive modulus of articular cartilage increased significantly from the articular 
surface to the deep zone [48]. The compressive modulus of the cell-laden hydrogel 
matrices from this study can also be correlated to each zone of articular cartilage, with 
PEG:CS:MMP-pep having the lowest compressive modulus,  followed by PEG:CS. 
PEG:HA has the highest compressive modulus.  
In summary, this chapter has demonstrated that hydrogels incorporating both 
synthetic and natural polymers as well as cell-induced degradability are suitable for the 
generation of zone-specific chondrogenic phenotypes from a single MSC population. 
Furthermore, this study is the first to report that specific biomaterial compositions have 
the capability of inducing MSC differentiation into a specific chondrogenic phenotype 
that can be correlated to the various zones of articular cartilage. Based on these specific 
correlations determined in this chapter, Chapter Five discusses the fabrication of a single 
multi-layered hydrogel construct and examines its ability to simultaneously differentiate 









4.5 FIGURES  
 














































Figure 4.1 Collagen II and X Gene Expression shown as average fold difference 
compared to undifferentiated D1 cells with PEG hydrogels for (A) collagen type II 







Figure 4.2 Collage I Gene Expression shown as average fold difference compared 
to undifferentiated D1 cells with PEG hydrogels for (A) collagen type I and (B) the 





Figure 4.3 End-point Agarose Gels for collagen type II, type X and GAPDA for 2, 4 

















Figure 4.4 Immunohistochemical Staining of paraffin-embedded sections of all 
hydrogels constructs at 2, 4 and 6 weeks for collagen II (green) and X (red) (63X 
objective, Leica SP2 AOBS).  At all time points, the fluorescent images showed 





Figure 4.5 GAG Concentrations of the hydrogel constructs is dependent on matrix 
composition and time point of assay.  Given the differences in material composition 
and cell density of the hydrogels, GAG content of blank (no cells) hydrogels were 
subtracted as background and matrix accumulation was normalized to DNA 














Table 4.2 Compressive Moduli of Cell Laden Hydrogel Constructs 
 2 Weeks 4 Weeks 6 Weeks 












PEG  197.65 ± 25.51 512.59 ±  96.62 751.18 ± 54.86 
PEG:MMP-pep  244.41 ± 37.00 492.34 ±  40.47 603.99 ± 64.26 
CS  26.42 ± 5.80 65.03 ±  9.98 68.18 ± 37.37 
PEG:CS  121.14 ± 36.00 284.00 ±  89.96 270.87 ± 31.55 
PEG:CS:MMP-pep  120.33 ± 28.62 147.88 ±  21.01 209.1 ± 38.16 
HA  41.66 ± 14.12 11.60 ±  4.68   
PEG:HA  271.57 ± 64.21 435.07 ±  59.52 1227.9 ± 102.14 
PEG:HA:MMP-pep  201.41 ±  4.77 360.63 ±  54.56 666.73 ± 118.35 
PEG:CS:HA  92.19 ± 10.47 204.50 ±  77.75 521.79 ± 31.39 








Figure 4.6 Correlations of Hydrogel Compositions to the Zones of Articular 
Cartilage. PEG:CS:MMP-pep corresponding to the superficial zone, PEG:CS to 
the transitional zone, PEG:HA:MMP-pep to the deep zone and CS corresponding 
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Simultaneous Differentiation of MSCs into Zonally Organized 
Articular Cartilage within a Multi-layered Hydrogel 
 
5.1 INTRODUCTION 
Although tissue engineered cartilage offers a promising solution, most efforts to 
date have focused on generating homogenous tissues whose bulk properties are similar 
to native articular cartilage [1-7]. However, anatomically and functionally, articular 
cartilage consists of four, spatially distinct regions; the superficial, transitional, deep, 
and calcified zones [8].  
As discussed in Chapter Two, each zone is characterized by unique extra-cellular 
matrix (ECM) compositions, mechanical properties, and cellular organization. The 
cartilage ECM is primarily composed of type II collagen and glycosaminoglycans 
(GAGs) whose relative concentrations vary spatially from the superficial to the deep 
zone leading to varying mechanical properties [9]. The superficial zone contains high 
levels of collagen II and low levels of GAG [10]. The transitional zone has lower 
collagen II content while the GAG concentration increases [11]. The deep zone contains 
the highest concentration of GAGs and the lowest level of collagen II fibers [8]. Finally, 
the calcified cartilage zone contains high levels of collagen X and integrates the cartilage 
to the subchondral bone [8, 10, 11]. The mechanical properties of articular cartilage are 
sensitive to changes in the ECM composition  because any compressive forces that are 
experienced by the tissue, stimulates GAG synthesis and ECM remodeling [12, 13]. 
Specifically, the compressive modulus increases significantly from the articular surface 
to the deep zone and is dictated by the varying ECM composition of the various zones 
and the structural organization of the ECM molecules [9].  
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Since the properties of articular cartilage are dictated by its structural 
organization, it is important to reproduce this zonal architecture and function when 
attempting to generate articular cartilage substitutes. The classical approach of creating 
homogenous tissue replacements has failed to achieve widespread clinical effectiveness 
because the bulk properties of the homogenous tissue cannot mimic native articular 
cartilage function. Thus the goal of this dissertation and the focus of this chapter were to 
create zonally organized articular cartilage that can function as proper mechanical 
substitutes. 
Chapter Four demonstrated that biomaterials can be used to direct stem cell 
differentiation into specific chondrocytes, within single layer hydrogels. Building on the 
findings of Chapter Four, a multi-layered hydrogel with the specific biomaterials was 
created in Chapter Five. The multi-layered hydrogel construct (MLHC) was fabricated 
for the purpose of simultaneously differentiating a single stem cell population into the 
specific zones of articular cartilage. The specific correlations determined in Chapter 
Four for each layer of the multi-layer construct are as follows: PEG:CS:MMP-pep, 
PEG:CS, and PEG:HA, representing the superficial, transitional, and deep zone 
respectively.  The findings indicate that three-dimensional matrices composed of both 
synthetic and natural biopolymers may provide specific environmental cues necessary 
for differentiating MSCs and directing them to develop into zone-specific cartilage 
phenotypes. 
 




5.2.1 Multi-Layered Hydrogel Fabrication  
The fabrication of the MLHC was performed from the bottom layer upward. The 
specific biomaterial compositions and concentrations of each layer are listed in Table 
5.1. Briefly, 100 µL of PEG:HA-MSC mixture was polymerized under UV for 3 
minutes to represent the deep zone. Then 100 µL of PEG:CS-MSC mixture was added 
on top of the partially polymerized bottom layer and placed under UV for an additional 
3 minutes to represent the transitional zone. Finally, for the superficial zone, 100 µL of 
PEG:CS:MMP-pep-MSC mixture was placed under UV on top of the previous two 
layers for 5 minutes to fully polymerize the entire multi-layered hydrogel. A schematic 
of the multi-layered hydrogel fabrication technique is illustrated in Figure 5.1A, S 
representing the superficial layer, T representing the transitional layer, and D 
representing the deep layer. This multi-layered scaffold was cultured in serum-free 
chondrogenic media containing 1% penicillin/streptomycin, 10nM Dexamethasone, 50 
µg/mL ascorbic acid-2-phosphate, 40 µg/mL L-proline, 5 mL ITS+1, and 10 ng/mL 
TGF-!1 for 2, 4, and 6 weeks in a 12-well plate [14]. Figure 5.1D showed the cell laden 
multi-layered hydrogel construct exhibiting distinct chondron formations, which are 
chondrocytes surrounded by a proteoglycan matrix, after 2 weeks in culture. 
 
5.2.2 Single Layer Hydrogel Fabrication and Cell Culture 
As illustrated in Figure 5.1B, single layer hydrogels were fabricated and 
cultured as controls for replication of previous experiments performed in Chapter Four. 
D1 bone marrow progenitor cells were encapsulated within polymer solutions of 
PEG:CS:MMP-pep, PEG:CS, and PEG:HA as single layered hydrogel constructs. 20 
million cells/mL were mixed with the syringe-filtered polymer solution of each layer 
and 100 µL  of the cell/polymer mixed was polymerized for 10 minutes using a long-
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wave ultraviolet lamp (Model B100AP, Blak-Ray) at an intensity of ~10 mW/cm2.  The 
hydrogels were cultured in serum-free chondrogenic media as detailed in Section 5.2.1.  
The media was changed every other day. 
 
5.2.3 Cell Viability  
Viability of encapsulated cells in the multi-layered hydrogel constructs was 
determined after 2, 4, and 6 weeks of culture.  At each time, the media were discarded, 
and the constructs were washed with PBS (Gibco, Carlsbad, CA) twice for 5 minutes. 
The MLHC were thinly sliced transversely with a razor. Cell viability was assessed 
based on previously published methods by Lee et al. [15]. Briefly, the Live/Dead 
Viability/Cytotoxicity Kit (Molecular Probes, Eugene, OR) that contains calcein-AM 
(“live” dye) and ethidium homodimer-1 (“dead” dye) was used to assess the integrity of 
the cellular membrane.  Dye solution was made with 0.5 %L of calcein-AM dye and 2 
%L of ethidium homodimer-1 dye in 1 mL of DMEM.  A transverse slice of the 
construct was incubated in 500 %L of the “Live/Dead” dye solution for 30 minutes.  
Fluorescence microscopy (Olympus, 4X) was performed using a fluorescein optical 
filter (485 ± 10 nm) for calcien-AM and a rhodamine optical filter (530 ± 12.5 nm) for 
ethidium homodimer-1. 
 
5.2.4 RNA Isolation ad RT-PCR 
Chondrogenesis was determined by the gene expression of collagen I, II, and X 
within these multi-layered hydrogel constructs at 2, 4, and 6 week time points.  The 
hydrogel constructs were removed from culture, and the gene expressions of 
encapsulated cells were analyzed. The single-layered hydrogels were homogenized, as 
detailed in Section 4.2.2.  The MLHC was first sliced with a razor to separate the layers 
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as illustrated in Figure 5.1C and the interface was used to determine the modulus.  The 
individual layers were placed into individual 2mL microcentrifuge tubes, and 200µL of 
TRIzol® was added to the tubes. Each layer was then crushed using a homogenizer 
(Wheaton).  After complete homogenization, another 800µL of Trizol® was added to the 
tube. The RNA isolation of the homogenized scaffolds was performed following the 
manufacture’s protocol, as detailed in Section 4.2.2.  Genomic DNA was removed using 
Deoxyribonuclease I (Invitrogen, Carlsbad, CA). The first strand of cDNA was 
synthesized by reverse transcription (RT) using Superscript
TM 
III kit (Invitrogen, 
Carlsbad, CA), following the manufacturer’s instructions, as detailed in Section 4.2.2. 
Quantitative polymerase chain reaction (PCR) was performed using an ABI Prism® 
7900 Real Time thermal cycler and HotStartTaq DNA Polymerase with SYBR 
green/ROX PCR master mix (SA Biosciences, Fredrick, Maryland). Primers for the 
housekeeping gene (GAPDH), collagen type II, type X and type I (SA Biosciences, 
Frederick, MD) are listed in Table 4.1. 
 
5.2.5 Histology and Immunohistochemistry 
Histology of these hydrogel matrices was performed to determine the 
chondrogenic differentiation within the MLHC and for verification of the quantitative 
real time data.  At 2, 4, and 6 week time points, hydrogels were removed from culture 
and fixed in 4% paraformaldehyde at 4°C for an overnight period. Fixed hydrogels were 
then dehydrated for paraffin embedding using 1-hr sequential steps in the following 
order: 80%, 95%, 95% ethanol in dH2O, 100% ethanol, 50/50 ethanol/CitriSolv, 100% 
CitriSolv, 100% CitriSolv, 60°C molten paraffin, and 60°C molten paraffin for an 
overnight period. Paraffin-embedded hydrogels were sliced in transverse sections at 
10%m using a rotary microtome. Sections were stained for differentiation.  
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Double sequential immunohistochemistry was performed to stain for collagen II 
(green) and collagen X (red) using rabbit polyclonal primary antibodies (Abcam, 
Cambridge, MA) and Texas red (collagen II) or FITC (collagen X) conjugated 
secondary antibodies. Slides containing sectioned hydrogels were blocked for 
nonspecific binding for 30 minutes at 37 °C using 3% (w/v) bovine serum albumin 
(BSA) in PBS (pH 7.4).  The slides were rinsed with 0.05% tween 20 in PBS solution 
three times.  The washed slides were incubated with primary antibody for 30 minutes at 
37 °C.  The slides were rinsed again before the second incubation with the secondary 
antibody for 30 minutes at 37 °C.  These steps were repeated for collagen X on the same 
slides.  The slides were imaged using a confocal fluorescence microscope (Leica SP2 
AOBS, 63X).   
 
5.2.6 Biochemical Characterization 
Glycosaminoglycan (GAG) production within each layer of the MLHC was 
determined using the Dimethylmethylene blue (DMMB) assay.  Briefly, at 2, 4, and 6 
week time points, hydrogels were removed from culture. Wet weights (ww) and dry 
weights (dw) after 48 hours of lyophilization were obtained for each construct (n=3).   
The dry constructs were then digested in 1 mL of papinase (papain, 125 µg/mL; Sigma, 
St. Louis, MO) at 60°C overnight. 200 µL of the DMMB solution was added to each 
well of the 96 well plates; then 50 µL of standard and samples were added. The plate 
was shaken for 10 seconds before reading the absorbance at 525nm.  To account for the 
hydrogel material, absorbance of blank hydrogels was subtracted from the sample 
values. The DNA content was determined using Sigma’s DNA quantification kit (DNA-
QF) in order to normalize the GAG production.  The assay was carried out following the 
manufacture’s protocol for multiwall assay, as detailed in Section 4.25.   
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5.2.7 Compression Studies of the MLHC 
The compressive modulus of the individual layers and the interfaces between 
layers of the MLHC were determined at room temperature on an In-spec 2200 Instron 
mechanical tester with a 125 N loading cell using a parallel plate apparatus and loading 
of 20% of the initial thickness per second (0.1 mm/sec).  The compressive modulus of 
the individual layers as well the interface between were determined by analyzing the 
linear region of the stress versus the strain curve of the samples at low deformations 
(<20% strain).  
 
5.2.8 Statistical Analysis 
All quantitative data were expressed as mean ± standard error and were verified 
by analysis of variance using one way ANOVA Fixed Effects Model [16]. P values of 





5.3.1 Viability of Encapsulated MSCs 
A cytotoxicity assay was performed to test for the viability of the MSCs 
encapsulated within the multi-layered hydrogel constructs at 2, 4, and 6 weeks. As 
shown in Figure 5.2, the majority of the cells stained green, indicating that there are 
more live cells than dead cells, which are stained red, at all time points.  At 2 weeks, the 
transitional layer exhibited the greatest amount of live cells, while the deep layer 
contained the largest amount of dead cells.  At 4 weeks, the cell density appears to be 
more evenly distributed within all the layers of the multi-layered construct with very few 
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dead cells. At 6 weeks, all the dead cells appear at the edge of the hydrogel construct 
with the greatest amount of dead cells in the deep layer.  Additionally, the deep layer 
also contains the highest cell density at 6 weeks. 
 
5.3.2 Chondrogenic Differentiation of MSCs 
The purpose of this chapter was to investigate the potential of a MLHC to 
simultaneously differentiate MSCs into zone specific chondrocytes. Again, gene 
expression of collagen type II, X, and I were used to verify chondrogenesis. The average 
fold difference as compared to undifferentiated cells encapsulated within PEG-only 
hydrogels for collagen II, X, and I of each layer of the MLHC and single layer controls 
(SLC) are shown in Figures 5.3, 5.4, and 5.5, respectively. Again, the PEG:CS:MMP-
pep composition represents the superficial layer, the PEG:CS composition represents the 
transitional layer, and the PEG:HA composition represents the deep layer for the SLC.    
Collagen II expression in the superficial layer was significantly (p < 0.05) higher 
compared to the deep layer at all time points as (Figure 5.3A).  Similarly, the SLC 
(Figure 5.3B) demonstrated significantly higher collagen II expression at all time points 
in the superficial composition (PEGS:CS:MMP-pep) as compared to the deep 
composition (PEG:HA). Additionally, at 2 weeks both the superficial and deep layer of 
the MLHC exhibited significantly higher collagen II expressed as compared to the 
PEG:CS:MMP-pep and PEG:HA SLC, respectively. 
Collagen X expression within the MLHC was significantly higher in the deep 
layer as compared to the superficial layer (Figure 5.4A) for both 4 and 6 weeks.  The 
SLC (Figure 5.4B) exhibited a trend of increasing collagen X expression from the 
superficial to the deep composition at all time points, but was only statistically different 
between the PEG:CS:MMP-pep and the PEG:HA at 2 weeks. Although the transitional 
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layer and the PEG:CS composition showed a trend of lower collagen II and higher 
collagen X when compared to the superficial layer and the PEG:CS:MMP-pep 
composition, the values were not statistically significant for both the SLC and between 
the layers of the MLHC.   
The expression of type I collagen was again very low for both the SLC as well as 
within the individual layers of the MLHC.  As shown in Figure 5.5A, at 2 weeks, the 
transitional layer of the multi-layered construct had significantly higher collagen I 
expression than the superficial layer. While at 6 weeks, both the superficial and 
transitional layer of the MLHC exhibited significantly lower collagen I expression 
compared to the deep layer.  Figure 5.5B shows the collagen I expression of the SLC.  
At both 4 and 6 weeks the PEG:HA composition had significantly higher collagen I 
expression than the PEG:CS:MMP-pep composition. At 4 weeks, the PEG:CS:MMP-
pep composition has significantly lower collagen I expression compared to the 
superficial layer of the multi-layered construct.  At 4 weeks the superficial, the 
transitional, and the deep layers of the multi-layered construct had higher collagen I 
expression than their opposing SLC. 
 
5.3.3 Histological Analysis of Imaged Hydrogels 
For further verification of chondrogenesis, immunohistochemical staining was 
performed to determine if the cells were producing collagen II and collagen X.  At all 
time points, the fluorescent images showed positive staining for both collagen II and X 
within all layers (Figure 5.6).  The collagen II staining increased with time and 
exhibited the highest intensity at 6 weeks.  At 2 weeks the collagen II staining appeared 
more evenly dispersed within the superficial and transitional layer but within the deep 
layer the collagen II staining appear to be aggregated into clusters.  At 4 and 6 weeks the 
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spatial organization of both collagen II appeared to correspond to native articular 
cartilage [8].  In the superficial layer the collagen II staining appeared to be relatively 
high and the collagen diameter appeared to be smaller, less clustered and aligned parallel 
to the top surface (articular surface). In the transitional layer the collagen II staining 
appeared to be higher than the collagen X staining and collagen diameters are larger and 
more clustered with a random orientation.  Finally, in the deep layer the collagen X were 
the most intense at all time points, with larger collagen diameter and clusters, which are 
aligned perpendicular to the bottom surface (subchondral plate). Again 
immunohistochemical staining was not performed for type I collagen due to low mRNA 
expression. 
 
5.3.4 Protein Analysis for Total GAG Production  
The GAG/DNA ratio for each layer of the MLHC is shown in Figure 5.7A. 
GAG production increased with time in all layers of the MLHC with cells in the deep 
layer exhibiting significantly higher GAG levels compared to the superficial layer at all 
time points. The transitional layer also had significantly lower GAG production 
compared to the deep layer at both 2 and 4 weeks.  Figure 5.7B shows the GAG 
concentration of the SLC and at all time points the PEG:HA composition had 
significantly higher GAG production compared to the PEG:CS:MMP-pep composition.  
At 2 and 6 weeks, the superficial layer of the multi-layered construct had significantly 
higher GAG production when compared to the PEG:CS:MMP-pep single layer control.  
However, the PEG:CS single layer composition exhibited significantly higher GAG 
production than the transitional layer of the multi-layered construct. At 4 weeks there 




5.3.5 Compressive Strength of the Individual Layers 
Table 5.2 and Table 5.3 list the compressive moduli of the individual layers of 
the blank and cell-laden MLHC, including the interface, respectively.  Table 5.4 lists the 
compressive modulus of the SLC. The compressive modulus of the interface shows a 
gradual increase between the superficial and transitional layer, as well as between the 
transitional and the deep layer within the MLHC.  Figure 5.8 shows the compressive 
modulus of the individual layers as a bar graph for easy comparison. Similar to our 
single layer results discussed in Chapter Four and the SLC, the MLHC showed 
increasing compressive strength from the superficial to the deep layer.  The compressive 
moduli of the individual layers as well as the interface all increased with time, with 6 
weeks exhibiting the highest modulus of all layers and interfaces.  The compressive 
modulus of the deep layer was significantly higher than the superficial layer at all time 
points.  Additionally, at 2 and 4 weeks the modulus of the deep layer was also 
significantly higher than that of the transitional layer. The compressive modulus of the 
superficial layer was not significantly different from the transitional layer at all time 
points.  The compressive modulus of the superficial layer at both 2 and 4 weeks is 
significantly higher than the modulus of the PEG:CS:MMP-pep composition found in 
chapter four and the SLC.  The 4 week modulus of the deep layer was also significantly 
higher than the modulus of the PEG:HA composition determined in chapter four.  
Additionally, at 4 weeks the moduli of all layers within the MLHC were significantly 
higher than the SLC.  At 6 weeks, the modulus of the transitional layer of the MLHC 
was significantly higher than the modulus of the PEG:CS composition obtained in 
Chapter Four.  Furthermore, the modulus of the deep layer of the MLHC is significantly 




Chapter Four directly compared the effects of CS and HA incorporation as well 
as MMP-pep for matrix degradation within a PEG-based hydrogel network for 
chondrogenesis from MSCs. Collectively, the single layer results demonstrated that 
these hydrogels not only induce MSCs to differentiate into chondrocytes, but also that 
the differentiated phenotype and matrix production can be tailored to specific zones of 
articular cartilage by altering the material composition.  Specifically, the PEG:CS:MMP-
pep composition exhibited the highest collagen II expression as well as the lowest GAG 
production, which can be correlated to the superficial zone of articular cartilage. Both 
the PEG:CS and PEG:MMP-pep compositions had midrange expression of collagen II 
as well as GAG content, which can be correlated to the transitional zone of articular 
cartilage. At the same time, the PEG:HA composition can be correlated to the deep zone 
because of its high GAG content and low expression of collagen II. Although both 
PEG:MMP-pep and PEG:CS can be correlated to the transitional zone, PEG:CS was 
used to formulate the transitional layer of the multi-layered construct because it 
exhibited less collagen X expression at both 4 and 6 weeks.  Based on these specific 
correlations, this chapter evaluated the ability of a MLHC to simultaneously differentiate 
the MSCs into the specific zones of articular cartilage.   
To ensure that the MSCs survived the fabrication process, the cell viability of the 
MLHC was assessed at 2, 4, and 6 weeks.  The images shown in Figure 5.2 demonstrate 
that the majority of the cells survived at all time points and within all layers of the multi-
layered construct.  Additionally, the cells also appeared to have proliferated, increasing 
in cell density from 2 to 6 weeks.   
The gene expressions of type I, II, and X collagens within the MLHC are in 
accordance with the single layer results found in Chapter Four.  There was high collagen 
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II expression in the superficial layer and high collagen X expression in the deep layer.  
The transitional zone did not exhibit any significant differences in the expression of 
collagen II or X to either the superficial or the deep layer. Additionally, type I collagen, 
a marker for fibrocartilage [17], remained low within all layers at all time points. The 
low-level expression of collagen I indicates that the MSCs were differentiating down the 
articular cartilage pathway and not towards fibrocartilage formation.  The formation of 
fibrocartilage is the major limitation of all previous cartilage repair strategies. 
Histology and immunohistochemistry confirmed the RT-PCR findings and 
revealed that cartilage-specific proteins were produced within each layer of the multi-
layered hydrogel constructs.  Immunohistochemical staining for types II and X collagen 
showed significant differences between 2 and 6 weeks as shown in Figure 5.6. At 2 
weeks the collagen II expression was spatially scattered with a few clusters within the 
deep layer. However, there was a significant increase in collagen II expression at 4 and 6 
weeks compared to the week 2 images.  Furthermore, the collagen staining at 4 and 6 
weeks showed larger clusters, especially in the deep layer with the majority of the 
clusters aligning perpendicular to the articular surface.  The size, clustering of the 
collagen and the alignment seen in the fluorescent images are similar to the structural 
organization of native articular cartilage. 
Greater matrix accumulation was observed in the deep layers of the MLHC at all 
time points, indicating that the PEG:HA formulation still enhances GAG production.  
The GAG production increases with time but appears to level off within the deep layer. 
The leveling off of GAG production at the 6 week time point is most likely due to the 
fact that the GAG accumulation has reached its threshold as discussed in Chapter Four.  
Once the threshold is reached, the cells begin to remodel the ECM and turnover the 
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ECM components, including GAG, resulting in the relatively same GAG concentration 
at both the 4 and 6 week time point. 
Similar to the SLC, the multi-layered hydrogel constructs showed increasing 
compressive strength from the superficial to the deep layer.  Since the primary function 
of articular cartilage is to resist compression it is critical that the multi-layered, 
composite cartilage-tissue, have comparable and spatially varying compressive strength, 
similar to native cartilage. Armstrong et al. obtained small, cylindrical plugs of human 
cartilage to study their mechanical properties and found that out of 103 samples of 
varying ages, the average compressive modulus was 790 kPa with a maximum value of 
1,910 kPa [18]. Shown in Figure 5.8 and Table 5.3 are the compressive moduli of the 
individual layers of the engineered MLHC.  The compressive modulus increased from 
the superficial (239 – 472 kPa) to the deep layer (534 – 1712 kPa) (p <0.05) at all time 
points, with the deep layer exhibiting the highest modulus (1,712kPa) at 6 weeks, similar 
to the maximum value obtained by Armstrong et al. [18]. Averaging the compressive 
modulus of all the individual layers at 6 weeks, we obtain a value of 950 kPa (± 216 
kPa, standard error), which is consistent with the average modulus of human cartilage 
plugs [18]. Additionally, the modulus of each layer within the MLHC increased with 
time, which is comparable to the SLC.   
Although the moduli of the individual layers of the MHLC exhibit the same 
trend as seen in the SLC, their compressive strength is significantly higher when 
compared to their corresponding SLC.  At 2 weeks, the superficial layer of the MLHC 
had significantly higher modulus than the PEG:CS:MMP-pep composition of the SLC, 
and at 6 weeks the modulus of the deep layer was significantly higher than the PEG:HA 
composition of the SLC.  At 4 weeks, the moduli of all the layers of the MLHC were 
significantly higher than the SLC.  The significant increase in compressive modulus of 
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each layer of the MLHC over their single-layer counterparts may be an indication that 
there is a synergistic effect between the layers that leads to enhanced ECM remodeling, 
resulting in improved mechanical properties.  
In summary, the findings of this chapter provides evidence that spatially varying 
biomaterial compositions within a MLHC can be used to induce differentiation of MSCs 
into a single and zonally organized 3D articular cartilage-like tissue. Chapter Six 
discusses the possible clinical applications of these findings.  The ability to create 
native-like, mechanically relevant articular cartilage consisting of zone specific layers 
provides a new direction in cartilage tissue engineering and could be invaluable for 



















Table 5.1 Biomaterial Composition of Each Layer 
Zone Material  PEG CS HA MMP-pep 
Superficial PEG:CS:MMP-pep 9% 9%  2% 
Transitional PEG:CS 10% 10%   

































Figure 5.1 MLHC Fabrication (A) Multi-layered scaffold composed of three 
distinctive layers each corresponding to the superficial, middle, and deep zone of 
articular cartilage. (B) Single layer hydrogels of same compositions were used as 
controls. Individual layers were fabricated using 100 µL of the layer specific 
composition polymerized for 5 minutes.  (C) To analyze the MLHC, each layer was 
carefully separated and the interface discarded. The separated layers were 
analyzed individually. (D) After 2 weeks of culture, the cell laden multi-layered 
hydrogel showed distinct formations of chondrons, which are chondrocytes 


















Figure 5.2 MLHC Live/Dead Staining of razor sliced sections of the MHLC at 2, 4, 
and 6 weeks (4X objective, Leica SP2 AOBS).  At all time points, the majority of 










Figure 5.3 MLHC & SLC Collagen II Gene Expression shown as average fold 
difference at 2, 4, and 6 weeks for gene expression of Collagen II of the (A) 
Individual layers of the MLHC, showing significantly higher (p<0.05, error bars 
represent standard error) collagen II expression in the superficial layer than in the 





Figure 5.4 MLHC & SLC Collagen X Gene Expression shown as average fold 
difference at 2, 4, and 6 weeks for gene expression of Collagen X of the (A) 
Individual layers of the MLHC, showing significantly lower collagen X expression 
in the superficial layer than the deep layer at 4 and 6 weeks.   (B) Collagen X 





Figure 5.5 MLHC & SLC Collagen I Gene Expression shown as average fold 
difference at 2, 4, and 6 weeks for gene expression of Collagen I of the (A) 
Individual layers of the MLHC, showing Collagen I expression remaining relative 
low within the multi-layered hydrogel constructs at all time points.  (B) Collagen X 





Figure 5.6 MLHC Immunohistochemical Staining of paraffin-embedded sections of 
the MLHC at 2, 4, and 6 weeks for collagen II (green) and X (red) (10X objective, 
Leica SP2 AOBS).  At all time points, the fluorescent images showed positive 












Figure 5.7 MLHC GAG Concentrations for (A) MLHC and (B) SLC. The deep 






Figure 5.8 MLHC Moduli Graph showing that the compressive strength increases 
with time and corresponds with the GAG concentration of each zone at all time 
points. The compressive modulus of the superficial layer and the transitional layer 
at both 2 and 4 weeks do not significantly differ. The deep layer, which has much 
higher GAG content, showed significantly higher compressive modulus than the 














Table 5.2 Compressive Moduli for Blank MLHC 
  Blanks 
Hydrogel 
Layer Moduli (kPa) Standard Error 
Superficial 199.71 ± 89.60 
ST Interface 200.9 ± 63.6 
Transitional 203.95 ± 65.35 
TD Interface 273.33 ± 122.18 


























Table 5.3 Compressive Moduli for Cell-Laden MLHC 















Superficial 239.1 ± 7.10 305.69 ± 3.47 472.16 ± 141.77 
ST 
Interface 262.95 ± 40.1 320.86 ± 6.8 521.64 ± 54.38 
Transitional 286.5 ± 81.3 364.45 ± 92.54 715.44 ± 215.49 
TD 
Interface 307.24 ± 6.075 401.56 ± 6.35 816.46 ± 76.53 


















Table 5.4 Compressive Moduli of the SLC 
  















PEG:CS:MMP-pep 98.11 ±  37.39 125.69 ±  5.31 227.57 ±   53.51 
PEG:CS 154.85 ± 51.41 117.51 ±  4.06 625.14 ±  63.06 
PEG:HA 296.55 ± 72.72 144.08 ±  13.45 836.45 ±   61.79 
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Overall Summary, Conclusions and Future Direction 
 
6.1 OVERALL SUMMARY 
The simultaneous differentiation of MSCs into zonal articular cartilage within a 
MLHC represents a novel approach for engineering articular cartilage tissue.  The multi-
layer approach discussed in this dissertation represents a fundamental advance in tissue 
engineering that and will encourage future research efforts to move away from creating 
homogenous tissue structures with bulk properties and turn towards engineering more 
physiologically and functionally relevant tissue substitutes with native-like and spatially 
varying properties.  
 
6.2 CONCLUSIONS 
This dissertation outlined the process of creating tissue substitutes that mimic the 
structure and function of native articular cartilage.  Chapter Three first introduced a 
novel technique to modify an enzymatically degradable synthetic peptide. Chapter Four 
then demonstrated that a unique combination of the synthetic peptide and biopolymers 
could successfully induce the differentiation of MSCs into distinctive chondrogenic 
phenotypes.  Finally, Chapter Five incorporated the findings of the previous two 
chapters to create a multi-layered hydrogel of varying biomaterial compositions to 
simultaneously induce the differentiation of MSCs into articular cartilage-like tissue 




6.2.1 Chapter Three Research Findings 
Chapter Three discussed the synthesis and modification of a matrix 
matelleoproteases sensitive peptide (MMP-pep) as well as the modification of 
biopolymers, including chondroitin sulfate (CS) and hyaluronic acid (HA).  These 
synthetic and natural materials were used in combination with poly(ethylene glycol)  
(PEG) to create hydrogel constructs of varying concentrations.  The physical properties 
of the hydrogel constructs—including the water content, swelling ratio, degradation rate, 
and compressive modulus—were found to be dependent on their material composition.  
Hydrogel constructs containing the MMP-pep had a lower compressive modulus than 
the hydrogels without the peptide.  The hydrogels containing the MMP-pep degraded 
faster than hydrogels containing HA but slower than hydrogels contain CS.  Pure CS and 
HA hydrogel degraded the fastest.  CS was found to increase water content and swelling 
ratio when incorporated into the hydrogel construct.  Hydrogels containing CS also 
exhibited higher degradation rates than those containing the MMP-pep or HA.  HA 
provided great mechanical strength when incorporated into the hydrogel construct, 
which resulted in the slowest degradation profile.  The conclusion of Chapter Three is 
that hydrogels’ physical properties can be tailored through manipulation of material 
compositions and concentrations. 
 
6.2.2 Chapter Four Research Findings 
Chapter Four described the use of material compositions, evaluated in Chapter 
Three, to induce the chondrogenic differentiation of mesenchymal stem cells (MSCs).  
The purpose of this study was to determine which material composition had the most 
inductive effect on the MSC differentiation into the chondrogenic phenotype.  It was 
determined that the combination of the MMP-pep and CS within the PEG-based 
 
 174 
hydrogel had a high inductive effect for the genetic expression of collagen II.  The 
incorporation of HA into the PEG-based hydrogel was found to be conducive for 
glycosaminoglycan (GAG) production.  Furthermore, plain CS hydrogels induced 
chondrocyte hypertrophy.  Chapter Four concludes that specific biomaterial 
compositions can induce the differentiation of MSCs into specific chondrogenic 
phenotypes, which can be correlated to the specific zones of articular cartilage. 
 
6.2.3 Chapter Five Research Findings 
Based on the findings of Chapter Four, Chapter Five discussed the fabrication of 
a multi-layered hydrogel construct (MLHC) for the simultaneous differentiation of 
MSCs into zone-specific chondrocytes.  The results demonstrated that the MLHC had 
the capability of creating zonal articular cartilage-like tissue.  MSCs within the 
PEG:CS:MMP-pep composition differentiated into chondrocytes that exhibited high 
gene expression and production of type II collagen as well as lower GAG production, 
which are characteristic of the superficial zone.   The PEG:CS biomaterial composition 
induced the differentiation of MSCs into chondrocytes that exhibited characteristic 
similar to the transitional zone, with mid-level type II collagen and GAG production. 
Due to the structural stability provided  by the PEG:HA composition, MSCs within the 
PEG:HA layer differentiated into chondrocytes that exhibited low type II collagen gene 
expression and high GAG production, characteristic of the deep zone.   
Furthermore, the overall multi-layered construct exhibited spatially varying 
properties similar to native cartilage.  The level of collagen II gene expression and 
production decreased from the superficial layer to the deep layer.  The GAG production 
and mechanical modulus increased from the superficial layer to the deep layer.  The 
chondrocytes appeared to be more elongated, with collagen fibers within the superficial 
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layer aligned parallel to the articular surface. Additionally, the chondrocytes in the 
transitional layer had a more spherical morphology, while collagen fibers in this layer 
exhibited a random orientation.  In the deep layer, both the chondrocytes and collagen 
fibers formed large clusters that were perpendicular to the subchondral plate.  Chapter 
Five concluded that a MLHC with varying biomaterial composition can effectively 
induce the simultaneous differentiation of MSCs into zonal articular cartilage-like tissue.   
 
6.3 FUTURE DIRECTIONS 
The goal of this dissertation research was to develop a methodology to tissue 
engineer an articular cartilage substitute that could subsequently eliminate the need for 
cartilage donor tissue.  The reported results are relevant because they clearly 
demonstrate that MSCs cultured within a MLHC with a varying biomaterial composition 
can be used to engineer zonally organized cartilage when provided with the appropriate 
inductive agents.   
The clinical relevance of this research is dependent on complementary in vivo 
studies that will determine some of the criteria for translating the in vitro results into 
animal models. After animal studies, the next step is to translate this MLHC approach 
into a human system by using human stem cells. 
 
6.3.1 Pre-Clinical Studies: Animal Models 
Pre-clinical studies involving in vivo animal models are essential in closing the 
gap between in vitro experiments and human clinical trials [1].  However, there is no 
such thing as a perfect pre-clinical animal model that exactly mimics human articular 
cartilage.  Therefore, researchers must carefully choose an animal model that most 
accurately represents the human condition being investigated in order to avoid 
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inaccurate generalizations caused by extrapolating findings from such animal models to 
human models.  
Anatomically, the thickness of human articular cartilage on the medial femoral 
condyle ranges from about 1.65 to 2.65 mm [2], and the average volume of human 
cartilage defects is approximately 550 mm3, with lesions that require treatment 
measuring 10mm or more in diameter [3]. Additionally, human articular cartilage has 
very low intrinsic repair capabilities. The ideal animal model would imitate human 
cartilage by having similar cartilage thickness, appropriately sized defects, and limited 
capacity for spontaneous repair.  Every available animal model has its benefits and 
limitations, both of which will be outlined in this section to provide a comparative 
analysis of various available species for in vivo studies.   Each species will be discussed 
in order of size. 
Murine models, including rodents such as mice and rats, are generally used to 
provide proof-of-concept data and serve as a bridge between in vitro studies and larger 
animal studies.  The major advantage of using a murine model is that it is a cost 
effective method to obtain mechanistic information on cartilage repair [4].  There are 
immunocompromised rodent strains including athymic, transgenic, and knockout that 
are readily available for implanting xenogenic cells and tissues.  Furthermore, the use of 
murine models provides researchers access to a larger array of probes, antibodies, and 
reagents that can enhance their studies [4]. The small size of the joint and thinness of the 
cartilage layer are the two main limitations of the murine model [5].  Additionally, rats 
have a better intrinsic repair capacity due to their long-term open growth plate [6], 
thereby limiting the transferability of findings to humans whose repair capabilities are 
much more limited. 
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Rabbits, a lapine model, are popular for research on cartilage regeneration 
because New Zealand White Rabbits have joints that are large enough to create 3-4 mm 
defects [4].  However, upon examining the thickness of rabbit cartilage, Rasanen 
determined that the average trochlear groove was only 0.44 ± 0.08 mm thick, and the 
anteromedial femoral condyle was only 0.3 ± 0.07 mm [7].  The thinness of the rabbit’s 
cartilage limits the size and depth of defects that can be made, since the average 
experimental defect is about 3 mm in depth [8-10].   If 3 mm defects are created, the 
majority of the defect volume will be within the subchondral bone layer and therefore 
will not be representative of human defects.  Similar to the murine model, the advantage 
of utilizing the rabbit model is that large quantities of genetically modified rabbits are 
available. The rabbits are easy to handle, with a relatively low cost associated with their 
purchase and care [11-13]. However, similar to rats, rabbits have the high potential for 
spontaneous healing, which is mediated by proliferation and differentiation of 
mesenchymal cells from the bone marrow [14].  Finally, the mechanical loading 
conditions for rabbit cartilage are significantly different from that of humans, making it 
impractical to translate rabbit models to human models. 
Canine models more closely resemble humans than murine or lapine models 
because dogs naturally suffer from cartilage defects such as osteoarthritis [15] and lack 
the intrinsic ability for cartilage repair [16-18]. Additionally, dogs can be used to study 
rehabilitation protocols or specific exercise programs since dogs can be easily trained to 
use treadmills [4].  The major drawback of using dogs in research is that there are 
significant ethical concerns due their societal status as family companions and pets [4].  
The canine model is also limited by cartilage size and thickness. Dogs’ cartilage 
thickness ranges from 0.95 mm to 1.3 mm, with an average defect size of 4 mm [5]. This 
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average is significantly smaller than the average human defects, which are greater than 
10 mm [3]. 
A goat, otherwise referred to as a caprine model, offers advantages over the 
previously mentioned models because of larger joints and thicker cartilage, which more 
closely resemble the human joint [4].  The average size of a goat defect is about 6 mm 
[5] in diameter, which  approaches  the average size of a human defect, and does not 
show spontaneous healing [19]. Additionally, the goat’s larger joint size allows 
accessibility for arthroscopic procedures, while the thicker cartilage range of 0.8 to 2.0 
mm [20] allows for the evaluation of the healing response to both partial and full 
thickness defects.  Niederauer et al. have successfully used a caprine model to examine 
the treatment of osteochondral defects using various implantable constructs, thereby 
showing that repair was achieved with hyaline-like cartilage and the underlying bone 
[21]. When compared to larger animal models, goats are relatively inexpensive and easy 
to care for if housed in appropriate facilities.  Although the larger goat joint allows for 
the creation of larger defects, when compared to the size of human defects, goat defects 
still fall in the lower end of what is considered clinically relevant in humans [4]. 
The porcine model is rarely used in cartilage research even though a pig’s joint 
size, cartilage thickness, and weight-bearing requirements more closely mimic the 
human condition [22-24]. Pigs are rarely used in research because they are large and 
aggressive animals, which make them difficult to deal with in a research environment 
[25, 26].  Due to this limitation, mini-pig strains have been bred to be docile with 
controlled weight and size. The mini-pig stifle joint, although still smaller than human 
joints, can be used to study cartilage repair because defects of 6-8 mm in diameter can 
be created in their femoral condyles or their trochlear grooves [1].  It is important to note 
that only skeletally mature pigs with full closure of the growth plate have a limited 
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endogenous repair response. Therefore, only skeletally mature mini-pigs between 18-22 
months of age are used in experimental models [24].  Similar to the caprine model, 
cartilage thickness is also an advantage of the porcine model.  The 1.5 mm [27] 
thickness of swine cartilage allows for the creation of partial and full thickness defects 
as well as arthroscopic evaluation after treatment [28, 29].  However, since mini-pigs are 
specially bred pigs, they can be costly to acquire and maintain [4]. 
The equine model is the largest of the animal models that are available for 
cartilage research [4].  Horse articular cartilage injury and repair are much better 
understood than in other animal models, due to the horse racing industry which has 
resulted in the need for clinical treatment of chondral or osteochondral injuries in horses 
[30].  Translating basic research into pre-clinical studies with horses can be smoother 
due to the amount of clinical treatment data that is available, making the equine model 
appealing to researchers.  Horses are similar to humans in that they suffer from cartilage 
injuries and osteoarthritis with no real intrinsic ability for self-repair [31, 32] of the 
cartilage.  The equine model is highly beneficial for pre-clinical evaluation of new 
cartilage repair techniques because the horse’s large joint size permits arthroscopic 
assessment [4]. Additionally, the lesions found in horses are approximately the same 
size and depth as seen in humans [5].  The horse stifle joint has a cartilage thickness of 
about 1.75 mm [27], which is the closest to that of human cartilage (2.35 mm) out of all 
the previously mentioned species.  Therefore, clinically relevant-sized defects in human 
cartilage correlate closely to full or partial thickness defects found in horses [5, 33-35].   
However, horses have distinctly different loading conditions than humans which 
result in a much harder subchondral bone layer than that of humans [36]. Thus, the 
major disadvantage of the equine model is that any treatment used for horse cartilage 
defect will be subjected to greater loading conditions than in humans, due to the horse’s 
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weight and physiology [4].  Other disadvantages include the extremely high cost of 
obtaining and caring for these animals.  In addition to needing the appropriate facilities 
to house the animals, veterinary support for surgical procedures as well as perioperative 
care are also required when working with horses [4].  Although factors such as joint 
size, cartilage morphology, and available clinical data make the equine model attractive 
for pre-clinical studies, high joint loading conditions, high cost, and the need for highly 
specialized facilities prevent most researchers from being able to use the equine model.  
Even though horses are a logical translational model for establishing the efficacy and 
safety of new cartilage treatments, the application of the equine model is not always 
readily available to all researchers. 
In summary, there are multiple factors that need to be considered when selecting 
the appropriate animal model.  Since costs increase with animal size, researchers with 
limited funding tend to conduct initial studies using smaller animal models to show 
proof-of concept.  Smaller animals offer the advantage of having genetically similar 
populations, which can significantly reduce variances in results, but the genetic diversity 
of large animals better mimic the human population.  While the disadvantage of small 
animal models is that they do not adequately mimic the human condition, the use of 
large animals requires larger sets of experimental animals due to their genetic variance 
which lead to different levels of healing responses.  As mentioned at the start of this 
section, no animal model is ideal for cartilage research since each animal species has its 
advantages as well as its disadvantages.  Therefore, when planning an animal study, 
research investigators must perform a detailed comparative analysis of cost 
effectiveness, anatomy, maturity, joint biomechanics, and postsurgical protocols 
associated with each species. 
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6.3.2 Clinical Application 
As illustrated in Fig. 6.1, cartilage defects are separated into two categories, 
partial thickness and full thickness defects. Partial thickness defects that do not penetrate 
the subchondral bone do not heal spontaneously.  Full thickness defects that do penetrate 
the subchondral bone elicit an intrinsic repair response that results in the formation of 
fibrocartilaginous tissue, which is a mechanically poor replacement for hyaline articular 
cartilage.  Over time the repaired tissue will degenerate due to repeated mechanical 
stress, leading to the continued degeneration of the articular cartilage.  
A number of clinical strategies for cartilage repair were discussed in Section 2.5, 
but each repair strategy has its drawbacks.  Arthroscopic procedures such as lavage and 
debridement are temporary solutions used to manage pain but these procedures do not 
repair the cartilage defect.  Microfracture surgery is an easy procedure that involves 
drilling into the subchondral bone to induce the natural healing response, but the surgery 
results in the formation of mechanically inferior fibrocartilage.  Due to the mechanical 
instability of fibrocartilage, continuous degeneration of the remaining articular cartilage 
will occur over time. Autologous chondrocyte implantation (ACI) and matrix-induced or 
matrix-associated ACI involve the isolation and expansion of the patient’s own 
chondrocytes for re-implantation at a later stage.  The first generation ACI required 
harvesting a periosteal graft from the patient’s medial tibia. The usage of the periosteal 
grafts became problematic due to graft hypertrophy and harvest site morbidity.  Thus, 
the 3rd generation MACI was developed to eliminate the need for a periosteal graft by 
using biomaterials as cell carriers. The matrices used for this technique include protein-
based polymers such as fibrin or collagen and carbohydrate-based matrices such as 
Hyleron and artificial polymers [37].  Although the third generation MACI has been 
proven to be superior to microfracture surgery [38], it is still not the preferred choice for 
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surgeons because the technique induces fibrocartilage formation [39].  Osteochondral 
transplants offer the unique advantage of using native cartilage tissue for replacement 
and repair.  Allogenic tissue from cadavers is a feasible tissue choice and can be 
successful in treating large cartilage defects [40]; however, it has been shown that fresh 
tissue has a better success rate than frozen tissue in terms of cell death and mechanical 
stability [41].  Additionally, immune rejection is still a potential problem when using 
allogenic tissues [42].  Osteochondral autologous grafts (OATS) are a better alternative 
to allogenic grafts, in terms of being fresh and non-immunogenic, but autologous graphs 
are limited in quantity and can cause donor site morbidity [43].  Lastly, matrix scaffolds 
of both synthetic and natural materials have been successfully used to develop functional 
tissue substitutes for the treatment of cartilage defects [44].   
The research findings of this dissertation could translate into clinical applications 
that offer a number of advantages over current cartilage repair strategies.  First, the use 
of a stem cell population eliminates the need for chondrocyte isolation and expansion, 
saving time and avoiding immune rejection problems. Adult stem cells are highly 
proliferative and are easily obtainable. The results discussed in this dissertation 
demonstrate the feasibility of differentiating a single stem cell population into specific 
chondrogenic phenotypes, which correlate to distinctive zones of articular cartilage.   
Secondly, the use of biomaterials enables researchers to fine-tune characteristics 
such as water absorption, nutrient diffusion, biodegradation, and mechanical stability.  
The various biomaterials discussed in this dissertation were shown to have different 
swelling capacities, degradation rates, and mechanical moduli, which can be modulated 
by changing the material composition and material concentration to match the properties 
of native articular cartilage.  
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 Finally, the layer-by-layer fabrication technique described in this dissertation 
provides the capability to treat both partial and full thickness cartilage defects.  The 
multi-layer hydrogel fabrication can be used to selectively engineer only the relevant 
zones of the damaged cartilage or to create layered osteochondral junctions.   For partial 
thickness injuries, the multi-layered fabrication technique can be used to create a 
construct consisting of only the layers that correspond to the thickness of the injury.  The 
MLHC can easily be implanted via an arthroscopic technique with fibrin glue, which is 
also used in both ACI and MACI. The fibrin glue can be applied to secure the construct 
within the defect area and eliminate the need to create a full thickness defect for 
construct integration.  For full thickness defects, the multi-layered construct can be 
fabricated to include a subchondral bone layer for easy integration.  Additionally, the 
cell-mediated degradability allows for matrix remodeling as well as chondrocyte ECM 
deposition. 
There are many advantages of using MLHC to clinically treat articular cartilage 
defects in humans, however, clinical trials are required to be conducted before hand to 
ensure that the MLHC are safe and to identify any side effects that may be associated 
with its use.  Clinical Trials are broken down into four phases. Clinical feasibility is 
Phase I assesses safety, determine proper dosage and identify any side effects [45].  
Phase II involves clinical research to verify effectiveness of treatment [45].  Clinical 
validation occurs in Phase III in which multiple clinical centers evaluate and attempt to 
reproduce the results of the initial studies.  Phase IV is for clinical acceptance in which 
the treatment is surveillance in the market to determine long term performance and 
possible adverse effects [45].  The time and cost that is required to conduct a clinical 
trial varies by the type of treatment or device.  In addition, the time requirement is also 
dependent on the number of patients available who meet the specific criteria and the 
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number of patients needed to achieve statistical significance accepted by the Food and 
Drug Administration (FDA) [45].  In general, clinical trials for orthopedic implants 
require a total of about 200 to 300 patients, which can take up to three years to acquire 
[45].  In addition, the FDA also requires a two-year follow-up period for orthopedic 
implants.  Therefore, it can take up to seven years and cost from $700,000 to $1 million 




















6.4 FIGURES  
 
Figure 6.1 Partial & Full Thickness Articular Cartilage Defect Illustration (A) 
Partial thickness articular cartilage defect and (B) Full thickness defect that 
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 APPENDIX A 
MSC Differentiation within Bi-Layer Hydrogels 
 
A.1 INTRODUCTION 
Many investigators have applied the concept of creating bi-layered matrix 
materials in cartilage regeneration [1-4].  Specifically, Bartlett et al. used  porcine type-
I/III collagen bi-layer seeded with chondrocytes in the matrix-induced autologous 
chondrocyte implantation (MACI) procedure to replace the need to harvest periosteal 
flaps [1, 2].  Additionally, both Sharma et al. and Ng et al. demonstrated that, when 
cultured in a bi-layer hydrogel, chondrocytes isolated from the superficial and deep zone 
improved chondrogenic properties over single layer controls [3, 4]. 
Even though the findings of Chapter Four demonstrate the feasibility of MSC 
differentiation into zonal chondrocytes, translating these findings by creating a multi-
layered construct with varying biomaterial composition may be difficult due to the 
complex nature of combining four different layers into one hydrogel construct.  As 
proof-of-concept for the simultaneous differentiation of MSCs, bi-layered hydrogels 
were created since there have been a number of reported successes with bi-layered 
constructs. The fabricated bi-layer consists of biomaterials established in Chapter Four, 
PEG:CS:MMP-pep representing the superficial layer and PEG:HA representing the deep 
layer.  
 




A.2.1 Bi-layered Hydrogel Fabrication  
The fabrication of the bi-layered hydrogel was performed from the bottom layer 
upward.  The specific biomaterial compositions and concentrations of each layer are 
listed in Table A.1.  First, 100 µL of PEG:HA-MSC mixture was polymerized under 
UV for 3 minutes to represent the deep zone. Then 100 µL of PEG:CS:MMP-pep-MSC 
mixture, representing the superficial zone, was added on top of the partially polymerized 
bottom layer and placed under UV for an additional 5 minutes to fully polymerize the 
entire hydrogel. This bi-layered scaffold was cultured in serum-free chondrogenic media 
containing 1% penicillin/streptomycin, 10nM Dexamethasone, 50 µg/mL ascorbic acid-
2-phosphate, 40 µg/mL L-proline, 5 mL ITS+1, and 10 ng/mL TGF-!1 for 2, 4, and 6 
weeks in a 12-well plate [5].   
 
A.2.2 Cell Viability 
Viability of encapsulated cells in the bi-layered hydrogel constructs was 
determined after 2, 4, and 6 weeks of culture.  At each time, the media were discarded 
and the constructs were washed with PBS (Gibco, Carlsbad, CA) twice for 5 minutes.  
The bi-layered hydrogels were thinly sliced transversely with a razor.  Cell viability was 
assessed based on previously published methods by Lee et al. [6]. Briefly, the Live/Dead 
Viability/Cytotoxicity Kit (Molecular Probes, Eugene, OR) that contains calcein AM 
(“live” dye) and ethidium homodimer-1 (“dead” dye) was used to assess the integrity of 
the cellular membrane.  Dye solution was made with 0.5 %L of calcein AM dye and 2 %L 
of ethidium homodimer-1 dye in 1 mL of DMEM.  A transverse slice of the construct 
was incubated in 500 %L of the “Live/Dead” dye solution for 30 minutes.  Fluorescence 
microscopy (Olympus, 4X) was performed using a fluorescein optical filter (485 ± 10 
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nm) for calcein AM and a rhodamine optical filter (530 ± 12.5 nm) for ethidium 
homodimer-1. 
 
A.2.3 RNA Isolation and RT-PCR  
Chondrogenesis was determined by the gene expression of collagen II, X, and I 
within these bi-layered hydrogel constructs at 2, 4, and 6 week time points.  The 
hydrogel constructs were removed from culture and the gene expressions of 
encapsulated cells were analyzed. The single-layered hydrogels were homogenized as 
detailed in Section 4.2.2.  The bi-layered hydrogels were first sliced with a razor to 
separate the layers. The individual layers were placed into individual 2mL 
microcentrifuge tubes and 200µL of TRIzol® was added to the tubes.  Each layer was 
then crushed using a homogenizer (Wheaton).  After complete homogenization, another 
800µL of TRIzol® was added to the tube. The RNA isolation of the homogenized 
scaffolds was performed following the manufacturer’s protocol, as detailed in Section 
4.2.2.  Genomic DNA was removed using Deoxyribonuclease I (Invitrogen, Carlsbad, 
CA). The first strand of cDNA was synthesized by reverse transcription (RT) using 
Superscript
TM 
III kit (Invitrogen, Carlsbad, CA), following the manufacturer’s 
instructions, as detailed in Section 4.2.2. Quantitative polymerase chain reaction (PCR) 
was performed using an ABI Prism® 7900 Real Time thermal cycler and HotStartTaq 
DNA Polymerase with SYBR green/ROX PCR master mix (SA Biosciences, Fredrick, 
MD).  Primers for the housekeeping gene (GAPDH), collagen type II, type X, and type I 




A.2.4 Histology and Immunohistochemistry  
Histology of these hydrogel matrices was performed to determine the 
chondrogenic differentiation within the bi-layered constructs and for verification of the 
quantitative real time data.  At 2, 4, and 6 week time points, hydrogels were removed 
from culture and fixed in 4% paraformaldehyde at 4°C for an overnight period. Fixed 
hydrogels were then dehydrated for paraffin embedding using 1-hr sequential steps in 
the following order: 80%, 95%, 95% ethanol in dH2O, 100% ethanol, 50/50 
ethanol/CitriSolv, 100% CitriSolv, 100% CitriSolv, 60°C molten paraffin, and 60°C 
molten paraffin for an overnight period. Paraffin-embedded hydrogels were sliced in 
transverse sections at 10%m using a rotary microtome. Sections were stained for 
differentiation.  
Double sequential immunohistochemistry was performed to stain for collagen II 
(green) and collagen X (red) using rabbit polyclonal primary antibodies (Abcam, 
Cambridge, MA) and Texas red (collagen II) or FITC (collagen X) conjugated 
secondary antibodies. Slides containing sectioned hydrogels were blocked for unspecific 
binding for 30 minutes at 37 °C using 3% (w/v) bovine serum albumin (BSA) in PBS 
(pH 7.4).  The slides were rinsed with 0.05% tween 20 in PBS solution three times.  
After washing, the slides were incubated with primary antibody for 30 minutes at 37 °C.  
The slides were rinsed again before the second incubation with the secondary antibody 
for 30 minutes at 37 °C.  These steps were repeated for collagen X on the same slides.  
The slides were imaged using a confocal fluorescence microscope (Leica SP2 AOBS, 




A.2.5 Biochemical Characterization 
Glycosaminoglycan (GAG) production within each layer of the bi-layered 
construct determined using the Dimethylmethylene blue (DMMB) assay.  Briefly, at 2, 
4, and 6 week time points, hydrogels were removed from culture. Wet weights (ww) and 
dry weights (dw) after 48 hours of lyophilization were obtained for each construct (n=3).   
The dry constructs were then digested in 1 mL of papinase (papain, 125 µg/mL; Sigma) 
at 60°C overnight. 200 µL of the DMMB solution was added to each well of the 96 well 
plates and then 50 µL of standard and samples were added. The plate was shaken for 10 
seconds before reading the absorbance at 525nm.  To account for the hydrogel material, 
absorbance of blank hydrogels was subtracted from the sample values. The DNA 
content was determined using Sigma’s DNA quantification kit (DNA-QF) in order to 
normalize the GAG production.  The assay was carried out following the manufacturer’s 
protocol for multiwall assay, as detailed in Section 4.2.5.   
 
A.2.6 Compression Studies of Bi-layered Hydrogels 
The compressive modulus of the individual layers and the interfaces between 
layers of the bi-layered hydrogel constructs were determined at room temperature on an 
In-spec 2200 Instron mechanical tester with a 125 N loading cell using a parallel plate 
apparatus and loading of 20% of the initial thickness per second (0.1 mm/sec).  The 
compressive modulus of the individual layers as well the interface between were 
determined by analyzing the linear region of the stress versus the strain curve of the 




A.2.7 Statistical Analysis 
All quantitative data were expressed as mean ± standard deviation and were verified 
by analysis of variance using student T-Test with equal variance. P values of less than 
0.05 were considered statistically significant. 
 
A.3  RESULTS 
 
A.3.1 Viability of Encapsulated MSCs 
Cytotoxicity was performed to test for the viability of the MSCs encapsulated 
within the bi-layered hydrogel constructs at 2, 4, and 6 weeks.  As shown in Figure A.1, 
the majority of the cells stained green, indicating that there are more live cells than dead 
cells. Dead cells are stained red at all time points.  At 2 weeks, there appeared to be 
more cells in the superficial than the deep layer.  At 4 weeks, the cell density appeared 
to be more evenly distributed within both layers with very few dead cells. At 6 weeks, 
the deep layer had the greatest amount of cells which appeared to form clusters 
perpendicular to the interface.   
 
A.3.2 Chondrogenic Differentiation of MSCs 
The purpose of this study was to provide proof-of-concept of the potential to 
simultaneously differentiate MSCs into chondrocytes of the superficial and deep zone.  
Gene expression of collagen type II, X, and I was used to verify chondrogenesis. The 
average fold difference as compared to undifferentiated cells encapsulated within PEG-
only hydrogels for collagen II, X, and I of each layer of the bi-layered constructs are 
shown in Figures A.2A, A.2B, and A.2C, respectively.  Although the results indicate 
that the collagen II expression is higher in the superficial zone and the collagen X 
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expression is higher in the deep zone at all time points, there were no significant 
differences between the two layers for gene expression.  The expression of collagen I 
was relatively low in both layers at all time points.  
 
A.3.3 Histological Analysis of Imaged Hydrogels 
To verify the quantitative gene expression results, immunohistochemical staining 
was performed to determine if the cells were producing collagen II and collagen X 
within the bi-layered constructs.  At all time points, the fluorescent images showed 
positive staining for both collagen II and X within both layers, as shown in Figure A.3.  
The collagen II staining is consistent with the mRNA data.  At 2 weeks the collagen II 
staining appeared more evenly dispersed within both layers.  However, at 4 weeks the 
collagen II staining appeared to decrease in both layers while the collagen X staining 
increased in deep layer.   At 6 weeks the spatial organization of collagen appeared to 
correspond to native articular cartilage [7].  In the superficial layer, the collagen II 
staining appeared to be aligned somewhat parallel to the top surface (articular surface).  
In the deep layer, collagen X levels were the highest at all time points, with larger 
collagen diameter and clusters, which were aligned perpendicular to the bottom surface 
(subchondral plate).  Again, immunohistochemical staining was not performed for type I 
collagen due to low mRNA expression. 
 
A.3.4 Protein Analysis for Total GAG Production  
The GAG/DNA ratio for each layer of the bi-layered hydrogels is shown in 
Figure A.4. GAG production increased with time in both layers of the bi-layered 
constructs, with cells in the deep layer exhibiting significantly higher GAG levels 
compared to the superficial layer at 6 weeks.   
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A.3.5 Compressive Strength of the Individual Layers 
Table A.2 lists the compressive moduli of the individual layers of the bi-layered 
hydrogel constructs, including the interface.  The compressive modulus of the deep layer 
was significantly higher than the modulus of the superficial layer at all time points. 
 
A.4  DISCUSSION 
Chapter Four demonstrated that biomaterial composition can direct MSC 
differentiation in specific chondrogenic phenotypes. It was determined that the 
PEG:CS:MMP-pep and PEG:HA composition differentiated chondrocytes with similar 
characteristics to the superficial and deep zone of articular cartilage, respectively.   Thus, 
as proof of concept, bi-layer hydrogels were created using these specific biomaterial 
combinations to differentiate MSCs into chondrocytes with varying phenotypes. 
The cytotoxicity test indicated that the majority of the cells survive the 
fabrication process and are proliferating.  At 6 weeks, the cells appeared to be aligned 
perpendicular to the interface, which indicated that they had remodeled the hydrogel 
network and structurally organized themselves in a similar orientation to that observed 
in the deep layer of native articular cartilage.  Expression of collagen II, X, and I was 
used to determine MSC chondrogenic differentiation.  The results demonstrated that 
there was higher collagen II expression in the superficial layer and higher collagen X 
expression in the deep layer at all time points.  However, statistical analysis revealed 
that there were no significant differences between the layers for both collagen II and X 
expression.  As mentioned in Chapters Four and Five, the expression of collagen I was 
used to determine fibrocartilage formation or de-differentiation of chondrocytes.  The 
relatively low expression of collagen I within both layers indicated that the MSCs did 
not differentiate into fibrocartilage nor did they de-differentiate. GAG production was 
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higher in the deep layer than the superficial layer at all time points, but a significant 
difference was only observed between both layers at 6 weeks.  Lastly, the mechanical 
strength of the deep layer was significantly greater than that of the superficial layer at all 
time points.   
Gene expression, biochemical analysis, and histochemical analysis showed 
spatially varying ECM composition and mechanical properties similar to the native 
articular cartilage tissue. The findings of this study provide proof of concept of the 
ability to direct a single stem cell population to different chondrogenic phenotypes 




A.5  FIGURES  
 
Table A.1 Biomaterial Composition of each Layer 
Zone Material PEG CS HA MMP-pep 
Superficial PEG:CS:MMP-pep 9% 9%  2% 





















Figure A.1 Bi-Layer Live/Dead Staining of razor sliced sections of the bi-layered 
hydrogels constructs at 2, 4, and 6 weeks (4X objective, Leica SP2 AOBS).  At all 





























Figure A.2 Bi-Layer Collagen II, X,  and I Gene Expression Average fold difference 
for gene expression of (A) Collagen II, (B) Collagen X, and (C) Collagen I of the bi-
layered constructs at 2, 4, and 6 weeks.  No significant differences are seen in all 
three gene expression between the superficial and the deep layer at all time points.  
Collagen I expression still remains relative low within the bi-layered hydrogel 





Figure A.3 Bi-Layer Immunohistochemical Staining of paraffin-embedded sections 
of bi-layered hydrogels constructs at 2, 4, and 6 weeks for collagen II (green) and X 
(red) (10X objective, Leica SP2 AOBS).  At all time points, the fluorescent images 






























Figure A.4 Bi-Layer GAG Concentrations.  The deep layer showed significantly 
















Table A.2 Compressive Moduli of Bi-Layer Hydrogels 
  















Superficial 120.38 ± 9.49 99.51 ± 13.5 445.42 ± 97.97 
Interface 127.20 ± 8.62 172.17 ± 28.16 409.99 ± 60.67 
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Supplementary Mechanical Studies for Future Work 
 
B.1  INTRODUCTION 
In Chapter Four, the modulus of pure HA hydrogels at 6 weeks could not be 
obtained due to their poor mechanical stability, which led them to the hydrogels collapse 
during culture before.  Additionally, Chapter Four results indicated that pure CS 
hydrogels were a good candidate to represent the calcified zone of articular cartilage. 
However, in Chapter Five, all attempts to utilize the pure CS formulation as the fourth 
layer of the multi-layered hydrogel construct (MLHC) failed because the structural 
integrity of the pure CS hydrogel prevented quantitative and qualitative analysis of 
chondrogenesis within this layer.  Therefore, the purpose of this study was to determine 
the 6 week compressive modulus of pure HA hydrogels and to determine the CS 
concentration that would provide the optimal compressive strength for future multi-layer 
studies. 
 
B.2  MATERIALS AND METHODS 
 
B.2.1 Compression Studies of Bi-Layered Hydrogels 
The compressive modulus of the cell-laden swollen hydrogels were determined 
at room temperature on an In-spec 2200 Instron mechanical tester with a 125 N loading 
cell using a parallel plate apparatus and loading 20% of the initial thickness per second 
(0.1 mm/sec).  The pre-sterilized cell-polymer solution was polymerized in a square 
mold (2 mm x 7 mm x 7 mm) for 10 minutes using a long-wave ultraviolet lamp (Model 
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B100AP, Blak-Ray) at the intensity of ~10 mW/cm2.  The polymerized hydrogel 
constructs were then used for mechanical testing and were compressed to the maximum 
thickness of 2 mm.  The compressive modulus of cell-laden hydrogels were determined 
by analyzing the linear region of the stress versus the strain curve of the samples at low 
deformations (<20% strain).  
 
B.2.2 Hydrogel Culture 
The hydrogels cell-laden hydrogels were cultured in serum-free chondrogenic 
media containing 1% penicillin/streptomycin, 10nM dexamethasone, 50 µg/mL ascorbic 
acid-2-phosphate, 40 µg/mL L-proline, 5 mL ITS+1, and 10 ng/mL TGF-!1 for 2, 4, and 
6 weeks in a 12-well plate.  The media were changed every other day.  Extreme care was 
taken during media changes in order to prevent hydrogel collapse.  The hydrogels were 
handled as minimally as possible and the medial was carefully aspirated from the well 
plates.  
 
B.2.3 Statistical Analysis 
All quantitative data were expressed as mean ± standard error and were verified by 
analysis of variance using student T-Test with equal variance. P values of less than 0.05 
were considered statistically significant. 
 
B.3  RESULTS 
 
B.3.1 Compressive Strength of CS and HA Hydrogels 
Table B.1 lists the compressive modulus of the first CS studying with high 
concentrations.  Table B.2 lists the compressive modulus of the second CS study with 
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lower CS concentrations.  Table B.3 lists the compressive modulus of CS, HA, and 
PEG:HA from previous studies conducted in Chapter Four and the modulus of the CS 
and HA hydrogels determined in this study.  
 
B.4   DISCUSSION 
Two studies were conducted to find the optimal CS concentration with the most 
appropriate compressive modulus for future multi-layer studies.  First, higher 
concentrations of CS were used due to the low mechanical strength of the 20% (w/v) 
concentration.  During this study the polymer solutions for the 75% (w/v) and the 100% 
(w/v) were too viscous to accurately pipet the correct volume.  Therefore, the thick 
polymer solutions were scooped out of the microcentrifuge tube into the mold for 
polymerization.  The modulus for all concentrations above 20% (w/v) was extremely 
high.  Therefore, a second study was done with lower CS concentrations.  The results of 
the second study indicated that the 30% (w/v) CS concentration had a blank modulus of 
511. 97 kPa, which is the most appropriate modulus, being reasonably higher than the 
blank modulus of PEG:HA formulation in Chapter Four.   
The 30% (w/v) CS concentration was used to determine the modulus of the cell-
laden hydrogels at 2, 4, and 6 weeks.  The modulus of 1% HA (w/v) was also 
determined in the same study.  By taking extreme care during HA hydrogel culture, the 
modulus was obtained at all time points.  The results indicate that the modulus 1% (w/v) 
HA is higher than 20% (w/v) CS hydrogels from the previous study at all time points.  
Additionally, 1% (w/v) HA hydrogels showed an increase in compressive strength with 
time, which is most likely due to the GAG production.  Furthermore, the modulus of 
30% (w/v) CS hydrogels also increased with time and was consistently higher than the 
PEG:HA formulation at all time points.  These results indicate that 30% (w/v) CS has 
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B.5  FIGURES  
 
Table B.1 Compressive Moduli of High % (w/v) Blank CS Hydrogels 
 05/06/10 Without Cells 
Hydrogel 
Concentration Modulus (kPa) Standard Error 
20% (w/v) CS 131.15 ± 7.70 
50% (w/v) CS 713.29 ± 53.59 
75% (w/v) CS 1171.90 ± 80.64 















Table B.2 Compressive Moduli of Low % (w/v) Blank CS Hydrogels 
 05/18/10 Without Cells 
Hydrogel 
Concentration Moduli (kPa) Standard Error 
20% (w/v) CS 240.12 ± 66.54 
25% (w/v) CS 312.06 ± 29.9 
30% (w/v) CS 511.97 ± 41.26 
35% (w/v) CS 669.82 ± 61.02 
40% (w/v) CS 727.00 ± 23.6 
45% (w/v) CS 813.39 ± 19.17 













Table B.3 Compressive Moduli of Cell-Laden CS and HA Hydrogels 
    2 Weeks 4 Weeks 6 Weeks 













1 % (w/v) 
HA 41.66 ± 14.12 11.60 ±  4.68     
20 % (w/v) 




20 % (w/v) 
PEG:HA 271.57 ± 64.21 435.07 ±  59.52 1227.9 ± 102.14 
1 % (w/v) 
HA 38.54 ± 3.82 45.95 ±  3.89 81.465 ± 11.31 Current 
Study 
6/14/10 30 % (w/v) 















List of Abbreviations 
 
 
ACI Autologous chondrocyte implantation 
ADSC Adipose-derived stem cell 
ASC Adipose stem cell 
ATCC American type culture collection 
bFGF basic Fibroblast growth factor 
BMSC Bone marrow stromal cell 
BSA Bovine serum albumin 
COMP Cartilage oligomeric matrix protein 
CS Chondroitin Sulfate 
DCM Dichloromethane 
DMEM Dulbecco's modified eagle medium 
DMMB Dimethylmethylene blue 
DNA Deoxyribonucleic acid 
DS Dermatan sulfate 
EB Embryoid body 
ECM Extracellular matrix 
EDTA Ethylene diamine tetra acetic acid 
EGF Epidermal growth factor 
ES Embryonic stem cell 
EWC Equilibrium water content 
FBS Fetal bovine serum 
FDA Food and Drug Administration 
FITC Fluorescein isothiocyanate 
GAG Glycosaminoglycan 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
GM Glycidyl methacrylate 
GMHA Glycidyl methacrylate hyaluronic acid 
HA Hyaluronic Acid 
hMSC Human mesenchymal stem cell 
HPLC High performance liquid chromatography 
kPa Kilo Pascals 
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KS Keratin sulfate 
LC Liquid chromatography 
MAA Methacrylic acid 
MACI Matrix-induced autologous chondrocyte implantation 
MALDI-TOF Matrix assisted laser de-ionization time of flight 
MLHC Multi-layered hydrogel construct 
MMP Matrix metalloproteinase 
MMP-pep Matrix metalloproteinase sensitive peptide 
MS Mass spectrometry 
MSC Mesenchymal stem cell 
NMP N-methylpyrrolidone 
NMR Nuclear magnetic resonance 
OA Osteoarthritis 
OATS Osteochondral autograft transfer system 
p(NIPAAm-co-AAc) N-isopropylacrylamide-acrylic acid copolymer 
PBS Phosphate buffered saline 
PCL Poly(#-caprolactone) 
PCR Polymerase chain reaction 
PEG Poly(ethylene glycol) 
PEG:CS PEG:Chondroitin Sulfate 
PEG:CS:MMP-pep PEG:Chondroitin Sulfate:MMP-sensitive peptide 
PEG:HA PEG:Hyaluronic Acid 
PEG:HA:MMP-pep PEG:Hyaluronic Acid:MMP-sensitive peptide 
PEGDA Poly(ethylene glycol) Diacrylate 
PEGDMA Poly(ethylene glycol) Dimethacrylate 
PG Proteoglycan 
PGA Polyglycolic acid 
Phos-PEG Phosphoester-poly(ethylene glycol) 
PLA Processed lipoaspirate 
PLEOF Poly(lactide ethylene oxide fumarate) 
PLGA Poly(lactic-co-glycolic acid) 
PRG4 Proteoglycan 4 or lubricin 
qPCR Quantitative polymerase chain reaction 
QPQGLAK Gln-Pro-Gln-Gly-Leu-Ala-Lys (MMP-sensitive peptide) 
RA Rheumatoid arthritis 
RGD Arginine-glycine-aspartate peptide 
RT  Reverse transcription 
SA Super Array 
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SDS Sodium dodecyl Sulfate 
SDSC Synovial-derived stem cell 
SEM Scanning electron microscope 
SFB Synovial fibroblasts 
sIPN Semi-interpenetrating polymer network 
SLC Single layer control 
TBE Tris borate EDTA 
TES Tris-EDTA 
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